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Abstract 
 
Copper metallochaperones help prevent mis-metallation of proteins and ensure copper 
incorporation in specific Cu(I)-binding proteins by ligand-exchange reactions.  The 
human copper metallochaperone (hCCS) for superoxide dismutase-1 (hSOD1) can 
interact via domain 1 with the carboxyl-terminal domain (CTD) of human β-secretase-1 
(hBACE1).  hBACE1 initiates the production of amyloid-β peptide (Aβ), the major 
constituent of senile plaques in Alzheimer’s disease (AD).  One of the aims of this thesis 
was to identify the residues involved in mediating the interaction between hCCS and 
hBACE1 CTD and to investigate the role of copper in mediating this interaction using a 
yeast two-hybrid system.   
The data show that the Cys residues in the CXXC motifs of hCCS and 
hBACE1 CTD are essential for this interaction.  The interaction is optimised by residues 
located close to the Cu(I)-binding sites.  The hCCS/hBACE1 CTD interaction decreases 
in copper-deficient conditions.  hBACE1 CTD was also shown to interact with the 
copper metallochaperone HAH1 involving the Cys residues in the CXXC motif of 
hBACE1 CTD.  A model has been proposed based on the physiological implications of 
these data with respect to AD pathology.  The interaction of hCCS with hSOD1 was 
also investigated using the yeast two-hybrid system.  The mutation of the Cu(I)-binding 
residues in hCCS do not have a significant effect on the hSOD1/hCCS interaction.  
Interestingly, the hSOD1/hCCS interaction increases in copper-deficient conditions 
which can also have implications for AD pathology, as discussed in the proposed 
model. 
The yeast two-hybrid system was also used to study the interaction of 
the copper metallochaperone Atx1 from Synechocystis PCC 6803 (ScAtx1) with the 
metal-binding domains (MBDs) of the Cu(I)-transporting ATPases, CtaA (CtaAN) and 
PacS (PacSN).  The data show that the residues on loop 5 of the ferredoxin-like fold of 
ScAtx1 (His61), CtaAN (Phe87) and PacSN (Tyr65) are important for mediating protein-
protein interactions.  Swapping the loop 5 residue disrupted complex formation of 
ScAtx1 with CtaAN and PacSN.  The mutation of ScAtx1 His61 to a charged residue or 
to a neutral Ala also weakens the interactions with the MBDs, demonstrating that His61 
is the best choice of amino acid in this position to enable ScAtx1 to interact optimally 
with both of its target proteins.  The possibility that ScAtx1 may form two structurally 
different complexes (side-to-side or head-to-head) with CtaAN and PacSN was also 
investigated.  The data indicate that both CtaAN and PacSN can likely form a side-to-
side complex although the possibility that they can also form a head-to-head complex 
can not be excluded.   
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1. Introduction 
1.1 Metals in Biology 
Metals are an essential cellular requirement for all three kingdoms of life – eukarya, 
bacteria and archaea (Woese and Fox, 1977), although the type of metal and the 
quantity required vary from organism to organism based upon their habitat and lifestyle.  
Iron and copper in particular, play a predominant role in facilitating enzyme catalysis in 
living organisms.  Until about 3 billion years ago ferric iron (Fe(III)) was the predominant 
redox-active ion utilised by living organisms.  However, the oxygenation of the Earth’s 
atmosphere rendered Fe(III) insoluble and the cupric ion (Cu(II)) soluble, thereby 
promoting the use of copper as one of the major redox-active protein co-factors 
(Frausto da Silva and Williams, 2001).  Therefore, metal availability is dependent upon 
its solubility in water in the presence of oxygen.  Metals are a vital metabolic 
requirement for all living organisms and their deficiency can be a major hindrance to 
cellular processes, as discussed below.  The transport, concentration and localisation of 
the metal ions within the cell have to be tightly regulated because in excessive amounts 
these metals can be cytotoxic resulting in severe repercussions including cell death.  All 
living cells have therefore developed mechanisms to maintain optimum metal 
homeostasis.  Eukaryotes in particular, require additional homeostatic mechanisms to 
ensure the correct localisation of the required metals in the appropriate cellular 
organelle (see section 1.3).  However, there are some common chemical and biological 
factors which contribute towards metal selectivity in all organisms. 
 
1.1.1 Factors determining Metal Selectivity 
While the natural habitat of an organism plays an important role in determining the 
variety of metals available to a cell, other chemical and biological factors determine the 
association of a metal ion with a specific coordination site.  The first challenge posed by 
the cell to metal uptake is the cell membrane itself.  The cell membrane not only acts as 
a physical barrier but the presence of membrane-associated transport proteins further 
regulates metal influx, albeit import proteins are not known for all types of metals 
(Frausto da Silva and Williams, 2001).  Once inside the cell, the metal ions can 
associate with an assortment of proteins which can themselves regulate metal ion 
localisation and concentration at the level of uptake, intracellular transport and efflux.  
For example, the binding of copper and iron to specific transcription factors determines 
their uptake in the appropriate cellular compartment by controlling the transcription of 
copper or iron importers (De Freitas et al., 2003; Frausto da Silva and Williams, 2001; 
Waldron et al., 2009).  In turn, the binding of metals to proteins is dependent upon a 
combination of chemical factors which can be broadly divided into thermodynamic and 
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kinetic considerations.  The thermodynamic components include metal selectivity on the 
basis of size, oxidation state, preferred coordination geometry, and the shape of the 
coordination site (Frausto da Silva and Williams, 2001; Waldron et al., 2009).  The latter 
three factors in particular are very important from a biological perspective.  For 
example, in the case of superoxide dismutase-1 (SOD1), coordination geometry is one 
of the factors that dictates the binding of copper and zinc to their respective sites.  
While Zn(II) is bound tetrahedrally, Cu(II) is coordinated in a tetragonal arrangement 
(Tainer et al., 1982), discussed further in section 1.3.2.3.  Metal ions are also restricted 
by their preference for the type of amino acid residues they bind to, as in the case of 
Cu(I) and Cu(II).  While Cu(I) prefers to bind to sulfur donor ligands (Cys or Met), Cu(II) 
preferentially binds to nitrogen (His) or oxygen donors (Asp and Glu) (Frausto da Silva 
and Williams, 2001).   
However, thermodynamic constraints alone are not sufficient to prevent 
mis-metallation of proteins, as exemplified by the Irving-Williams series (Mg(II), Ca(II) < 
Mn(II) < Fe(II) < Co(II) < Ni(II) < Cu(II) > Zn(II)).  According to this series or the ‘natural 
order of stability’ Cu(II) forms the most stable complexes with ligands compared to other 
divalent cations (Frausto da Silva and Williams, 2001; Irving and Williams, 1948).  The 
acquisition of the required metal ions by the cyanobacterial proteins MncA and CucA 
exemplifies some of the mechanisms that the cell has evolved in order to overcome the 
problem of mis-metallation.  MncA and CucA were found to be the predominant 
manganese- and copper-binding proteins in vivo (Tottey et al., 2008).  However, both 
MncA and CucA readily and preferentially bind Cu(II) in vitro in comparison to 
manganese, as expected, based on the the Irving-Williams series.  Tottey et al. (2008) 
demonstrated that the cell ensured correct metallisation of these proteins by 
compartmentalising MncA in the cytosol to acquire Mn(II) and CucA in the periplasm to 
acquire Cu(II) during protein folding.  Once the proteins have acquired the appropriate 
metal ions, protein folding ensures that the bound-metal ions are buried and therefore 
protected from substitution by other metals (Tottey et al., 2008).  Cells also prevent mis-
metallation by ensuring that there are essentially no ‘free’ metal ions in vivo.  In fact, it 
has been estimated that there is less than one ‘free’ atom of copper per cell (Rae et al., 
1999).  Proteins such as metallothionein (see section 1.3.2.1) which have a very high 
affinity for metals, are a major contributor in maintaining low free metal ion 
concentration in vivo.  Since metalloproteins have variable metal-binding affinities, a 
further challenge is to ensure that all proteins acquire the required metal co-factor.  
Protein-protein interactions assist in overcoming some of these restraints, for example, 
metallochaperones (see sections 1.2.2 and 1.3.2.4) interact very specifically with their 
target proteins and ensure the transfer of metal to the appropriate binding site.  The role 
of protein-protein interactions in the context of copper-homeostasis is discussed further 
in section 1.4, and is the main focus of this study.   
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1.1.2 The Biochemistry of Copper 
Copper is one of the most important trace elements for all living cells.  Copper-binding 
proteins are found in most living organisms and account for up to 1 % of the total 
cellular proteome (Andreini et al., 2008).  Copper is required as an essential co-factor in 
plastocyanin for transferring electrons between proteins involved in photosynthesis 
(Redinbo et al., 1994), and in cytochrome c oxidase for the reduction of dioxygen to 
water in aerobic respiration, two of the most fundamental processes in living organisms 
(Bento et al., 2006).  Copper is also a vital co-factor for haemocyanin which mediates 
oxygen transport in some crustaceans, multicopper oxidases which catalyse the 
reduction of dioxygen to two molecules of water (Bento et al., 2006; Crichton and 
Pierre, 2001) and several other proteins, some of which are listed in Table 1.  The main 
chemical property of copper that makes it such an attractive protein co-factor is its 
ability to exist in two different biologically-relevant oxidation states – Cu(I) and Cu(II), 
which allows it to bind to a variety of ligands (Crichton and Pierre, 2001), as discussed 
in section 1.1.1.  Due to the reducing environment of the cytoplasm (Ostergaard et al., 
2004), copper predominantly exists as Cu(I) in the eukaryotic cytosol.  Most of the 
known cytosolic copper-binding proteins bind Cu(I) while copper-binding proteins that 
are compartmentalised into different organelles within the cytoplasm can alternate 
between the Cu(I) and Cu(II) states (Banci et al., 2010c; Bertini et al., 2010).  In the 
bacterial periplasm Cu(II) can co-exist with Cu(I) since the periplasm appears to have a 
comparatively higher redox potential than the eukaryotic cytoplasm (Messens et al., 
2007).   
In addition to their preference for different amino acids, Cu(I) and Cu(II) 
also differ in their preferred coordination number.  While Cu(I) can be bound in a 2, 3 or 
4 coordinate state, Cu(II) prefers a coordination number of 4, although it can also be 
bound by 5 or 6 coordinating ligands (Davis and O'Halloran, 2008; Frausto da Silva and 
Williams, 2001).  Copper can readily oscillate between the Cu(I) and Cu(II) states and 
this redox-active property of copper is exploited by the proteins involved in 
photosynthesis and respiration (Crichton and Pierre, 2001; Frausto da Silva and 
Williams, 2001).  However, the redox-active feature of copper can also result in 
cytotoxicity.  Cu(I) can react with hydrogen peroxide and undergo Fenton-like reactions 
leading to the production of  superoxide (O2
-●) and hydroxyl radicals (OH●) which can 
cause oxidative damage to nucleic acids, lipids and proteins (Equations 1-3) (Molina-
Holgado et al., 2007).   
 
Cu(I)   +   H2O2    →    Cu(II)  +   OH
-  + OH●   [1]  
Cu(II)  +   O2
-●      →     Cu(I)  +   O2      [2] 
 O2
-●    +   H2O2    →      O2     +   OH
-  + OH●   [3] 
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Table 1: Some of the known copper-binding proteins in Humans and their 
Functions. 
 
Protein Function 
Ceruloplasmin Ferroxidase that transports iron to 
transferrin (see section 1.3.2.2) 
Copper-transporting ATPases (ATP7A 
and ATP7B) 
Transport copper across cellular or 
organelle membranes (see sections 
1.3.3) 
Copper metallochaperones (e.g. hCCS, 
HAH1) 
Transport copper to their specific copper-
requiring target proteins (see sections 
1.3.2.4) 
Copper transport protein-1 (hCTR1) Copper uptake in eukaryotic cells (see 
section 1.3.1) 
Cytochrome c oxidase Catalyzes the conversion of molecular 
oxygen to water as a component of the 
respiratory electron transport chain in the 
mitochondria coupled to proton pumping 
Divalent metal transporter-1 (DMT1) Uptake of divalent metals in eukaryotic 
cells (see section 1.3.1) 
Dopamine β-hyroxylase Neurotransmitter synthesis, catalyses the 
conversion of dopamine to 
norepinephrine 
Hephaestin Transmembrane ferroxidase involved in 
iron transport from enterocytes (see 
section 1.3.2.2) 
Human inhibitor of apoptosis  Inhibitor of apoptosis (Mufti et al., 2006) 
Metallothioneins Multi-metal binding Cys-rich proteins 
involved in the storage of metal ions (see 
section 1.3.2.1) 
Superoxide dismutase-1 (hSOD1) Anti-oxidant enzyme that catalyzes the 
dismutation of superoxide into hydrogen 
peroxide and water (see section 1.3.2.3) 
Tyrosinase Catalyses oxidation of phenols, melanin 
synthesis 
 
1.1.3 The Biochemistry of Iron 
Similar to copper, iron is also utilised for its redox-active properties in photosynthesis 
and respiration.  Iron can exist in three biologically relevant oxidation states – Fe(II), 
Fe(III) and Fe(IV) (Frausto da Silva and Williams, 2001).  Iron is an extensively used co-
factor for proteins involved in a wide variety of functions, and as a result the cellular 
requirement for iron is very high.  It is estimated that an adult male contains contains ~ 
3.5 grams of iron (Munoz et al., 2009).  Iron can be present in the cell as a heme-
constituent in proteins involved in mediating redox reactions such as cytochromes and 
in oxygen transporting proteins like haemoglobin and myoglobin.  Iron can also be 
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bound as a co-factor in proteins containing iron-sulphur (Fe-S) clusters such as the 
proteins involved in electron-transfer reactions, like the ferredoxins, proteins involved in 
DNA replication and transcription (Frausto da Silva and Williams, 2001; Ye and 
Rouault, 2010).  The biological importance of iron is further highlighted by the fact that it 
is the most prevalent dietary deficiency amongst human beings, especially in the 
developed countries (Waldron et al., 2009).   
Similar to copper, iron can also undergo Fenton-chemistry and lead to 
oxidative stress (Molina-Holgado et al., 2007).  Apart from the similarities in their 
chemical nature, copper and iron are also closely-linked biologically (De Freitas et al., 
2003; Gambling et al., 2008).  Iron homeostasis is known to be strongly influenced by 
copper homeostasis and vice versa.  In humans, Cu(II) and Fe(II) share a common 
importer – the divalent metal transporter-1 (DMT1) (see section 1.3.1), while the 
ferroxidase ceruloplasmin is the major copper-binding protein within the blood serum 
(see section 1.3.2.2).  In the baker’s yeast Saccharomyces cerevisiae (S. cerevisiae), 
copper is transported from the cytosol to the copper-transporting ATPase Ccc2 (see 
section 1.3.3.1) (Huffman and O'Halloran, 2000; Pufahl et al., 1997) which subsequently 
transfers it to Fet3 – the yeast homologue of ceruloplasmin (Yuan et al., 1995), to 
mediate the high affinity uptake of iron in the cells via association with the iron-
transporter Ftr1 (Stearman et al., 1996).   
 
1.1.4 The Biochemistry of Zinc 
Unlike copper and iron, zinc has a single oxidation state – Zn(II), and is therefore redox-
inactive.  Despite its lack of redox-activity, zinc is a widely used structural co-factor in 
more than 3000 proteins encoded by upto 10 % of the human genome (Maret and Li, 
2009; Takeda and Tamano, 2009).  Zinc poses a particular risk to copper-binding 
proteins due to the similarities in their chemical properties and because zinc is also 
more bioavailable than copper.  Zinc and copper are similar in size and charge density, 
and in addition, share some common ligands including Cys and His (Frausto da Silva 
and Williams, 2001).  Zinc-binding proteins are involved in cell division, cell 
differentiation, neurotransmission and brain function (Maret and Li, 2009; Takeda and 
Tamano, 2009).  The disruption of zinc homeostasis is implicated in several 
neurological disorders, as discussed below. 
 
1.1.5 The Role of Metals in Neurodegenerative Diseases 
As mentioned above, the redox-active metals copper and iron can result in the 
production of reactive oxygen species (ROS) and as a consequence can lead to 
oxidative stress.  Oxidative stress is defined as the imbalance between the production 
of ROS and the inability of the cellular defence mechanisms in clearing these (Molina-
Holgado et al., 2007).  The brain, in particular, is very susceptible to oxidative stress 
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due to its high consumption of oxygen and the presence of relatively high 
concentrations of redox-active metal ions which are an integral part of synaptic 
transmission (Molina-Holgado et al., 2007).  The healthy human brain possesses 
remarkably efficient metal homeostatic mechanisms to maintain a delicate balance 
between metal utility and metal toxicity, despite containing relatively low levels of anti-
oxidant agents.  However, with increasing age the brain’s defence mechanisms start to 
deteriorate and the brain becomes increasingly susceptible to oxidative stress (Molina-
Holgado et al., 2007).  Hence, it is not surprising that with the increase in life 
expectancy the number of people suffering from neurodegenerative diseases is also 
rapidly accelerating.   
Two features that many neurodegenerative diseases including Alzheimer’s 
disease (AD), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS), and Prion 
diseases have in common are protein aggregation in the affected neural tissue and 
oxidative damage.  Both of these factors are associated with the interaction between 
metal ions and the amyloidogenic proteins involved in these diseases (Bush, 2000; 
Molina-Holgado et al., 2007).  Although several metals including manganese, 
aluminium, mercury and lead have been implicated, the most common metals 
associated with neurodegenerative diseases are copper, iron and zinc (Bush, 2000; 
Molina-Holgado et al., 2007).  In AD, copper is found in increased quantities in senile 
plaques, one of the main pathological hallmarks of AD.  copper has also been shown to 
contribute to the aggregation of the amyloid-β peptide (Aβ), the main constituent of 
these plaques.  Aβ has also been shown to be precipitated by zinc and iron (Bush, 
2003; Maynard et al., 2005; Molina-Holgado et al., 2007).  The implications of altered 
copper homeostasis in AD are discussed in further in section 1.5.  PD, the second most 
common neurodegenerative disease after AD, is characterised by the presence of Lewy 
bodies and protofibrils composed of aggregated α-synuclein protein (Bisaglia et al., 
2009).  Copper has been reported to be the main metal involved in mediating α-
synuclein aggregation followed by iron and zinc (Bisaglia et al., 2009; Uversky et al., 
2001a; Uversky et al., 2001b).  The prion protein has been shown to be able to bind 
multiple copper ions which can result in conformational changes facilitating its 
aggregation (Brown, 2009; Molina-Holgado et al., 2007).  Although the cascade of 
events leading up to metal-associated protein aggregation and a causal link between 
metallotoxicity and neurodegeneration needs to be deciphered further, there is 
nevertheless substantial evidence to indicate that the association of metals with the 
amyloidogenic proteins is an integral part of neuronal pathogenesis (Brown, 2009; 
Bush, 2000; Molina-Holgado et al., 2007).   
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1.2 Regulation of Copper in Prokaryotes 
Copper proteins have been identified in both bacteria and archaea and comprise on 
average 0.3 % - 0.4 % of the proteome, respectively (Andreini et al., 2008).  Amongst 
all of the organisms studied by Andreini et al. (2008), Nanoarchaeum equitans 
(archaeon), Chlamydia trachomatis (bacterium), Onion yellows phytoplasma 
(bacterium), Mesoplasma florum (bacterium) and Borrelia burgdorferi (bacterium) were 
the only organisms in which a copper protein was not identified.  Unlike eukaryotes, 
there is no cytosolic requirement for copper in prokaryotes apart from two exceptions – 
cyanobacteria and methanotrophic bacteria (Banci et al., 2010c).  In gram-negative 
bacteria copper-dependent proteins are typically localised in the periplasm or are 
attached to the plasma membrane (Tottey et al., 2005).  In gram-positive bacteria 
copper-dependent proteins are known to be bound to the plasma membrane which 
either protrude into the extracellular space or are secreted (Banci et al., 2010c).  In 
contrast, cyanobacteria require copper to be translocated to the membrane-bound 
thylakoid compartment for insertion into the photosynthetic proteins plastocyanin and 
cytochrome c oxidase (Kerfeld and Krogmann, 1998).  Similarly, in methanotrophic 
bacteria copper is an essential cofactor for the internal membrane-bound particulate 
methane monooxygenase enzyme (Balasubramanian and Rosenzweig, 2007).  In order 
to maintain tight copper homeostasis, the presence of intracellular copper is regulated 
at multiple levels including import, export and intracellular transport, as discussed 
below. 
 
1.2.1 Import of Copper in Prokaryotes 
The presence of copper inside prokaryotic cells is an enigma considering the fact that 
apart from a few exceptions, no copper import pathway has been elucidated in most 
bacterial and archaeal species.  There is some evidence to suggest that copper import 
in gram-negative bacteria may proceed via non-specific metal ion diffusion through the 
outer membrane embedded proteins called porins (Nies, 2007; Nikaido and Vaara, 
1985) or through methanobactins in methanotrophic bacteria (Balasubramanian and 
Rosenzweig, 2008; Kim et al., 2004).  However, conclusive evidence of a copper import 
pathway in most prokaryotes remains largely unavailable (Banci et al., 2010c; Magnani 
and Solioz, 2007).  The copper-transporting ATPases - CtaA from cyanobacteria and 
CopA from the gram-positive bacterium Enterococcus hirae (E. hirae) have also been 
implicated in mediating copper import into the cytosol; however, doubts have been 
raised regarding the direction of copper transport via these transporters, as discussed 
below. 
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1.2.1.1 Prokaryotic copper-transporting ATPases 
Copper-ATPases are a part of the P1B-type or CPx-type ATPases which transport heavy 
metal ions across membranes by coupling it with the catalytic phosphorylation of the 
Asp residue in the conserved DKTGT sequence (Lutsenko et al., 2007b).  Copper-
ATPases are found in all three kingdoms of life and contain some common features 
including eight transmembrane domains, cytosolic N-terminal domains which contain 1-
6 soluble metal-binding domains (MBDs), an actuator domain, a phosphorylation 
domain, a nucleotide-binding domain and a conserved CPX amino acid sequence 
(where X represents any amino acid) in the sixth transmembrane domain which 
determines the metal-binding specificity of the ATPase, as shown in Figure 1 (Arguello 
et al., 2007).  The number of MBDs varies amongst prokaryotes and eukaryotes.  While 
prokaryotes tend to have one or two MBDs, some eukaryotic species including Homo 
sapiens (H. sapiens) contain upto six MBDs (Arguello et al., 2007).  Of particular 
interest to this study is the interaction between copper metallochaperones and the 
MBDs of the copper-ATPases.  MBDs and copper metallochaperones are structurally 
very similar to each other as they typically possess a ferredoxin-like fold (βαββαβ) and a 
CXXC metal-binding motif located on loop 1 and the first α-helix (Boal and Rosenzweig, 
2009a). While numerous studies have reported the interaction of copper 
metallochaperones with the cognate MBDs, the precise role of MBDs remains unclear. 
 
1.2.1.1.1 The E. hirae copper-transporting ATPase CopA 
E. hirae demonstrates one of the best understood prokaryotic copper homeostatic 
systems.  The E. hirae copper homeostasis system comprises two copper-transporting 
ATPases – CopA (EhCopA) and CopB (EhCopB), a copper metallochaperone CopZ 
and a copper metallosensor CopY, which together form the cop operon.  The copA 
gene from E. hirae was one of the first copper-transporting ATPases encoding gene to 
be identified (Odermatt et al., 1992; Odermatt et al., 1993).  Cells lacking copA were 
reported to be phenotypically similar to the wild-type (WT) cells in terms of copper 
resistance under copper-replete conditions but their growth ceased in copper-deficient 
conditions after two to three generations (Odermatt et al., 1993).  E. hirae copA∆ 
mutants were also found to be significantly more sensitive to silver ions suggesting that 
EhCopA may function as a silver importer (Odermatt et al., 1993; Odermatt et al., 
1994).  Due to the chemical similarities between Ag(I) and Cu(I), any protein capable of 
transporting Ag(I) cations is a strong candidate for transporting Cu(I) cations too.  Thus, 
the combination of data from growth studies under different copper conditions and the 
studies with Ag(I) led to the suggestion that EhCopA may be involved in copper uptake.  
However, doubts have been raised recently regarding the direction of copper transport 
by EhCopA (Ma et al., 2009; Robinson and Winge, 2010).   
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Figure 1: Generic structure of P1B-type copper-ATPases.  The soluble MBD containing 
the CXXC metal-binding motif is shown at the N-terminus, albeit the number of MBDs can vary, 
as discussed in section 1.2.1.1.  The transmembrane domains are shown as black ovals 
connected by loops.  The conserved CPX motif in the sixth transmembrane domain is also 
shown.  The presence of the actuator (A), phosphorylation (P) and the nucleotide binding (N) 
domains are represented by yellow, green and blue circles respectively. 
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EhCopA possesses a single N-terminal MBD (Figure 2) which has been shown to 
interact with the E. hirae CopZ (EhCopZ) protein (Multhaup et al., 2001).  Surface 
plasmon resonance (SPR) experiments demonstrated that the presence of Cu(I) 
enhanced the interaction between EhCopZ and the MBD of EhCopA, and that the Cu(I)-
induced enhancement was dependent upon the presence of the Cys residues in the 
M15XCXXC20 motif of EhCopA MBD (Multhaup et al., 2001).   
1.2.1.1.2 The cyanobacterial copper-transporting ATPase CtaA 
Cyanobacteria are prokaryotic photosynthetic organisms and the evolution of an 
oxygen-rich atmosphere has mainly been attributed to their photosynthetic capabilities 
(Farquhar et al., 2000; Kasting and Siefert, 2002).  Two copper-transporting P1B-type 
ATPases have been discovered in cyanobacteria – CtaA and PacS (Kanamaru et al., 
1993; Phung et al., 1994; Tottey et al., 2001).  CtaA was first identified in 
Synechococcus PCC 7942 (Phung et al., 1994).  CtaA was hypothesised to be involved 
in mediating copper-uptake based on its sequence homology with EhCopA and from 
ctaA∆ strains which were found to be more resistant to copper than WT cells (Phung et 
al., 1994).  Of particular interest to this study is the homologue of this protein identified 
from Synechocystis PCC 6803 by Tottey et al. (2001).  The subsequent mention of 
CtaA in this study will refer to the copper-transporter from Synechocystis PCC 6803, 
unless stated otherwise.  In contrast to the CtaA homologue from Synechococcus PCC 
7942, the deletion of the gene encoding CtaA in Synechocystis PCC 6803 did not 
protect against copper toxicity albeit these mutants did exhibit decreased copper 
content compared to WT cells (Tottey et al., 2001).   
It has previously been shown that green algae and cyanobacteria contain 
two electron carrier proteins – plastocyanin and cytochrome c6 which transfer electrons 
between photosystems I and II (Merchant and Bogorad, 1986; Wood, 1978).  While 
electron transfer is mediated by plastocyanin during copper-replete conditions, the cells 
can switch to the heme-containing cytochrome c6 protein under copper-deficient 
conditions (Merchant and Bogorad, 1986).  Homologues of both plastocyanin and 
cytochrome c6 have been identified in the thylakoid compartment of Synechocystis PCC 
6803 and similar copper-dependent switching between the carriers has also been 
demonstrated (Zhang et al., 1992). Studies by Tottey et al. (2001) have shown that the 
deletion of ctaA resulted in decreased transcription of the gene encoding plastocyanin 
and increased transcription of the gene encoding cytochrome c6 compared to the WT 
cells.  The ctaA∆ strain also exhibited increased oxidation of cytochrome c6 when 
exposed to a pulse of actinic light and decreased cytochrome c oxidase activity 
compared to the WT strain.  These results subsequently led to the hypothesis that CtaA 
may function as a plasma-membrane bound cytosolic copper importer (Tottey et al., 
2001).    
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AfCopAa      --------MVKD--------TYISSASKTPPMERTVRVTGMTCAMCVKSIETAVGSLEGVEEVRVNLATETAFIRFDEKRIDFETIKRVIEDLGYG------------VVDEQAA---- 87 
AfCopAb      LAMAMSSVSVVANSLLLRNYVPPIRRGGDSVEKIVLELSGLSCHHCVARVKKALEEA-GAKVEKVDLN--EAVVAGN--KEDVDKYIKAVEAAGYQAK----------LRS-------- 96 
BsCopAa      ---------------------------MSEQKEIAMQVSGMTCAACAARIEKGLKRMPGVTDANVNLATETSNVIYDPAETGTAAIQEKIEKLGYH------------VVT-------- 72 
BsCopAb      -------------------------------EKAEFDIEGMTCAACANRIEKRLNKIEGVANAPVNFALETVTVEYNPKEASVSDLKEAVDKLGYKLK----------LKGEQDSE--- 75 
CtaA         --------MVQLSPTPASTLTYKDANGQNRTASLTLDVGGMKCAGCVAAVERQLDQLTGVTDSCVNLVTAVAVVRYEPEKIQPQAIAEHLSQRGFPSQIRHGHGAIPATIGEKETRENV 111 
EhCopA       --------------------------MATNTKMETFVITGMTCANCSARIEKELNEQPGVMSATVNLATEKASVKYT--DTTTERLIKSVENIGYGA---------------------- 69 
PacS         -----------------------------MAQTINLQLEGMRCAACASSIERAIAKVPGVQSCQVNFALEQAVVSYHG-ETTPQILTDAVERAGYHAR----------VLK-------- 71 
 
 
Figure 2: Sequence alignment of the soluble metal-binding domains of prokaryotic CopA-type copper-ATPases.  The sequence alignment of 
the 2 MBDs of Archaeoglobus fulgidus CopA (GenBank accession code: 029777) denoted AfCopAa and AfCopAb (discussed in section 1.2.3.1), 2 MBDs of 
Bacillus subtilis CopA (GenBank accession code: 032220) denoted BsCopAa and BsCopAb (discussed in section 1.2.3.1), MBD of CtaA (GenBank accession 
code: NP_441938.1) (discussed in sections 1.2.1.1.2 and 1.4.3), EhCopA (GenBank accession code: AAA61835) (discussed in section 1.2.1.1.1) and PacS 
(GenBank accession code: NP_440588.1) (discussed in sections 1.2.3.2 and 1.4.3).  Fully conserved residues are highlighted in black while semi-conserved 
residues are shown in grey.   
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However, several reports have disputed the direction of copper transport by CtaA (Ma 
et al., 2009; Robinson and Winge, 2010).  An alternative model suggests that CtaA 
might be located in the thylakoid membrane similar to the PacS copper-transporter and 
may mediate copper import into the thylakoid compartment at a different stage to PacS 
(Robinson and Winge, 2010).   
CtaA possesses one MBD at the N-terminus with an M33XCXXC38 metal-
binding motif (Figure 2) which has been shown to interact with the copper 
metallochaperone from Synechocystis PCC 6803 (ScAtx1) in a bacterial two-hybrid 
system (Tottey et al., 2002), as discussed further in section 1.4.3.  Badarau et al. (2010) 
have reported that CtaA MBD remains monomeric both in the apo- and copper-bound 
form.  A recent study has also reported CtaA, in conjunction to PacS and ScAtx1, to be 
involved in copper acquisition by CucA (Waldron et al., 2010). 
 
1.2.2 Prokaryotic Copper Metallochaperones 
Copper metallochaperones are typically ~8 kDa in size and ~70 amino acids in length.  
They contain the classic βαββαβ ferredoxin-like fold and the CXXC metal-binding motif 
(Markossian and Kurganov, 2003).  While copper metallochaperones were initially 
discovered in eukaryotes (Lin and Culotta, 1995) (see section 1.3.2.4), homologues of 
them have been found in prokaryotes.  Copper metallochaperones not only help to 
prevent copper toxicity by sequestering Cu(I), but also prevent aberrant copper-binding 
in proteins by directly delivering Cu(I) to their specific target proteins.   
 
1.2.2.1 The E. hirae copper metallochaperone CopZ  
The first bacterial copper metallochaperone was discovered in E. hirae and was termed 
CopZ (EhCopZ) (Figure 3 and Figure 4) (Odermatt and Solioz, 1995).  EhCopZ was 
also the first copper metallochaperone to be structurally characterised (Wimmer et al., 
1999), albeit primarily in its apo-state (Figure 3).  An NMR structure for the Cu(I)-bound 
EhCopZ was also reported but due to the relatively large structural movement in the 
M9XCXXC14 motif the region around the metal-binding region could not be fully resolved 
(Wimmer et al., 1999).  In addition, the binding of copper was reported to lead to 
aggregation – most likely dimerisation of Cu(I)-EhCopZ resulting in protein precipitation.  
However, sufficient information was obtained from this partially resolved structure for 
the authors to propose that Cu(I) was likely trigonally coordinated in Cu(I)-EhCopZ, 
although the identity of the third ligand in addition to Cys11 and Cys14 was not deduced 
(Wimmer et al., 1999).   
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Figure 3: The NMR structure of apo-EhCopZ.  The side chains of the proposed Cu(I)-
binding Cys residues in the CXXC motif of apo-EhCopZ (PDB accession code: 1cpz) are shown 
as sticks (Wimmer et al., 1999).   
   
 14 
As mentioned above (section 1.2.1.1.1), EhCopZ has been shown to interact directly 
with EhCopA MBD by SPR (Multhaup et al., 2001).  In addition, EhCopZ can also act as 
the activator or de-repressor of the E. hirae cop operon depending upon its copper 
occupancy (Cobine et al., 1999).  In the absence of Cu(I)-bound EhCopZ, CopY binds a 
Zn(II) ion and represses the transcription of the downstream cop operon genes.  In the 
presence of copper, the Cu(I)-bound EhCopZ transfers two Cu(I) ions to CopY which 
results in the removal of zinc from CopY and the release of CopY from the promoter 
leading to the expression of copA and copB genes (Odermatt and Solioz, 1995; Solioz 
and Stoyanov, 2003).  In support of this model, copZ∆ cells were reported to contain 
reduced levels of EhCopA and EhCopB (Odermatt and Solioz, 1995).  An interaction 
between CopZ and EhCopB has also been reported, although further experiments are 
required to demonstrate this and to determine if copper is transferred from EhCopZ to 
EhCopB for copper efflux (Solioz et al., 2010).  Interestingly, EhCopZ is itself a part of a 
feedback loop where the expression of EhCopZ is copper-dependent.  The levels of 
EhCopZ were reported to increase when the concentration of added copper in the 
growth medium was less than 0.5 mM.  Further increase in copper concentration was 
shown to result in the proteolytic degradation of EhCopZ suggesting that excess Cu(I)-
EhCopZ may be cytotoxic (Lu and Solioz, 2001).  Recently, EhCopZ was also shown to 
interact with the stress-response regulator Gls24 by both in vivo and in vitro 
experiments (Stoyanov et al., 2010) implicating it to be an integral member of the E. 
hirae copper homeostasis system. 
 
1.2.2.2 The Bacillus subtilis copper metallochaperone CopZ 
The copper metallochaperone from Bacillus subtilis (B. subtilis) was identified in 2001 
and was subsequently termed BsCopZ (Figure 4 and Figure 5) (Banci et al., 2001b).  
Similar to other copper metallochaperones, the copper source for BsCopZ is also not 
known (Banci et al., 2010c; Radford et al., 2003).  To date, BsCopZ remains one of the 
best characterised prokaryotic copper metallochaperones as it has been studied both in 
vivo and in vitro and solution and crystal structures are available for this 
metallochaperone (Banci et al., 2001b; Banci et al., 2003b; Hearnshaw et al., 2009; 
Kihlken et al., 2002; Singleton et al., 2009).  The interaction of BsCopZ with its target 
protein – the CopA copper-transporter from B. subtilis (BsCopA) has also been studied 
(Banci et al., 2003a; Radford et al., 2003; Singleton et al., 2009).  The first BsCopZ 
structure to be reported was in its Cu(I)-bound form solved by NMR spectroscopy 
(Figure 5a) (Banci et al., 2001b).  The overall protein fold was found to be similar to 
apo-EhCopZ (Figure 3) although due its Cu(I)-bound state the structure of Cu(I)-
BsCopZ provided additional information regarding metal-binding.  As shown in Figure 
5a, Cu(I) is bound directly by Cys13 and Cys16 comprising the M11XCXXC16 motif in 
BsCopZ.  A hydrophobic interaction between Met11 and Tyr65 was also observed 
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which was hypothesised to protect the bound Cu(I) ion from oxidation by restricting its 
access by solvent (Banci et al., 2001b).  The structure of apo-BsCopZ provided further 
support for this hypothesis as in the apo-BsCopZ structure Met11 is exposed to the 
solvent (Banci et al., 2003b) whereas in Cu(I)-BsCopZ Met11 points towards the bound 
Cu(I) ion (Figure 5a-b) (Banci et al., 2001b).  Similarly, Tyr65 was also found to be more 
solvent exposed in apo-BsCopZ (Figure 5a) compared to the Cu(I)-BsCopZ structure 
(Figure 5b) (Banci et al., 2003b).   
While BsCopZ was initially shown to be a monomer in solution in its apo- 
and Cu(I)-bound forms in the presence of dithiothreitol (DTT) (Banci et al., 2001b), it 
was later reported that at high protein concentrations BsCopZ is a dimer in both apo- 
and Cu(I)-bound forms (Banci et al., 2003c).  Kilhken et al. (2002) found that in the 
absence of DTT and in the presence of 0.5 Cu(I) per protein, BsCopZ was primarily 
dimeric while in the presence of DTT and 0.5 Cu(I) per protein there was an equilibrium 
between the monomeric and dimeric states.  Further Cu(I)-bound forms of BsCopZ 
have also been reported in solution (Kihlken et al., 2002).  The crystal structures of a 
Cu(I)-bound BsCopZ trimer (Singleton et al., 2009) and a BsCopZ dimer containing four 
Cu(I) ions (Figure 5c) (Hearnshaw et al., 2009) have also been determined.  In the 
BsCopZ trimer Cu(I) was coordinated by both of the Cys residues in the MXCXXC motif 
and the Cys16 residue from a neighbouring subunit.  Additional interactions reported in 
the BsCopZ trimer included interactions between Ser12 and a water molecule, between 
Tyr65 and two water molecules, and between His15 and Gln63 (Singleton et al., 2009).  
In the four Cu(I)-bound BsCopZ dimer His15 from both subunits were shown to directly 
bind Cu(I) in addition to Cys13 and Cys16, as shown in Figure 5c (Hearnshaw et al., 
2009).  A hydrophobic bond between Met11 and Tyr65 was also reported to contribute 
to the structural integrity of the protein and thus indirectly towards copper binding as 
well.  Although the existence of the multiple copper-bound BsCopZ structures has not 
been reported in vivo, the formation of these structures highlights the flexibility in the 
copper-binding site of copper metallochaperones allowing it to adopt multiple copper-
bound states which may exist in conditions of intracellular copper stress.   
 
1.2.2.3 The Archaeoglobus fulgidus copper metallochaperone CopZ 
The CopZ copper metallochaperone from the archaeon Archaeoglobus fulgidus (A. 
fulgidus) referred to as AfCopZ, is a relatively recent but perhaps the most unique 
member of the family of copper metallochaperones (Sazinsky et al., 2007).   
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AfCopZ-CTD      GEKKAAKRVEIKLDGLTCMGCVSAVKAALEEA-GANVVEIGLD--RAVVEVDEE-AELQKLVEAVEGAGYSARLEKR 73 
BsCopZ          -----MEQKTLQVEGMSCQHCVKAVETSVGELDGVSAVHVNLEAGKVDVSFDADKVSVKDIADAIEDQGYDVAK--- 69 
EhCopZ          -----MKQE-FSVKGMSCNHCVARIEEAVGRISGVKKVKVQLKKEKAVVKFDEANVQATEICQAINELGYQAEVI-- 69 
ScAtx1          ------MTIQLTVPTIACEACAEAVTKAVQNEDAQATVQVDLT--SKKVTITSA-LGEEQLRTAIASAGHEVE---- 64 
 
 
Figure 4: Sequence alignment of prokaryotic copper metallochaperones.  The sequence alignments of the C-terminal copper 
metallochaperone domain of A. fulgidus CopZ denoted as AfCopZ-CTD (discussed in section 1.2.2.3) (GenBank accession code: 029901), BsCopZ 
(GenBank accession code: 032221) (discussed in section 1.2.2.2), EhCopZ (GenBank accession code: Q47840) (discussed in section 1.2.2.1), and 
ScAtx1 (GenBank accession code: NP_440560.1) (discussed in sections 1.2.2.4 and 1.4.3).  Fully conserved residues are highlighted in black while semi-
conserved residues are shown in grey.   
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Unlike the other known CopZ copper metallochaperones, AfCopZ contains an additional 
~130 amino acids at the N-terminal end denoted as AfCopZ-NTD fused to the typical 
copper metallochaperone domain with the ferredoxin-like fold at the C-terminus denoted 
as AfCopZ-CTD (Figure 4) (Sazinsky et al., 2007).  The crystal structure of AfCopZ-
NTD revealed a βααβββα-fold in addition to the presence of a 2Fe-2S cluster (Sazinsky 
et al., 2007).  AfCopZ-NTD and AfCopZ-CTD can both bind copper, while AfCopZ-NTD 
can also bind zinc.  In addition, AfCopZ-NTD was shown to reduce Cu(II) to Cu(I) 
(Sazinsky et al., 2007) which led to the hypothesis that perhaps Cu(II) is bound first by 
AfCopZ-NTD, reduced to Cu(I) and subsequently transferred to AfCopZ-CTD.  It has 
further been proposed that the fusion of AfCopZ-NTD to AfCopZ-CTD may be a relic of 
evolutionary divergence between proteins containing only the ferredoxin-like fold found 
in the other CopZ metallochaperones (CopZ-like domain) and those containing the 
CopZ-like domain fused to a redox-active domain (Kim et al., 2008).  The transfer of 
Cu(I) has been demonstrated between Cu(I)-bound AfCopZ and the MBDs of AfCopA, 
and Cu(I)-bound AfCopZ-CTD has also been shown to deliver Cu(I) to the 
transmembrane metal-binding site (MBS) in AfCopA (Gonzalez-Guerrero et al., 2009).  
In addition, Cu(I)-bound AfCopZ has also been shown to activate the Cu(I)-dependent 
turnover of AfCopA (Gonzalez-Guerro and Arguello, 2008). 
 
1.2.2.4 The cyanobacterial copper metallochaperone ScAtx1 
The cyanobacterial copper metallochaperone was discovered in Synechocystis PCC 
6803 and was denoted as ScAtx1 (Tottey et al., 2002).   Synechocystis PCC 6803 cells 
devoid of the scAtx1 gene exhibited decreased cytochrome c oxidase activity, although 
the effects were smaller than the cells lacking pacS suggesting that the effects of 
scAtx1 deletion on the cytochrome c oxidase activity required the presence of PacS.  In 
contrast, the deletion of both scAtx1 and ctaA resulted in a greater decrease in 
cytochrome c activity compared to the cells lacking only one of these genes implying 
that ScAtx1 may be functional in the absence of CtaA (Tottey et al., 2002).  In addition, 
no significant difference in copper sensitivity was evident in the scAtx1∆ cells (Tottey et 
al., 2002).  ScAtx1 has also been shown to bind Zn(II), although the physiological 
importance of this has not been determined (Badarau et al., 2010; Banci et al., 2010b; 
Dainty et al., 2010).   
The solution structures of apo- and Cu(I)-bound ScAtx1 found it to 
contain a slightly shorter ferredoxin-like fold as it lacked the final β-strand in the usual 
βαββαβ-fold which is probably due to the fact that it is comparatively shorter (64 amino 
acids) than the other CopZ metallochaperones such as EhCopZ and BsCopZ (Figure 4) 
(Badarau et al., 2010; Banci et al., 2004a).   
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Figure 5: The structures of apo- and Cu(I)-bound BsCopZ.  The solution structure of 
apo-BsCopZ (PDB accession code: 1p8g) (Banci et al., 2003b) (A), Cu(I)-BsCopZ (PDB 
accession code: 1k0v) (Banci et al., 2001b) (B), and the crystal structure of four Cu(I)-bound 
BsCopZ homodimer (PDB accession code: 2qif) (Hearnshaw et al., 2009) where each subunit is 
shown in different shades of blue (C).  In all of the figures the side chains of the metal-binding 
Cys residues are shown as yellow sticks.  In (A) and (B) the side chains of Met11 and Tyr65 are 
shown as green and purple sticks, respectively.  Cu(I) ions are shown as spheres in (B) and (C).  
The side chains of His15 are shown as sticks in (C).   
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Similar to BsCopZ, Cu(I) in ScAtx1 was also found to be trigonally coordinated in the 
solution structure (Banci et al., 2004a).  In addition to Cys12 and Cys15 of the 
C12XXC15-motif, His61 residue in loop 5 of ScAtx1 was reported as the third Cu(I)-
binding ligand (Banci et al., 2004a).  The His61 residue in ScAtx1 is located in the 
analogous position to the BsCopZ Tyr65 residue, although Tyr65 was not shown to be 
involved in binding Cu(I) directly in the Cu(I)-bound BsCopZ structure (Banci et al., 
2001b).  Another difference between BsCopZ and ScAtx1 involves the substitution of 
the Met residue in the MXCXXC motif by Ile (Ile10) in ScAtx1 which in contrast to 
BsCopZ Met11 residue does not change its orientation irrespective of Cu(I)-loading in 
ScAtx1 (Banci et al., 2004a).  In contrast to the solution structure of Cu(I)-ScAtx1, His61 
was not shown to bind Cu(I) directly in most of the crystal structures of the Cu(I)-bound 
ScAtx1 dimers reported by Badarau et al. (2010).   
The crystal structures demonstrated two Cu(I)- and four Cu(I)-bound 
ScAtx1 dimers in two different structural arrangements – head-to-head and side-to-side.  
In the head-to-head arrangement, ScAtx1 was found to dimerise either with two Cu(I) 
(shown in Figure 6a) or four Cu(I) ions (shown in Figure 6b).  In the former structure 
Cu(I) atoms are directly coordinated by Cys12 and Cys15 of one subunit and Cys15 of 
the neighbouring subunit (Figure 6a).  Whereas in the four Cu(I) per dimer, two of the 
Cu(I) ions are bound by Cys12 of one subunit and Cys15 and His61 of the other 
subunit, while the other two Cu(I) ions are coordinated by Cys12 and Cys15 of the 
monomer, as shown in Figure 6b (Badarau et al., 2010).  A crystal structure for the four 
Cu(I)-bound ScAtx1 homodimer in the side-to-side arrangement has also been 
determined in the presence of chloride (Badarau et al., 2010).  In this structure (Figure 
6c), two of the Cu(I) ions are coordinated by Cys12 and Cys15 of each monomer while 
the other two Cu(I) ions are coordinated by Cys12 of each subunit and a chloride ion 
(Badarau et al., 2010).  In addition, His61 from both subunits also forms a hydrogen 
bond with one of the bound chloride ions (Badarau et al., 2010).  The importance of 
His61 is further highlighted by the fact that the mutation of this residue to Tyr resulted in 
the monomerisation of ScAtx1 at low Cu(I) concentrations (Badarau et al., 2010).  
Further support for the physiological role for this residue was demonstrated in the 
studies investigating the interactions of ScAtx1 with CtaA MBD and the PacS MBD, as 
discussed further in section 1.4.3.   
Similar to BsCopZ, the existence of multiple Cu(I)-bound structures of 
ScAtx1 may indicate the different structural conformations that ScAtx1 can adopt under 
conditions of copper stress.  Badarau et al. (2010) also suggested that the presence of 
the head-to-head and the side-to-side ScAtx1 dimers may be reflective of the 
complexes formed between ScAtx1 and PacS MBD or CtaA MBD, as discussed further 
in section 1.4.3.  While apo-ScAtx1 was reported to exist as a monomer in solution 
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(Badarau et al., 2010; Banci et al., 2004a), Cu(I)-bound ScAtx1 has been shown to form 
Cu(I)-mediated dimers (Badarau et al., 2010).  The dimerisation of ScAtx1 may not only 
help to sequester excess Cu(I) in vivo, but can also influence the transfer of Cu(I) from 
ScAtx1 to its target proteins (Badarau et al., 2010), as discussed further in section 
1.4.3. 
 
1.2.2.5 The Escherichia coli copper metallochaperone CusF 
For a long time it was thought that Escherichia coli (E. coli) did not contain a copper 
metallochaperone (Franke et al., 2003; Gatti et al., 2000).  While an E. coli CopZ-like 
copper metallochaperone has not been identified to date, in 2003 the small periplasmic 
protein CusF (EcCusF), part of the E. coli cusCFBA operon was shown to interact with 
the periplasmic copper-binding protein CusB (EcCusB) and the copper-ATPase CusC 
(EcCusC) (Franke et al., 2003).   
The role of CusF as a copper metallochaperone was not established until 
2008 when direct copper transfer was demonstrated between EcCusF and EcCusB 
(Bagai et al., 2008).  The crystal structure of apo-EcCusF demonstrated it to be a highly 
unusual copper metallochaperone as unlike most of the other CopZ metallochaperones 
it does not form a βαββαβ-fold; instead, the CusF structure comprises five β-strands 
that fold into a small β-barrel (Loftin et al., 2005).  Even more unusually, it does not 
contain any Cys residues, probably due to the oxidising environment of the E. coli 
periplasm which may lead to the formation of disulfide bridges between potential metal-
binding Cys residues (Loftin et al., 2007; Xue et al., 2008).  Combination of the data 
from Cu(I)-bound EcCusF and Ag(I)-bound EcCusF crystal structure and X-ray 
absorption spectroscopy on Cu(I)-bound EcCusF revealed the metal-binding site of 
EcCusF to trigonally coordinate one Cu(I) ion per EcCusF molecule by His36, Met47 
and Met49 (Loftin et al., 2005; Loftin et al., 2007; Xue et al., 2008).  In addition, Trp44 
residue was also shown to interact with the Cu(I)-binding site in CusF (Loftin et al., 
2005; Loftin et al., 2007; Xue et al., 2008).  Isothermal titration calorimetry (ITC) 
experiments demonstrated a Cu(I)- or Ag(I)-dependent interaction between EcCusF 
and EcCusB where one of the two proteins was required in its apo-form (Bagai et al., 
2008).  Both EcCusF and EcCusB were reported to have similar metal-binding affinities 
and in support of this, the transfer of metal between EcCusF and EcCusB was also 
shown to be reversible (Bagai et al., 2008).  This led to the suggestion that vectorial 
transfer of metal from EcCusF to EcCusB is likely achieved by the constant transport of 
Cu(I) or Ag(I) from EcCusB to the Cu(I) or Ag(I)-exporting ATPase CusC resulting in a 
favourable thermodynamic gradient for copper transfer (Bagai et al., 2008).   
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Figure 6: The crystal structures of ScAtx1 dimers.  The crystal structure of ScAtx1 2 
Cu(I)-bound head-to-head dimer (PDB accession code: 2xmt) (A), 4 Cu(I)-bound head-to-head 
dimer (PDB accession code: 2xmu) (B) and side-to-side dimer (PDB accession code: 2xmk) (C) 
(Badarau et al., 2010).  Each subunit in the dimer is represented in brown and yellow, Cu(I) ions 
are shown as blue spheres, chloride ions as green spheres and the side chains of the metal-
binding Cys residues as orange sticks.  The side chain of His61 from each subunit is shown as 
sticks.   
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1.2.3 Copper efflux in Prokaryotes 
In order to minimise the concentration of free Cu(I) ions, Cu(I) is actively exported from 
the cells via copper-transporting ATPases.  Copper-exporting ATPases from some of 
the prokaryotic organisms are discussed below.   
 
1.2.3.1 CopA and CopB copper-exporting ATPases 
CopA transporters have been identified in many prokaryotic organisms including B. 
subtilis, E. coli and A. fulgidus.  The expression of the gene encoding CopA ATPase 
from B. subtilis (BsCopA) is induced by the presence of elevated copper levels and its 
deletion leads to increased copper sensitivity (Gaballa and Helmann, 2003).  BsCopA 
contains two soluble MBDs at the N-terminus, denoted as BsCopAa and BsCopAb, 
which both contain the MXCXXC motif (Figure 2).  Both of the BsCopA MBDs have 
been structurally characterised and were found to be similar to BsCopZ (Banci et al., 
2002; Singleton et al., 2008).  Although the MBDs have been shown to interact with 
BsCopZ and acquire copper from Cu(I)-bound BsCopZ (Banci et al., 2003a; Radford et 
al., 2003), the exact function of the MBDs is not known.  A structural model between 
BsCopZ-Cu(I)-BsCopAb highlighted the role of the electrostatic interactions between 
Asp62 and Glu21 in BsCopZ and Lys23 and Arg20 of BsCopAb respectively, in 
mediating protein-protein interaction (Banci et al., 2003a).  The BsCopZ interaction with 
BsCopAb was proposed to progress by a ligand-transfer mechanism involving a three 
coordinate Cu(I)-bound intermediate, where Cu(I) was transferred from Cu(I)-BsCopZ to 
apo-BsCopAb (Banci et al., 2003a).  Formation of a multinuclear Cu(I) cluster in the 
presence of excess Cu(I) has also been reported to result in the dimerisation of the 
MBDs in vitro (Singleton et al., 2008; Singleton and Le Brun, 2009).  However, neither 
the presence nor the physiological relevance of these multiple Cu(I)-bound forms of 
BsCopA MBDs has been established.  The CopA ATPase from E. coli (EcCopA) also 
contains two MBDs at the N-terminus (Rensing et al., 2000).  Similar to BsCopA, 
EcCopA is also induced by Cu(I) and confers copper resistance in vivo by mediating 
Cu(I)-efflux from the cell (Fan and Rosen, 2002; Rensing et al., 2000).  Determining the 
role of EcCopA MBDs is more challenging than in B. subtilis since no known CopZ-like 
metallochaperone has been found in E. coli.  Studies by Fan et al. have shown that the 
deletion of EhCopA MBDs leads to perturbed copper transport and copper resistance 
(Fan et al., 2001; Fan and Rosen, 2002).  
AfCopA is unusual since unlike most of the copper-transporting P1B-type 
ATPases, it contains a MBD at both its N- and C-termini denoted as AfCopAa and 
AfCopAb respectively (Mandal et al., 2002).  Similar to the MBDs from the other CopA 
proteins, both AfCopA MBDs demonstrate the βαββαβ-fold (Wu et al., 2008) although 
recently an unusual crystal structure was reported for AfCopAb (Agarwal et al., 2010).  
The structure of AfCopAb reveals it to be a homodimer where the N-terminal β-strand 
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was shown to “swap” with the analogous strand from the other monomer.  However, this 
structure was suggested to be an artefact of crystallisation as the copper-binding Cys 
residues in the C16XXC19 motif were shown to form intramolecular disulfide bonds and 
the structure itself was shown to be stabilised by the binding of a citrate molecule, 
neither of which are expected to be present in vivo (Agarwal et al., 2010). Similar to 
ScAtx1, AfCopAb also does not contain a MXCXXC site, as the Met residue is replaced 
by Leu (Leu14).  Leu14 is expected to perform a similar function to Met11 in BsCopZ in 
stabilising the hydrophobic packing of the protein (Agarwal et al., 2010).  Cu(I)-transfer 
has been reported between Cu(I)-AfCopZ and apo-AfCopA MBDs (Gonzalez-Guerro 
and Arguello, 2008; Sazinsky et al., 2007), although Cu(I) was shown to be transferred 
more efficiently from Cu(I)-AfCopZ to AfCopAb than AfCopAa (Gonzalez-Guerro and 
Arguello, 2008).  Agarwal et al. (2010) proposed that the higher Cu(I) affinity of 
AfCopAb may be due to the presence of two His residues in the C16HHC19 motif of 
AfCopAb, one of which (His18) may provide a third ligand to Cu(I) in addition to Cys16 
and Cys19, whereas His18 and His19 are replaced by Ala and Met respectively, in 
AfCopAa (Figure 2).  
A low resolution electron microscopy determined structure of AfCopA 
revealed AfCopAa to be positioned between the N- and the A-domains of the protein 
(Wu et al., 2008).  This led the authors to propose a model where the apo-AfCopAa can 
interact with the N-domain of AfCopA and occlude the binding of ATP to AfCopA (Wu et 
al., 2008).  Cu(I)-bound AfCopAa may not be able to interact with the N-domain of 
AfCopA resulting in the binding of ATP and Cu(I)-transport across the membrane (Wu 
et al., 2008).  In support of this model, both of the AfCopA MBDs have been shown to 
interact with the N-domain of AfCopA, while the AfCopAb can also interact with the A-
domain of AfCopA (Gonzalez-Guerrero et al., 2009).  However, in vivo studies are 
required to render support for the proposed model.  A. fulgidus also contains another 
P1B-type copper-transporting ATPase termed CopB (AfCopB) which is also involved in 
copper efflux (Mana-Capelli et al., 2003).  Unlike AfCopA, AfCopB contains a singular 
His-rich MBD at its N-terminus which has been implicated in mediating enzyme turnover 
(Mana-Capelli et al., 2003).  The AfCopB MBD is similar to the MBD of EhCopB which 
also contains several His residues.  EhCopB is located in the cytoplasmic membrane of 
E. hirae and has also been shown to mediate copper efflux from the cytoplasm 
(Odermatt et al., 1993; Odermatt et al., 1994).   
 
1.2.3.2 The cyanobacterial copper-transporting ATPase PacS 
PacS was first identified in Synechococcus PCC 7942 located primarily at the thylakoid 
membrane (Kanamaru et al., 1993).  However, this study will focus on the PacS 
homologue identified in Synechocystis PCC 6803 (Tottey et al., 2001) and unless 
stated otherwise, in this study PacS refers to the copper-ATPase from Synechocystis 
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PCC 6803.  PacS has been shown to mediate copper transport into the thylakoid 
compartment where Cu(I) is required for plastocyanin and cytochrome c oxidase (Tottey 
et al., 2001).  Tottey et al. (2001) demonstrated that the deletion of pacS in 
Synechocystis PCC 6803 led to copper sensitivity, decreased transcription of the gene 
coding for plastocyanin and simultaneous increase in the transcription of the gene 
coding for cytochrome c6 suggesting that Cu(I) import by PacS is essential for 
plastocyanin-mediated Cu(I) delivery to cytochrome c oxidase.  PacS contains a single 
MBD at its N-terminus (PacS MBD) which is a monomer in solution in the apo-state 
(Badarau et al., 2010; Banci et al., 2006c) and in the presence of one equivalent of 
Cu(I) (Badarau et al., 2010).  PacS MBD has been structurally characterised in solution 
in its apo-state (Banci et al., 2006c) and by X-ray crystallography in its Cu(I)-bound form 
(Badarau et al., 2010).  The Cu(I)-bound PacS MBD was the first native metal bound 
MBD from a copper-transporting ATPase to be characterised by X-ray crystallography 
(Badarau et al., 2010).  The crystal structure demonstrated a PacS MBD homotrimer 
where each subunit contains the βαββαβ-fold and binds one Cu(I) via Cys14 and Cys17 
located in the M12XCXXC17 motif, in addition to a weak bond provided by Cys14 of the 
neighbouring subunit, as shown in Figure 7 (Badarau et al., 2010).  While there are 
similarities between the Cu(I)-PacSN trimer and the Cu(I)-BsCopZ trimer, there are also 
several differences between them including the role of the Tyr residue located in the 
loop 5 of these proteins.  As mentioned previously (1.2.2.2), Tyr65 in the Cu(I)-BsCopZ 
trimer hydrogen bonds with two water molecules, whereas in the Cu(I)-PacS MBD 
trimer Tyr65 hydrogen bonds with the Cu(I)-coordinating Cys17 residue (Badarau et al., 
2010).  PacS MBD has also been shown to acquire Cu(I) by direct interaction with 
ScAtx1, as discussed in section 1.4.3.  Investigating the interaction between PacS MBD 
and ScAtx1 was one of the aims of this study. 
 
1.3 Regulation of copper in Eukaryotes 
Unlike prokaryotes, there is a cytosolic requirement for copper in eukaryotic cells.  
Copper is required to traverse the plasma membrane in order to be incorporated into 
copper-dependent cytosolic proteins such as SOD1 (see section 1.3.2.3) and for the 
function of various proteins in other cellular organelles such as the mitochondria and 
the golgi compartment.  Another major difference between the copper homeostasis in 
prokaryotes compared to eukaryotes includes the multi-cellular nature of most 
eukaryotic organisms and the complex regulation of copper concentration and 
localisation in the multiple membrane-encoded organelles within the eukartyotic cells.  
These differences account for the considerably larger number of copper-binding 
proteins present in eukaryotes (31 to 160 proteins) compared to the average number of 
copper-binding proteins present in archaea (0 to 38 proteins) and bacteria (0 to 31 
proteins) (Andreini et al., 2008).   
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Figure 7: The crystal structure of Cu(I)-PacS MBD trimer.  The structure of Cu(I)-
bound PacS MBD (PDB accession code: 2xmw) trimer solved by X-ray crystallography (Badarau 
et al., 2010).  The metal-binding Cys residues are shown as sticks and Cu(I) are shown as 
spheres.   
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1.3.1 Import of copper in Eukaryotes 
Copper is imported in eukaryotes by the family of copper-transport proteins (CTR) and 
DMT1.  CTR proteins are membrane-bound copper-transporters that mediate high 
affinity uptake of Cu(I) into the eukaryotic cytoplasm.  The number of CTR proteins 
varies between different eukaryotic organisms, for instance, S. cerevisiae and the fruit-
fly Drosophila melanogaster (D. melanogaster) have three isoforms while, H. sapiens 
possess two known isoforms (Balamurugan and Schaffner, 2006).   
The most ubiquitous isoform of CTR proteins in eukaryotes is the CTR1 
transporter.  While the size and localisation of CTR1 may vary, some conserved 
characteristics include the presence of an extracytoplasmic N-terminal domain (NTD), 
three transmembrane helices and a cytoplasmic C-terminal domain (CTD).  All CTR1 
proteins possess a conserved MXXXM motif in the second transmembrane helix which 
is known to be vital for mediating Cu(I) transport (Kaplan and Lutsenko, 2009; Molloy 
and Kaplan, 2009; van den Berghe and Klomp, 2010).  The NTD of human CTR1 
(hCTR1) and yeast Ctr1 (Ctr1) contain several Met and His residues which can 
potentially bind Cu(I) and mediate its uptake from currently unidentified sources (Guo et 
al., 2004; Jiang et al., 2005; Maryon et al., 2007; Puig et al., 2002).  In addition, yeast 
two-hybrid experiments have implicated hCTR1 NTD in mediating oligomerisation of 
hCTR1 (Klomp et al., 2003).  It has previously been shown that the transport of Cu(I) 
via CTR1 is not dependent on ATP hydrolysis (Lee et al., 2002a).  Electron 
crystallography deduced structures show three monomers of hCTR1 arranged as a 
trimer in the lipid bilayer forming a ‘cone-shaped pore’ which would enable the passage 
of Cu(I) through it (Aller and Unger, 2006; De Feo et al., 2009).  De Feo et al. (2009) 
suggested that the transport of Cu(I) through hCTR1 is likely thermodynamically 
favourable as the ‘HCH’ Cu(I)-binding site in hCTR1 CTD would probably form a more 
stable Cu(I)-bound complex than the intramembranous Met-rich Cu(I)-binding site.  The 
Cys residue in the hCTR1 CTD HCH-motif has also been implicated in oligomerisation 
of hCTR1 (Eisses and Kaplan, 2005).  The import of the anti-cancer drug cisplatin via 
hCTR1 has further highlighted its importance in humans (Holzer et al., 2004; Holzer et 
al., 2006). 
  hCTR1 is primarily localised at the plasma membrane and in the 
membranes of endocytic vesicles (Eisses and Kaplan, 2005; Kaplan and Lutsenko, 
2009; Maryon et al., 2007; Prohaska, 2008).  Based on the data Ctr1 and Ctr3 from S. 
cerevisiae, it has been hypothesised that hCTR1 may also be localised to the cell 
membrane when the extracellular copper concentration is low but gets internalised to 
endocytic vesicles in the presence of high extracellular copper concentration.  However, 
there is conflicting evidence regarding this hypothesis and no consensus has been 
reached (Bauerly et al., 2004; Eisses et al., 2005; Klomp et al., 2002; Molloy and 
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Kaplan, 2009; Petris et al., 2003).  CTR1 is also regulated at the transcriptional level.  In 
yeast, the transcription of CTR1 is regulated by the activity of Mac1 such that the 
transcription of CTR1 is induced in the presence of low intracellular copper levels and 
inhibited at high concentrations of copper (Graden and Winge, 1997; Jensen et al., 
1998; Joshi et al., 1999; Pena et al., 1998).  In humans, the transcription of hCTR1 has 
recently been shown to be regulated by the zinc-finger domain of the transcription factor 
Sp1 in response to intracellular copper levels, similar to the regulation of CTR1 by Mac1 
(Song et al., 2008).  This is in contrast to the previous findings where Mac1-like 
regulation was not associated with hCTR1, and it was thought to be regulated primarily 
at the post-translational level (Kuo et al., 2007; Maryon et al., 2007; Prohaska, 2008; 
Song et al., 2008; van den Berghe and Klomp, 2010).  Further in vivo studies are 
therefore required to confirm the transcriptional and copper-dependent regulation of 
hCTR1.  Unlike hCTR1, the hCTR2 transporter is predominantly localised to the 
lysosomal and endosomal membranes in humans.  In yeast, Ctr2 has been shown to be 
localised in the vacuolar membrane and is hypothesised to regulate the release of Cu(I) 
from internal Cu(I) storage pools (Portnoy et al., 2001; Rees et al., 2004; van den 
Berghe et al., 2007).  While both CTR1 and CTR2 proteins are vital for high affinity 
copper uptake, there is some evidence to suggest the presence of CTR-independent 
copper uptake as well in mammalian cells (Lee et al., 2002b).  Although the identity of 
the CTR-independent copper uptake protein is not known, a possible candidate 
includes the DMT1 transporter. 
DMT1 also known as Nramp2 or DCT1 is a membrane-bound cation 
transporter expressed ubiquitously in eukaryotes (Garrick et al., 2003).  While its main 
substrate is Fe(II), DMT1 is also known to transport other divalent cations including 
Cu(II), Zn(II), Mn(II), Co(II) and Ni(II) (Gunshin et al., 1997; Knopfel et al., 2000; Sacher 
et al., 2001).  There is also some evidence to suggest that copper may be transported 
through DMT1 in its Cu(I) oxidation state, although the bulk of the evidence indicates 
Cu(II) to be the preferred oxidation state for transport (Arredondo et al., 2003; Garrick et 
al., 2003; Knopfel et al., 2000; Knopfel et al., 2005).  DMT1 may play a more important 
role in the brain where CTR1 is expressed in reduced levels compared to its expression 
in other tissues (Gunshin et al., 1997; Lee et al., 1998; Zhou and Gitschier, 1997).  
DMT1 has also been implicated in several neurodegenerative disorders including PD 
and AD (Xu et al., 2008; Zhang et al., 2009; Zheng et al., 2009).  In AD, DMT1 has 
been dectected in senile plaques, and also found to down-regulate the expression of 
the amyloid precursor protein (APP) resulting in decreased production of Aβ (Zheng et 
al., 2009).  Further studies are however required to establish the extent of DMT1-
mediated copper uptake in eukaryotic cells and, in particular, its role in the brain. 
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1.3.2 Copper binding proteins in the Eukaryotic cytoplasm 
Inside the cell Cu(I) remains bound to cytosolic proteins such as the copper 
metallochaperones and SOD1 or by small proteins like metallothionein and the 
tripeptide glutathione which all contribute in maintaining strict copper homeostasis. 
 
1.3.2.1 Metallothioneins and Glutathione 
Metallothioneins are small, cysteine-rich polypeptides found in all eukaryotic organisms 
and some prokaryotic organisms.  They have a very high affinity for Cu(I), in addition to 
other metals including Zn(II) and Cd(II) (Blindauer and Leszczyszyn, 2010; Egli et al., 
2006).  Multiple Cu(I) ions can be bound by metallothioneins resulting in the formation 
of metal-sulfur clusters (Blindauer and Leszczyszyn, 2010).  In addition to metal-ion 
detoxification, metallothioneins have also been associated with other functions including 
neuroprotection, anti-inflammation and anti-oxidation in mammals (Blindauer and 
Leszczyszyn, 2010).  The number of metallothionein proteins in eukaryotes has been 
shown to vary between different organisms.  While S. cerevisiae contain only two 
metallothionein proteins (Cup1 and CRS5) (Butt et al., 1984; Culotta et al., 1994; Fogel 
and Welch, 1982), D. melanogaster (MtnA-D) (Egli et al., 2006) and mammals contain 
four metallothionein proteins (MT1-4) (Balamurugan and Schaffner, 2006).  The genes 
encoding metallothioneins are induced in the presence of copper toxicity, and Cu(I)-
bound metallothioneins can also act as intracellular copper stores mediating copper 
release in the event of copper deficiency (Balamurugan and Schaffner, 2006; Miyayama 
et al., 2009; Prohaska and Gybina, 2004; Suzuki et al., 2002). 
The most prominent anti-oxidant defence mechanism in eukaryotes 
involves the tripeptide glutathione comprised of glutamate, cysteine and glycine.  It is a 
ubiquitously expressed non-protein thiol present in upto 10 mM concentration in both 
eukaryotes and prokaryotes (Dalle-Donne et al., 2009; Penninckx, 2002).  Glutathione 
is present in the cells in either its reduced state (GSH) or in an oxidised state (GSSG) 
and is vital for maintaining a net reducing environment in the cell (Dalle-Donne et al., 
2009).  Under normal unstressed conditions the ratio of GSH:GSSG is more than 100 
(Maher, 2005).  GSH is a vital co-factor for the enzyme GSH peroxidase which 
catalyzes the breakdown of hydrogen peroxide into water and dioxygen, and therefore 
limits one of the substrates for potential Fenton reactions (see equation 1) (Chance et 
al., 1979).  Reduced GSH is in turn regenerated by the reduction of GSSG by GSH 
reductase (Dalle-Donne et al., 2009).  GSH also contributes in limiting copper-mediated 
cytotoxicity by sequestering Cu(I) (Equation 4) and is especially important in the brain 
which is particularly vulnerable to oxidative stress (Aoyama et al., 2008).   
   2Cu(II) + 6GSH → 2Cu(I)-[GSH]2 + GSSG  [4] 
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The Cu(I)-[GSH]2 complex can act as a copper source for the copper-free forms of 
metallothionein, SOD1 and ceruloplasmin (Carroll et al., 2004; Ciriolo et al., 1990; 
Ferreira et al., 1993; Musci et al., 1996).  However, Cu(I)-[GSH]2 complex has also 
been implicated in facilitating the generation of superoxide anions as a consequence of 
its reaction with molecular oxygen (Speisky et al., 2008; Speisky et al., 2009).  This 
suggests that a tight balance has to be maintained in the cell to limit the pro-oxidant 
capacity of GSH and enhance its role as an anti-oxidant, which requires the concerted 
support from other proteins involved in copper homeostasis including SOD1 and 
metallothionein.  
 
1.3.2.2 Ceruloplasmin and Hephaestin 
In mammals up to 95 % of copper in the serum is bound by the ferroxidase 
ceruloplasmin (Takahashi et al., 1984).  Ceruloplasmin oxidises Fe(II) to Fe(III) for the 
cellular distribution of iron by transferrin.  Ceruloplasmin is primarily located in the liver 
where it receives copper from the P1B-type ATPase ATP7B (section 1.3.3.3), although it 
is also expressed in other tissues including the brain (Fleming and Gitlin, 1990; Klomp 
and Gitlin, 1996).  Ceruloplasmin is capable of binding upto seven Cu(II) ions per 
molecule (Takahashi et al., 1984).  Copper-binding increases the stability of 
ceruloplasmin and is necessary for its ferroxidase activity (Gitlin et al., 1992; Holtzman 
and Gaumnitz, 1970) but does not affect the rate of synthesis or the secretion of 
ceruloplasmin (Takahashi et al., 1984).  Decreased concentration of ceruloplasmin is 
observed in patients suffering from Wilson’s disease, and is one of the diagnostic tests 
for identifying this disease (Hellman and Gitlin, 2002; Scheinberg and Gitlin, 1952).  In 
addition, patients suffering from the disease aceruloplasminemia contain significantly 
decreased levels of serum ceruloplasmin and demonstrate excessive iron accumulation 
in the liver and brain (Hellman and Gitlin, 2002; Morita et al., 1995).    
  Hephaestin, a homologue of ceruloplasmin was identified in mammals in 
1999 (Vulpe et al., 1999).  Although both ceruloplasmin and hephaestin are multi-
copper ferroxidases involved in the export of iron, their different expression patterns 
establish a requirement for both of these proteins in mammals.  While hephaestin is 
predominantly expressed in the small intestine and the colon, ceruloplasmin is 
expressed primarily in the liver with no expression detected in the small intestine (Harris 
et al., 1999; Vulpe et al., 1999).  Unlike ceruloplasmin, hephaestin is a membrane-
bound protein similar to Fet3p, the yeast homologue of ceruloplasmin, and has 
subsequently been shown to complement for the lack of ferroxidase activity in S. 
cerevisiae cells lacking the gene coding for Fet3p (Li et al., 2003).  Although the lack of 
hephaestin has not been implicated in a specific disorder, its presence explains the 
absence of anaemia in patients suffering from Wilson’s disease (Vulpe et al., 1999). 
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Thus, the presence of ceruloplasmin and hephaestin intricately links the homeostasis of 
copper and iron in eukaryotes. 
 
1.3.2.3 Superoxide Dismutases 
The superoxide dismutase (SOD) enzymes are vital for catalytically mediating the 
disproportionation of superoxide radicals into hydrogen peroxide and molecular oxygen 
(McCord and Fridovich, 1969).  SOD proteins are not exclusive to eukaryotes but are 
also expressed in prokaryotes (Culotta et al., 2006).  There are three types of known 
SOD proteins in eukaryotes denoted SOD1, SOD2 or SOD3 on the basis of the 
transition metal co-factor involved in mediating the dismutation reaction, and the 
localisation of the expressed protein.  SOD1 is a copper- and zinc-binding enzyme 
located primarily in the cytosol in addition to the intermembrane space of mitochondria, 
lysosomes, peroxisomes and the nucleus (Chang et al., 1988; Keller et al., 1991; Wood 
and Thiele, 2009).  Eukaryotic SOD1 exists as a dimer where each subunit binds one 
copper, one zinc, and contains a conserved intra-subunit disulfide bond between two 
conserved cysteines – Cys57 and Cys146 in human SOD1 (hSOD1), as shown in 
Figure 8 (Parge et al., 1992; Strange et al., 2003).  While copper is essential for the 
dismutation reaction, the binding of Zn(II) contributes to the thermal stability of SOD1 
(Forman and Fridovich, 1973).   
Initially it was thought that the activation of SOD1 which includes the 
formation of the intrasubunit disulfide bond and the acquisition of copper, was wholly 
dependent on the presence of the copper metallochaperone for SOD1 (CCS) (Leitch et 
al., 2009b).  However, it is now evident that the dependence on CCS for the activation 
of SOD1 can vary between different organisms (Leitch et al., 2009a).  The activation of 
SOD1 from S. cerevisae (Sod1) is completely dependent on yeast CCS (Ccs1), 
whereas SOD1 from Caenorhabitis elegans (C. elegans) is activated completely 
independently of CCS as it even lacks a CCS homologue (Jensen and Culotta, 2005; 
Leitch et al., 2009a).  In humans and other mammals, SOD1 can be activated by both 
CCS-dependent and independent pathways (Leitch et al., 2009a; Leitch et al., 2009b).  
Leitch et al. (2009b) have found that the CCS-independent activation of SOD1 is only 
possible with SOD1 proteins that lack a Pro residue at position 144.  It has been shown 
that mutation of Sod1 Pro144 to Leu, Ser or Gln enables CCS-independent activation of 
Sod1 like hSOD1 and C. elegans  SOD1 which lack a Pro at this position (Leitch et al., 
2009a).   
The importance of SOD1 is highlighted in the progressive motor 
neurodegeneration disease familial ALS (fALS).  Amongst the 10 % of the ALS cases 
that are known to be familial, almost one-fifth of those are caused by mutations in the 
SOD1 gene (Valentine et al., 2005).  More than 100 fALS-causing mutations are known 
in SOD1 including mutations at the dimer interface and the metal-binding region 
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(Valentine et al., 2005).  Mutation in SOD1 results in the gain-of-function of toxic 
properties which underlie SOD1-associated fALS pathogenesis (Valentine et al., 2005).  
The two major proposed gain-of-functions associated with fALS SOD1 mutants include 
the acquirement of a pro-oxidant activity and an increased propensity to aggregate.  
However, the precise mechanism underlying SOD1-mediated fALS pathogenesis and 
its link with neurodegeneration is yet to be determined conclusively (Furukawa and 
O'Halloran, 2006; Valentine et al., 2005). 
Eukaryotic SOD2 is a manganese-binding enzyme largely localised in 
the mitochondria where it is the chief anti-oxidant enzyme involved in the dismutation of 
the superoxide radicals produced as an undesired by-product of respiration (Culotta et 
al., 2006).  The deletion of the SOD2 gene in mice and D. melanogaster has been 
shown to result in early mortality (Duttaroy et al., 2003; Kirby et al., 2002; Lebovitz et 
al., 1996; Li et al., 1995).  Unlike SOD1, the mechanism underlying manganese 
incorporation in SOD2 is currently not known (Culotta et al., 2006).  SOD3 is a copper- 
and zinc-binding enzyme found in mammals, but unlike SOD1 it is produced and 
secreted by the vascular smooth muscle cells and is therefore localised extracellularly 
(Culotta et al., 2006; Stralin et al., 1995).  In addition, SOD3 has been reported to 
acquire its copper co-factor not from CCS but by the ATX1 copper metallochaperones 
(Itoh et al., 2008; Itoh et al., 2009), as discussed in section 1.3.2.4.1. 
 
1.3.2.4 Eukaryotic Copper Metallochaperones 
The eukaryotic copper metallochaperones are classified into three main categories – 
the ATX1 proteins, CCS, and the metallochaperones involved in mediating copper 
delivery to cytochrome oxidase in the mitochondria. 
 
1.3.2.4.1 The Anti-oxidant 1 (ATX1) family of copper metallochaperones 
The cytosolic 73 amino acid anti-oxidant 1 protein from S. cerevisiae (Atx1) (Figure 9a) 
was first discovered in 1995 as a mediator of defence against superoxide-related 
cellular toxicity (Lin and Culotta, 1995).  However, its role as a physiological antioxidant 
was later dismissed as copper-bound Atx1 was shown to dismutate superoxide in a 
stoichiometric and non-catalytic manner (Portnoy et al., 1999).  The function of Atx1 as 
a copper metallochaperone for the P1B-type ATPase Ccc2 was established in 1997 (Lin 
et al., 1997; Pufahl et al., 1997).   
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Figure 8: The crystal structure of holo-hSOD1 and the residues coordinating the 
binding of Cu(II) and Zn(II) in it.  The crystal structure of Cu(II) (brown sphere)- and Zn(II)-
bound (purple sphere) hSOD1 dimer (PDB accession code: 1hl5) is shown in (A) (Strange et al., 
2003).  The subunits are shown in pink and yellow.  The intrasubunit disulfide bonds are shown 
in black.  The ligands coordinating the binding of Cu(II) and Zn(II) in (A) are shown in (B), as 
labelled.    
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Atx1        -------MAEIKHYQFNVVMTCSGCSGAVNKVLTKLEPDVSKIDISLEKQLVDVYTTLPYDFILEKIKKTGKEVR-SGKQL--   73 
HAH1        ----------MPKHEFSVDMTCGGCAEAVSRVLNKLGG--VKYDIDLPNKKVCIESEHSMDTLLATLKKTGKTVSYLGLE---   68 
hCCSD1      MASDSGNQGTLCTLEFAVQMTCQSCVDAVRKSLQGVAG-VQDVEVHLEDQMVLVHTTLPSQEVQALLEGTGRQAVLKGMG---   79 
Ccs1D1      -----MTTNDTYEATYAIPMHCENCVNDIKACLKNVPG-INSLNFDIEQQIMSVESSVAPSTIINTLRNCGKDAIIRGAGKPN   77 
                                     
      
        (A) 
        
Ccs1        MTTN-----DTYEATYAIPMHCENCVNDIKACLKNVPGINSLNFDIEQQIMSVESSVAPSTIINTLRNCGKDAIIRGAGKPNSSAVAILE   85 
hCCS        MASDSGNQGTLCTLEFAVQMTCQSCVDAVRKSLQGVAGVQDVEVHLEDQMVLVHTTLPSQEVQALLEGTGRQAVLKGMGSGQ------LQ   84 
                 
 
Ccs1        TFQKYTIDQKKDTAVRGLARIVQVGENKTLFDITVNGVPEAGNYHASIHEKGDVSKGVESTGKVWHKFDEPIECFNESD-----LG--KN   168 
hCCS        NLGAAVAILGGPGTVQGVVRFLQLTPERCLIEGTIDGL-EPGLHGLHVHQYGDLTNNCNSCGNHFNPDGASHGGPQDSDRHRGDLGNVRA   173 
                  
 
Ccs1        LYSGKTFLSAP---LPTWQLIGRSFVISKSLN------HPENEPS-SVKDYSFLGVIARSAGVWENNKQVCACTGKTVWEERKDALANNI   248 
hCCS        DADGRAIFRMEDEQLKVWDVIGRSLIIDEGEDDLGRGGHPLSKITGNSGERLACGIIARSAGLFQNPKQICSCDGLTIWEERGRPIAGKG   263 
                    
 
Ccs1        K---------- 249 
hCCS        RKESAQPPAHL 274 
                 
                           (B) 
        
Figure 9: Sequence alignment of Eukaryotic copper metallochaperones.  The sequence alignments of Atx1 (GenBank accession code: 
NP_014140) (discussed in section 1.3.2.4.1), HAH1 (GenBank accession code: NP_004036) (discussed in section 1.3.2.4.1), H. sapiens CCS domain 1 
(hCCSD1; GenBank accession code: NP_005116) (discussed in sections 1.3.2.4.2 and 1.4.4) and Ccs1 domain 1 (CCSD1; GenBank accession code: 
NP_013752) (discussed in sections 1.3.2.4.2 and 1.4.4) are shown in (A).  The sequence alignment of hCCS and Ccs1 is shown in (B).  Fully conserved 
residues are highlighted in black while semi-conserved residues are shown in grey.   
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In vitro and in vivo studies have shown that Cu(I) transported from Atx1 to Ccc2 is 
subsequently required for incorporation in the copper-dependent ferroxidase Fet3 (Lin 
et al., 1997; Stearman et al., 1996; Yuan et al., 1995).  Yeast mutants lacking Atx1 were 
shown to be deficient in the high affinity uptake of iron (Lin et al., 1997).  In vitro 
experiments have shown Atx1 to receive Cu(I) from the Cu(I)-bound cytosolic domain of 
Ctr1, although this is yet to be verified in vivo (Xiao and Wedd, 2002; Xiao et al., 2004).  
Solution structures of Cu(I)-bound Atx1 were shown to contain the βαββαβ-fold where 
Cu(I) (Arnesano et al., 2001b), is coordinated by Cys15 and Cys18 of the M13XCXXC18 
motif in Cu(I)-Atx1, although a higher co-ordination number has also been proposed for 
Cu(I)-binding (Arnesano et al., 2001b; Pufahl et al., 1997; Rosenzweig et al., 1999).  
Lys65 in loop 5 of Atx1 (analogous to Tyr65 of BsCopZ), has also been proposed to be 
important for stabilising the metal-bound complex (Arnesano et al., 2001b).  The 
orientation of this residue towards the metal-binding site after Cu(I)-binding has been 
suggested to induce the movement of loop 5 such that it helps to protect the metal-
bound Cys ligands from solvation (Arnesano et al., 2001b).  In vivo studies have also 
shown Lys65 to be important for interaction with the Ccc2 MBDs (Portnoy et al., 1999), 
as discussed further in section 1.4.1.  
The human homologue of Atx1 (HAH1) is a cytosolic 68 amino acid 
protein containing the M10XCXXC15 motif (Figure 9a) that binds Cu(I) and transports it to 
the P1B-type ATPases ATP7A and ATP7B (Hamza et al., 1999; Hung et al., 1998; Larin 
et al., 1999).  HAH1 is a functional homologue of Atx1, as the presence of this protein 
was shown to reconstitute the growth defects and impaired iron homeostasis in yeast 
cells lacking Atx1 (Klomp et al., 1997).  The Cu(I)-bound crystal structure of HAH1 was 
the first structure to be solved by X-ray crystallography of a copper metallochaperone 
bound to its physiological substrate (Wernimont et al., 2000).  In the Cu(I)-bound HAH1 
dimer, a single Cu(I) ion was shown to be tri-coordinated by Cys12 and Cys15 of one 
monomer and Cys15 of the other subunit, as shown in Figure 10.  The HAH1 dimer was 
shown to be further stabilised by various intermolecular hydrogen-bonding interactions.  
These include the intersubunit interactions between Cys12 and Thr11 where Thr11 was 
also shown to hydrogen bond to a water molecule which in turn interacted with Asp9 of 
the same monomer (Wernimont et al., 2000).  Thr11 was therefore proposed to 
contribute to the orientation of the metal-binding loop and its stabilisation upon Cu(I)-
binding (Wernimont et al., 2000).  The Lys60 residues in the Cu(I)-HAH1 dimer were 
shown to interact with the Cu(I)-binding residues via hydrogen-bonding to a bridging 
water molecule (Wernimont et al., 2000).  Unlike Lys65 in Atx1, the mutation of HAH1 
Lys60 to Gly was not shown to be important for mediating the yeast two-hybrid 
interactions with its target proteins (Larin et al., 1999), as discussed further in section 
1.4.2.   
   
 35 
 
 
 
Figure 10: The crystal structure of Cu(I)-HAH1 dimer.  The crystal structure of HAH1 
dimer with one Cu(I) atom bound (PDB accession code: 1fee) (Wernimont et al., 2000).  
Subunits in the dimer are represented in brown and purple, Cu(I) is shown as a sphere, and the 
metal-binding Cys residues are shown as sticks.  The side chains of Thr11 and Lys60 from one 
of the subunits are also shown as orange and blue sticks, respectively.   
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While the Cu(I)-bound crystal structure of HAH1 was shown to be a dimer, both 
monomer and dimer forms of Cu(I)-bound HAH1 have been reported in solution 
(Anastassopoulou et al., 2004; Tanchou et al., 2004).  HAH1 has also been shown to 
regulate the expression of SOD3 in a copper-dependent manner and transport Cu(I) to 
SOD3 (Itoh et al., 2008; Itoh et al., 2009).  It has been suggested that the intracellular 
copper concentration may be a possible factor in determining the function of HAH1 as 
either a metallochaperone or a transcription factor (Itoh et al., 2008; Itoh et al., 2009).   
HAH1 has also been implicated as a possible link between cisplatin-
mediated anti-cancer therapy and copper homeostasis (Safaei et al., 2009).   Crystal 
structures of monomer and homodimer cisplatin-bound HAH1 have also been reported 
where the platinum ion was shown to be coordinated in a square planar manner by the 
Cys12 and Cys15 residues in the monomer (Boal and Rosenzweig, 2009b).  In the 
cisplatin-bound HAH1 dimer, the platinum ion is coordinated by Cys12 of each subunit 
with further stabilisation provided by hydrogen-bonding interactions between the amine 
groups of cisplatin, Thr11 and Cys12 (Boal and Rosenzweig, 2009b). 
1.3.2.4.2 Copper metallochaperone for Superoxide Dismutase 1 (CCS) 
The first copper metallochaperone for SOD1 was discovered in S. cerevisiae (Ccs1) as 
the protein involved in the incorporation of copper in SOD1 (Culotta et al., 1997).  The 
human homologue (hCCS) was reported simultaneously and was found to be a 
functional homologue of Ccs1 (Culotta et al., 1997).  hCCS has been found to be 
expressed ubiquitously in all human tissues and is largely cytosolic, although some of it 
was detected in the nucleus and peroxisome as well (Casareno et al., 1998; Islinger et 
al., 2009).  As shown in Figure 9b, there is a high amino acid sequence homology 
between hCCS and Ccs1.  Both hCCS and Ccs1 are modular proteins that contain 
three structurally and functionally distinct domains (Casareno et al., 1998; Lamb et al., 
1999; Schmidt et al., 1999a; Schmidt et al., 2000).  CCS Domain 1 (CCSD1) shares a 
high amino acid homology with Atx1 and HAH1, as shown in Figure 9a.  The crystal 
structure of Ccs1 and the solution structure of hCCSD1 reveal them to comprise the 
βαββαβ-fold (Figure 11a and Figure 12) similar to Atx1, HAH1 and CopZ 
metallochaperones (Lamb et al., 1999).  Ccs1 domain 1 (Ccs1D1) has only been found 
to be essential for Sod1 activation under copper-limiting conditions (Schmidt et al., 
1999a), as opposed to the mammalian cells where CCSD1 is vital for mediating the 
CCS-dependent activation of SOD1 irrespective of the cellular copper concentration 
(Caruano-Yzermans et al., 2006).  CCS Domain 2 (CCSD2) is structurally and 
sequentially homologous to SOD1 and has been shown to be vital for the interaction 
with SOD1 (Lamb et al., 2001; Schmidt et al., 1999a).  hCCS domain 2 (hCCSD2) 
contains all of the metal-binding residues as SOD1 apart from one of the copper-
binding His (His120) at position 200, as a result of which hCCSD2 can bind Zn(II) but 
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not copper, whereas Ccs1 domain 2 (Ccs1D2) contains neither a zinc nor a copper-
binding site (Lamb et al., 2000).  The mutation of Asp200 to His in hCCSD2 enables it 
to bind copper and the mutant protein displays SOD1-like activity (Schmidt et al., 
1999b).  Domain 3 (D3) is the most conserved yet the most unique domain of CCS.  It 
does not bear a particular resemblance to any other known protein domains and is the 
shortest and possibly the most flexible portion of CCS (Lamb et al., 1999).  CCSD3 
contains a conserved CXC-motif which can bind Cu(I) (Eisses et al., 2000; Rae et al., 
2001; Stasser et al., 2005).  CCSD3 has been shown to be essential for mediating 
CCS-dependent activation of SOD1, as discussed further in section 1.4.4 (Caruano-
Yzermans et al., 2006; Schmidt et al., 1999a; Schmidt et al., 2000). 
The information regarding the binding of copper in CCS arises primarily 
from a combination of in vitro and in vivo mutation studies since there is no copper-
bound structure available for either Ccs1 or hCCS.  In the crystal structure of apo-Ccs1 
dimer, the D1 Cys residues in the MXCXXC motif are present in an oxidised state 
(Lamb et al., 1999).  While the D1 Cys residues were reduced in the Ccs1-Sod1 crystal 
structure, no copper atoms were present in this complex either (Figure 11b) (Lamb et 
al., 2001).  A solution structre of apo-hCCSD1 has also been deposited in the protein 
data bank (code: 2crl) but there is very little information available regarding this 
structure (Figure 12).  hCCSD1 and Ccs1D1 both contain the MXCXXC motif.  The Cys 
residues in the MXCXXC motifs have been proposed to bind Cu(I) (Eisses et al., 2000; 
Rae et al., 2001; Stasser et al., 2005).  However, not all CCS homologues contain this 
motif such as the CCS homologue from D. melanogaster (Kirby et al., 2008) and 
Schizosaccharomyces pombe (Laliberte et al., 2004).   
The structural and copper-binding information for CCSD3 is also very 
limited since this domain was very disordered in the Ccs1 homodimer (Lamb et al., 
1999).  Ccs1D3 was partly folded into an α-helix in the Ccs1-Sod1 complex, as shown 
in Figure 11b (Lamb et al., 2001).  A disulfide bond between Ccs1 Cys229 and Sod1 
Cys57 was also observed (Figure 11b) (Lamb et al., 2001).  A study by Eisses et al. 
(2000) reported an interaction between hCCSD1 and hCCSD3 via a Cys-bridged 
dinuclear Cu(I) cluster, which is further supported by the X-ray absorption spectroscopy 
data reported by Stasser et al. (Stasser et al., 2005; Stasser et al., 2007).  Stasser et al. 
(2007) found that mutation of either of the hCCS Cys residues to Ala in the CXXC or the 
CXC motifs in D1 or D3 respectively, resulted in the binding of only one Cu(I) per hCCS 
molecule as opposed to the hCCS WT protein which can bind two Cu(I) ions per protein 
molecule.  Stasser et al. further reported the formation of a D3-mediated hCCS dimer 
via the formation of a Cu(I) cluster involving Cu(I) binding by the Cys residues in 
hCCSD3 (Stasser et al., 2005; Stasser et al., 2007).   The authors further proposed that 
the formation of a D3 mediated hCCS homodimer would promote interaction with 
hSOD1 as it would free hCCSD2 for interaction with hSOD1 (Stasser et al., 2005; 
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Stasser et al., 2007).  However, there is no evidence to date indicating the presence of 
a Cu(I)-hCCS cluster in vivo.  
As discussed previously in section 1.3.2.3, not all organisms contain 
homologues for CCS and SOD1 can be activated in a CCS-independent manner in 
some organisms (Leitch et al., 2009a).  SOD1-independent functions of hCCS have 
also been implicated (Angeletti et al., 2005; Gray et al., 2010; McLoughlin et al., 2001).  
hCCSD1 has been shown to interact with the β-secretase-1 (BACE1) enzyme involved 
in AD pathology (Angeletti et al., 2005; Gray et al., 2010) as discussed further in section 
1.5.6.  Investigating the interaction of hCCSD1 with BACE1 was one of the main aims 
of this study.  hCCSD3 has been reported to interact with the neuronal adaptor protein 
X11α (McLoughlin et al., 2001).  Although the implications of these interactions are not 
fully understood, it nevertheless highlights the potential multi-faceted involvement of 
hCCS in cellular biology, especially in neuronal copper homeostasis. 
1.3.2.4.3 Copper metallochaperones for Cytochrome c Oxidase 
Eukaryotic cytochrome c oxidase (COX) is the terminal mitochondrial-membrane-bound 
enzyme in the respiratory electron transfer chain.  COX is composed of multiple 
subunits whose assembly requires several co-factors including copper and heme 
(Capaldi, 1990).  The copper-requiring sites in COX include the binding of two Cu(I) 
ions in the COX2 subunit and one Cu(I) ion in the COX1 subunit (Capaldi, 1990).  The 
incorporation of Cu(I) in COX1 and COX2 involves the transfer of Cu(I) via several 
copper-binding proteins including COX17, SCO1, and COX11 (Horng et al., 2004).  In 
human cells, the incorporation of Cu(I) in COX also requires the SCO2 protein (Leary et 
al., 2004), as opposed to yeast where Sco2 is not essential for COX activation (Glerum 
et al., 1996a).   
Cox17 was first discovered in S. cerevisiae as a crucial cytoplasmic 
protein involved in the activation of COX via the delivery of copper to mitochondria 
(Glerum et al., 1996b).  COX activity was severely decreased in yeast cells lacking 
COX17 but could be rescued by the addition of excess copper salts to the growth 
medium (Glerum et al., 1996b).  Human COX17 (hCOX17) is a soluble 63 amino acids 
protein localised in the cytoplasm and the inner membrane space (IMS) of mitochondria 
(Amaravadi et al., 1997; Petruzzella et al., 1998).  COX17 proteins differ in their metal-
binding site and the protein structure in comparison to the above mentioned eukaryotic 
metallochaperones.  Instead of the ferredoxin-fold, Cox17 is folded into a helical hairpin 
or the coiled-coil helix CHCH structure (Arnesano et al., 2005).   
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Figure 11: The crystal structures of Ccs1 and Ccs1-Sod1.  The crystal structure of 
Ccs1 dimer with Ccs1D1 and Ccs1D2 shown in different shades of blue and green respectively 
(PDB accession code: 1qup) (Lamb et al., 1999) (A) and Ccs1-Sod1 complex (PDB accession 
code: 1jk9) with Sod1 shown in yellow, Ccs1D1 in blue, Ccs1D2 in green and Ccs1D3 in black 
(B) (Lamb et al., 2001).  The disulfide bond between Sod1 Cys57 (black sticks) and Ccs1 
Cys229 (red sticks) is also shown.   
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Figure 12: The superimposed structures of hCCSD1 and CcsD1.  The solution 
structure of hCCSD1 (PDB accession code: 2crl) shown in green was superimposed on Ccs1D1 
from Figure 11a, shown in blue.   
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Cu(I) binding in Cox17 is also unusual since it can be coordinated by two sequentially 
adjacent Cys residues (Cys22 and Cys23 in hCox17) (Banci et al., 2008b) whereas in 
most of the known copper metallochaperones Cu(I) is coordinated by the Cys residues 
in the CXXC motif (see sections 1.2.2.1,1.2.2.2,1.2.2.3 and 1.3.2.4.1).  Cox17 can also 
bind Cu(I) in a polycopper cluster and may act as a copper store in the mitochondria 
(Arnesano et al., 2005).  In addition, the structure of Cox17 is not similar to its partner 
proteins Sco1 and Cox11, unlike Atx1 and CCS which have similar structures to their 
target proteins (Robinson and Winge, 2010).  However, like the other copper 
metallochaperones, direct copper transfer has been reported between Cox17, Sco1 and 
Cox11 by both in vitro and in vivo experiments in yeast cells (Horng et al., 2004).  Sco1 
and Cox11 subsequently transfer Cu(I) to Cox2 and Cox1 respectively, assisting in the 
assembly of the COX enzyme (Carr et al., 2002; Glerum et al., 1996a; Khalimonchuk et 
al., 2007; Lode et al., 2000).  In humans, the maturation of COX2 has been shown to 
require both SCO1 (hSCO1) and SCO2 (hSCO2), and it has been proposed that 
hSCO2 may additionally function as a thiol-disulfide oxidoreductase that oxidises the 
Cys residues in hSCO1 facilitating the transfer of copper from hSCO1 to COX2 (Leary 
et al., 2009). 
 
1.3.3 Eukaryotic copper-transporting ATPases 
The Atx1 and HAH1 copper metallochaperones deliver Cu(I) the to P1B-type ATPases 
Ccc2 or ATP7A and ATP7B respectively, located in the secretory parthway in 
eukaryotes, as discussed below.   
 
1.3.3.1 The S. cerevisiae copper-transporting ATPase Ccc2 
Ccc2 is a P1B-type copper-transporting ATPase found in S. cerevisiae (Fu et al., 1995).  
It is localised in the membrane of the trans-golgi compartment and is indirectly involved 
in the high affinity uptake of iron in yeast cells (Yuan et al., 1997).  Ccc2 receives Cu(I) 
from Atx1 via direct protein-protein interaction (section 1.4.1) and transfers it to Fet3 
(Portnoy et al., 1999; Pufahl et al., 1997; Stearman et al., 1996).  Hence, Ccc2 
mediates the transport of Cu(I) from the cytosol to the secretory pathway (Pufahl et al., 
1997; Yuan et al., 1995).  Ccc2 contains two soluble MBDs at the N-terminus, each ~70 
amino acids long (Figure 13a) which can both interact with Atx1 (van Dongen et al., 
2004).  While there is no structure available for the second MBD of Ccc2 (Ccc2b), there 
are NMR structures available for the first MBD of Ccc2 (Ccc2a) in its apo- and Cu(I)-
bound forms (Banci et al., 2001a).  The NMR structures depict the βαββαβ-fold similar 
to Atx1.  In the holo-Ccc2a structure, a single Cu(I) ion is bound by the Cys residues in 
the M11XCXXC16 motif.  Thr17 in Cu(I)-Ccc2a was suggested to form a hydrogen-
bonding interaction with Cys13 which may contribute in optimising the conformation of 
Cys13 in holo-Ccc2a (Banci et al., 2001a).  Met11 in Ccc2a performs an analogous 
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function to the Met11 and Ile10 residue in BsCopZ and ScAtx1 respectively, by acting 
as a hydrophobic tether in stabilising the MXCXXC site for Cu(I)-binding (Banci et al., 
2001a).   Phe64 of Cu(I)-Ccc2a was proposed to be important for optimising the 
conformation of the metal-binding loop as it was shown to mediate hydrophobic 
interactions with Met11 and Van der Waals contact with Cys16 (Banci et al., 2001a).  
The replacement of the basic Lys residue in Atx1 (Lys65) by the hydrophobic Phe64 
residue in Ccc2a loop 5 is a conserved feature amongst these proteins and has been 
implicated in mediating Cu(I)-binding and protein-protein interactions with the copper 
metallochaperones (Banci et al., 2006a; DeSilva et al., 2005; Portnoy et al., 1999), as 
discussed below. 
 
1.3.3.2 The H. sapiens copper-transporting ATPase ATP7A 
ATP7A, the human homologue of Ccc2, is expressed in most tissues apart from liver 
where ATP7B is the dominant copper-transporting ATPase (Tumer and Moller, 2010).  
ATP7A is important for the biosynthesis of several enzymes including peptidyl-α-
monoxygenase, lysyl oxidase and tyrosinase (Lutsenko et al., 2007b).  In addition, 
ATP7A mediates the export of Cu(I) from enterocytes into the extracellular milieu for the 
utilisation of copper by other proteins (Lutsenko et al., 2007b).   
The importance of ATP7A is highlighted by the Menkes disease where 
genetic mutations in ATP7A lead to impaired copper export from enterocytes resulting 
in systemic copper deficiency (Chelly et al., 1993; Mercer et al., 1993; Vulpe et al., 
1993).  Unlike Ccc2, ATP7A can traffic to different subcellular locations in response to 
copper concentration.  At physiological copper concentrations ATP7A is located at the 
trans-golgi membrane, however, in the presence of excess copper ATP7A can relocate 
to vesicles which can fuse with the plasma membrane leading to the extracellular export 
of copper (Greenough et al., 2004; Petris et al., 1996).  Thus the biosynthetic and 
homeostatic functions of ATP7A are dependent upon its subcellular location (Lutsenko 
et al., 2007b).   
The N-terminus of ATP7A comprises 6 soluble MBDs (Figure 13b) and 
NMR structures are available for all of them.  The NMR structures display the βαββαβ-
fold similar to the previously mentioned copper metallochaperones (Banci et al., 2004b; 
Banci et al., 2005a; Banci et al., 2005b; Banci et al., 2006a; DeSilva et al., 2005; 
Gitschier et al., 1998; Jones et al., 2003).  In all of the Cu(I)-containing structures, Cu(I) 
is bound by the Cys residues in the MXCXXC motif (Banci et al., 2004b; Banci et al., 
2005a; Banci et al., 2005b; Banci et al., 2006a; DeSilva et al., 2005).   
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      Ccc2a           ------MREVILAVHGMTCSACTNTINTQLRALKGVTKCDISLVTNECQVTYD-NEVTADSIKEIIEDCGFDCEILRDSEI 74 
      Ccc2b           -----STKEGLLSVQGMTCGSCVSTVTKQVEGIEGVESVVVSLVTEECHVIYEPSKTTLETAREMIEDCGFDSNIIM---- 72 
                                      ^  ^ **** ^*  *^   ^    *^    ^^*      ^ ^             ^   **   ^      
 
              (A) 
  
ATP7A-1         MDPSMGVNSVTISVEGMTCNSCVWTIEQQIGKVNGVHHIKVSLEEKNATIIYDPKLQTPKTLQEAIDDMGFDAVIHN---- 77 
ATP7A-2         -----GEVVLKMKVEGMTCHSCTSTIEGKIGKLQGVQRIKVSLDNQEATIVYQPHLISVEEMKKQIEAMGFPAFVKK---- 72 
ATP7A-3         -----NDSTATFIIDGMHCKSCVSNIESTLSALQYVSSIVVSLENRSAIVKYNASSVTPESLRKAIEAVSPGLYRVS---- 72 
ATP7A-4         -----LTQETVINIDGMTCNSCVQSIEGVISKKPGVKSIRVSLANSNGTVEYDPLLTSPETLRGAIEDMGFDATLSD---- 72 
ATP7A-5         -----NSSKCYIQVTGMTCASCVANIERNLRREEGIYSILVALMAGKAEVRYNPAVIQPPMIAEFIRELGFGATVIE---- 72 
ATP7A-6         -----GDGVLELVVRGMTCASCVHKIESSLTKHRGILYCSVALATNKAHIKYDPEIIGPRDIIHTIESLGFEASLVK---- 72 
ATP7B-1         -----QVATSTVRILGMTCQSCVKSIEDRISNLKGIISMKVSLEQGSATVKYVPSVVCLQQVCHQIGDMGFEASIAE---- 72 
ATP7B-2         -----QEAVVKLRVEGMTCQSCVSSIEGKVRKLQGVVRVKVSLSNQEAVITYQPYLIQPEDLRDHVNDMGFEAAIKS---- 72 
ATP7B-3         -----HVVTLQLRIDGMHCKSCVLNIEENIGQLLGVQSIQVSLENKTAQVKYDPSCTSPVALQRAIEALPPGNFKVS---- 72 
ATP7B-4         -----TCSTTLIAIAGMTCASCVHSIEGMISQLEGVQQISVSLAEGTATVLYNPSVISPEELRAAIEDMGFEASVVS---- 72 
ATP7B-5         -----APQKCFLQIKGMTCASCVSNIERNLQKEAGVLSVLVALMAGKAEIKYDPEVIQPLEIAQFIQDLGFEAAVME---- 72 
ATP7B-6         -----SDGNIELTITGMTCASCVHNIESKLTRTNGITYASVALATSKALVKFDPEIIGPRDIIKIIEEIGFHASLA----- 71 
          
      (B) 
                 
Figure 13: Sequence alignment of the soluble metal-binding domains of Eukaryotic copper-ATPases.  The sequence alignment of the Ccc2 MBDs 
denoted as Ccc2a and Ccc2b (GenBank accession code NP_010556) (discussed in sections 1.3.3.1 and 1.4.1) is shown in (A).  The sequence alignments of the six 
MBDs of ATP7A denoted as ATP7A-1 to 6 (GenBank accession code NP_000043) (discussed in sections 1.3.3.2 and 1.4.2) and the six MBDs of ATP7B denoted 
as ATP7B-1 to 6 (GenBank accession code NP_000044) (discussed in sections 1.3.3.3 and 1.4.2) is shown in (B).  Fully conserved residues are highlighted in 
black while semi-conserved residues are shown in grey.  The residues highlighted in yellow indicate the residues that are not conserved in MBD3 unlike the other 
MBDs of ATP7A and ATP7B. ‘*’ denotes the residues that are fully conserved and ‘^’ denotes the residues that are semi-conserved compared to MBDs 1, 2, 4-6 of 
ATP7A and ATP7B too.   
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Similar to Phe64 of Ccc2a, the Phe residues in loop 5 of ATP7A MBDs 1, 2 and 4 have 
also been shown to be important for mediating hydrophobic interactions which help 
maintain the hydrophobic core of the structure (Banci et al., 2004b; DeSilva et al., 2005; 
Gitschier et al., 1998; Jones et al., 2003).  This is further supported by the results 
obtained by De Silva et al. (2005) who found that mutation of Phe71 to Ala in ATP7A 
MBD1 resulted in partial unfolding of the protein.  However, the mutation of Phe72 to 
Ala in ATP7A MBD2 did not have a significant effect on the rate of Cu(I) removal from 
Cu(I)-bound ATP7A MBD2 (Jones et al., 2003).  The authors suggested that the 
presence of Phe72 may be important for optimising the MBS for Cu(I)-binding and may 
also prevent the aberrant binding of other metal ions (Jones et al., 2003).  The Phe 
residue in loop 5 is substituted Pro (Pro66) in MBD3 (Figure 13b) which has been 
implicated in contributing to the lowest Cu(I)-binding affinity of MBD3 compared to the 
other ATP7A MBDs (Banci et al., 2006a; Banci et al., 2010a) and the lack of formation 
of an adduct with HAH1 (Banci et al., 2006a). 
While the exact function of MBDs is not known, mutation of the copper-
binding Cys residues in the MXCXXC motifs of the MBDs has been shown to disrupt 
the copper-dependent trafficking of ATP7A to the plasma membrane in the presence of 
excess copper (Voskoboinik et al., 1999).  The MBDs have also been shown to interact 
with the oxidoreductase glutaredoxin 1 (GRX1) in a yeast two-hybrid system in a 
copper-dependent manner (Lim et al., 2006a).  The interaction of ATP7A MBDs with 
GRX1 was shown to be mediated by the copper-binding Cys residues in the MXCXXC 
motifs of the MBDs.  The authors proposed that the interaction of MBDs with GRX1 may 
promote Cu(I)-binding to the Cys residues by either de-glutathionylation of the Cys 
residues or by reducing the formation of potential intramolecular disulfide bonds in the 
MBDs (Lim et al., 2006a).   Of particular interest to this study is the interaction of the 
ATP7A MBDs with its copper metallochaperone HAH1 (section 1.4.2). Although all of 
the MBDs are capable of binding Cu(I) in vitro and in vivo (Lutsenko et al., 1997), the 
Cu(I)-binding affinities of the MBDs are not equivalent (Banci et al., 2010a).  The Cu(I)-
binding affinities of ATP7A MBDs 1 and 6 were shown to be higher than the Cu(I)-
affinity of MBDs 2, 3 and 5 (Banci et al., 2010a).  In addition, the Cu(I)-affinities of 
MBDs 1, 2 and 6 were significantly higher than the Cu(I)-binding affinity of HAH1 which 
may have implications for the Cu(I)-dependent interactions of ATP7A MBDs with HAH1, 
discussed in section 1.4.2.   
 
1.3.3.3 The H. sapiens copper-transporting ATPase ATP7B 
ATP7B, the second copper-transporting ATPase in humans, is predominantly 
expressed in the liver, in addition to brain, kidney and other tissues (Lutsenko et al., 
2007b).  Similar to ATP7A, ATP7B also resides in the trans-golgi membrane and 
receives Cu(I) from HAH1 via direct protein-protein interaction (see section 1.4.2).  
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ATP7B is responsible for the incorporation of copper into ceruloplasmin under 
physiological copper concentrations (Terada et al., 1998).  In the presence of excess 
copper, ATP7B has been shown to relocate near the apical surface in hepatocytes 
resulting in the export of Cu(I) via bile (Hung et al., 1997; Schaefer et al., 1999).  
Genetic mutations in ATP7B can lead to the Wilson’s disease due to the disruption of 
copper export from hepatocytes resulting in the accumulation of copper leading to liver 
cirrhosis and neurodegeneration (Das and Ray, 2006; Lutsenko et al., 2007b).  Like 
ATP7A, ATP7B also contains six soluble MBDs in its NTD which all contain the 
MXCXXC motif (Figure 13a) and can bind Cu(I) ions via the Cys residues of this motif 
(Lutsenko et al., 1997; Yatsunyk and Rosenzweig, 2007).  The mutation of the Cu(I)-
binding Cys residues in the MBDs to Ser has been shown to disrupt the Cu(I)-
translocating activity of ATP7B and its trafficking (Mercer et al., 2003).  MBDs 5 and 6 in 
particular have been shown to be important for the Cu(I)-dependent trafficking of 
ATP7B (Mercer et al., 2003; Strausak et al., 1999).   
The ATP7B MBDs have also been shown to interact with GRX1 (Lim et 
al., 2006a) and with the p62 subunit of dynactin (Lim et al., 2006b).  Both of these 
interactions were reported to be Cu(I)-dependent and mediated by the copper-binding 
Cys residues in the MBDs.  The ATP7B MBDs have also been shown to interact with 
the Murr1 protein which may be important for facilitating the ATP7B-mediated Cu(I) 
excretion into bile (Tao et al., 2003).  A recent study also reported intercommunication 
between the MBDs via hydrogen-bonding interactions to influence the redox status and 
the conformation of the N-terminus of ATP7B (LeShane et al., 2010).  However, this 
study will focus primarily on the molecular basis of the interaction of HAH1 with the 
MBDs of ATP7B, as discussed further in section 1.4.2. 
   
1.4 The Molecular Basis of the Interaction of Copper metallochaperones with 
their partner proteins 
The major goal of this study was to further investigate the molecular basis of the 
complex formation of copper metallochaperones with their interacting partner proteins.  
Most of the copper metallochaperones and their target proteins share two common 
features namely the ferredoxin-like fold and the CXXC metal-binding motif.  However, 
not all of the copper metallochaperones and their target proteins contain these two 
factors.  For example, COX17, SCO1, SCO2 and the CusF copper metallochaperones 
do not contain either of these two factors.  Similarly, the presence of these two factors 
is not sufficient to enable Cu(I) transfer from a copper metallochaperone to a Cu(I)-
binding protein.  For example, Atx1 and Ccs1D1 both contain the CXXC motif and the 
ferredoxin-fold yet Atx1 is unable to substitute for Ccs1D1 in vivo (Schmidt et al., 
1999a).  Thus, in order to understand the specificity with which copper 
metallochaperones associate with and deliver Cu(I) to their target proteins it is vital to 
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study the molecular basis of these protein-protein interactions.  As highlighted by some 
of the examples discussed below, the interactions are governed by several factors 
including the surface charge of the proteins, hydrogen bonding and hydrophobic 
interactions between the proteins. 
 
1.4.1 Interaction of Atx1 with Ccc2 
Several studies have reported the complex formation between Atx1 and the MBDs of 
Ccc2 to be mediated by Cu(I)-binding (Arnesano et al., 2001a; Portnoy et al., 1999; 
Pufahl et al., 1997).   Atx1 interacts with Ccc2a and Ccc2b by a combination of 
electrostatic, hydrophobic and hydrogen-bonding interactions (Arnesano et al., 2001b; 
Banci et al., 2006b).  Atx1 contains several surface-exposed Lys residues that provide 
an overall positively charged surface.  In similar positions Ccc2 MBDs contain several 
residues that provide it with a negatively charged surface, and thus assist in complex 
formation with Atx1 on the basis of electrostatic interactions (Arnesano et al., 2001b; 
Banci et al., 2006b).  This is further supported by the results reported by Portnoy et al. 
(1999) who found that the mutation of Lys24 and Lys28 to Ala or Glu in Atx1 decreased 
the uptake of 55Fe in yeast cells lacking ATX1.  While the mutation of Atx1 Lys65 to Glu 
also resulted in reduced uptake of 55Fe in atx1∆ cells, the Atx1 Lys65Ala, Lys65Phe did 
not have a significant effect on 55Fe uptake (Portnoy et al., 1999).  Similar results were 
also reported for the yeast two-hybrid interaction between Atx1 and Ccc2 MBDs, where 
the Atx1 Lys24Glu,Lys28Glu; Lys61Glu,Lys62Glu; and Lys65Glu mutations also 
abolished the interactions (Portnoy et al., 1999).  The high ambiguity driven protein-
protein docking (HADDOCK) model of Atx1-Cu(I)-Ccc2a provided further evidence for 
the role of Atx1 Lys65 in mediating protein-protein interactions.  While in apo-Atx1, 
Lys65 appears to be further away from the metal site (Arnesano et al., 2001b), in the 
complex of Cu(I)-Atx1 with Ccc2a, the side chain of Atx1 Lys65 forms intermolecular 
hydrogen bonds with either Ala15 or Asn18 of Ccc2a (Arnesano et al., 2004). 
  An NMR derived Cu(I)-mediated complex between Atx1 and Ccc2 
(Figure 14) has also been reported (Banci et al., 2006b).  This complex depicted Cu(I) 
to be tri-coordinated by Cys15 of Atx1 and Cys13 and Cys16 of Ccc2a.  Cu(I) transfer 
was shown to be mediated by ligand transfer reactions via the formation of this complex 
(Banci et al., 2006b), as proposed previously by Pufahl et al. (1997).  In addition, the 
Atx1-Ccc2 MBD interactions were shown to be dependent on the copper concentration.  
Both high and low copper concentrations resulted in significantly weaker yeast two-
hybrid interactions between Atx1 and Ccc2 MBDs (Pufahl et al., 1997; van Dongen et 
al., 2004).  The dependence of the interaction between Atx1 and Ccc2 MBDs on copper 
is further highlighted by the evidence that mutation of the Cu(I)-binding Cys residues in 
the CXXC motif of Atx1 to Ala abolished the yeast two-hybrid interactions between them 
(Portnoy et al., 1999). 
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Figure 14: The solution structure of Cu(I)-bound Atx1-Ccc2a complex.  The solution 
structure of Atx1-Cu(I)-Ccc2a (PDB accession code: 2ggp) where Atx1 is shown in green and 
Ccc2a is shown in blue (Banci et al., 2006b).  The Cu(I)-binding Cys residues are shown as 
sticks and Cu(I) is shown as a sphere.   
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1.4.2 Interaction of HAH1 with ATP7A and ATP7B 
HAH1 has been shown to interact with the MBDs of ATP7A and ATP7B both in vitro 
and in vivo in a Cu(I)-dependent manner which requires the Cu(I)-binding Cys residues 
of the CXXC motif (Hamza et al., 1999; Larin et al., 1999; Strausak et al., 2003).  
However, there is some discrepancy regarding which MBDs can interact with and 
acquire Cu(I) from Cu(I)-bound HAH1.  Yeast two-hybrid studies have revealed HAH1 
to interact with constructs containing ATP7A MBDs 2-6 (Larin et al., 1999), MBDs 1 and 
2, and MBDs 3 and 4 (Strausak et al., 2003).  No yeast two-hybrid interaction was 
reported between HAH1 and a construct containing ATP7A MBDs 5 and 6 (Strausak et 
al., 2003).  In contrast, experiments using SPR found HAH1 to interact with all of the 
individual MBDs in ATP7A (Strausak et al., 2003).  Initially, Cu(I) transfer was reported 
between HAH1 and ATP7A MBD2 or 5 (Banci et al., 2005b).  However, studies using 
NMR spectroscopy revealed the formation of Cu(I)-mediated protein complexes 
between Cu(I)-HAH1 and ATP7A MBD1, between Cu(I)-HAH1 and ATP7A MBD4, but 
not between Cu(I)-HAH1 and ATP7A MBDs 2 or 3 (Banci et al., 2007).  In addition, 
Cu(I)-HAH1 was shown to transfer Cu(I) to ATP7A MBD1, MBD4,  MBD6 and possibly 
MBD5 (Banci et al., 2007).  It is possible that this discrepancy may be due to the fact 
that the previous study was conducted using the isolated domain of ATP7A MBD5 
(Banci et al., 2005b) whereas the latter study used a construct containing all of the 
MBDs of ATP7A which is likely more physiologically relevant (Banci et al., 2007).   
The results are in partial agreement with the Cu(I)-binding affinity data 
where the Cu(I)-binding affinity of HAH1 was reported to be significantly weaker than 
the Cu(I)-affinity of ATP7A MBDs 1, 2 and 6 (Banci et al., 2010a).  Whereas, the Cu(I)-
affinity of ATP7A MBDs 5 was found to be only slightly higher than the Cu(I)-affinity of 
HAH1 (Banci et al., 2010a).  A solution structure has also been reported for the Cu(I)-
containing HAH1-ATP7A MBD1 complex (Banci et al., 2009).  The HAH1-Cu(I)-ATP7A 
MBD1 complex was shown to be bridged by a Cu(I) ion and the interaction was also 
reported to be electrostatically favourable as HAH1 has a positively charged surface 
compared to ATP7A MBD1 (Banci et al., 2009).  Site-directed mutagenesis studies 
indicated that the HAH1-Cu(I)-ATP7A MBD1 adduct formation required only three of the 
four Cu(I)-binding Cys where HAH1 Cys12 and ATP7A MBD1 Cys15 were found to be 
essential (Banci et al., 2009), similar to the Atx1-Cu(I)-Ccc2a complex formation (Banci 
et al., 2006b). 
  Discrepancies have also been reported between the interactions of 
Cu(I)-HAH1 with ATP7B MBDs.  Larin et al. (1999) found that HAH1 can interact with a 
construct comprising ATP7B MBDs 1-6 and various other combinations including MBDs 
1-4 but not with a construct containing only MBDs 5 and 6 in a yeast two-hybrid system.  
In support of these experiments, no complex formation or Cu(I) transfer was evident 
between Cu(I)-HAH1 and ATP7B MBDs 5 and 6 in vitro (Achila et al., 2006).  However, 
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titration of apo-ATP7B MBDs 5 and 6 with Cu(I)-ATP7A MBD4 demonstrated partial 
Cu(I) transfer, suggesting that ATP7B MBDs 5 and 6 may be able to acquire Cu(I) from 
other Cu(I)-bound MBDs in vivo (Achila et al., 2006).  Cys-labelling and ITC studies 
have also reported that Cu(I) may preferentially be transferred first from Cu(I)-HAH1 to 
the ATP7A MBD2 (Walker et al., 2004; Wernimont et al., 2004), whether a similar 
preference is reflected in vivo is not known.  Cu(I)-dependent complex formation and 
Cu(I) transfer has also been reported between Cu(I)-HAH1 and ATP7B MBD4 (Achila et 
al., 2006; Banci et al., 2008a; Bunce et al., 2006; Hussain et al., 2009).  Hussain et al. 
(2009) found that the HAH1-Cu(I)-ATP7B MBD4 interaction was disrupted by the 
mutation of Lys60 to Ala or Tyr in HAH1, in addition to decreased Cu(I)-transfer 
between these HAH1 mutants and ATP7B MBD4.   Met10 and Thr11 of HAH1 were 
also shown to be important for mediating Cu(I) transfer to ATP7B MBD4, as the 
mutation of these residues resulted in decreased Cu(I) transfer (Hussain et al., 2009).  
Molecular mechanics studies further suggested that the transfer of Cu(I) from Cu(I)-
HAH1 to apo-ATP7B MBD4 likely involves a 3 coordinate intermediate species where 
the N-terminal Cys residues in the MXCXXC sites of both proteins are vital for Cu(I) 
transfer (Rodriguez-Granillo et al., 2010).  Cu(I)-transfer has also been shown between 
HAH1 and ATP7B MBD1, although whether this can also occur in vivo is not known 
(Bunce et al., 2006). 
 
1.4.3 Interaction of ScAtx1 with the metal-binding domains of PacS and CtaA 
Synechocystis PCC 6803 provides a rare example where a P1B-type copper transporter 
(CtaA) has been proposed to mediate Cu(I)-import into the prokaryotic cytosol.  In 
addition, the copper metallochaperone ScAtx1 has been shown to interact with the 
MBDs of both CtaA and PacS (Tottey et al., 2001).  Compared to the interaction of 
ScAtx1 with PacS MBD there is relatively little information available regarding the 
interaction of ScAtx1 with CtaA MBD.  Bacterial two-hybrid assays have demonstrated 
that the interaction of ScAtx1 with PacS MBD and CtaA MBD require the Cys12 and 
Cys15 residues of the CXXC motif in ScAtx1 (Tottey et al., 2002).  The presence of 
His61 in loop 5 of ScAtx1 in place of Tyr or Lys – the usual amino acids in prokaryotic 
and eukaryotic copper metallochaperones respectively, is unusual and has been 
proposed to be one of the main driving forces in mediating the transfer of Cu(I) from 
CtaA MBD to ScAtx1 and the subsequent transfer of Cu(I) from ScAtx1 to PacS MBD 
(Banci et al., 2004a; Tottey et al., 2002).  In the proposed model, the movement of 
ScAtx1 His61 towards the Cu(I)-binding site is suggested to promote the acquisition of 
Cu(I) from CtaA MBD while its outward movement results in the release of Cu(I) from 
ScAtx1 to PacS MBD (Banci et al., 2004a).  In addition, the mutation of ScAtx1 His61 to 
Arg was shown to enhance the bacterial two-hybrid interaction between ScAtx1 and 
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PacS MBD but did not have a significant effect on the interaction with CtaA MBD 
(Borrelly et al., 2004).  The authors therefore suggested that this residue can interact 
differently with both domains (Borrelly et al., 2004).  Previously, based on the solution 
structure of Cu(I)-ScAtx1, the His61 residue was also proposed to bind Cu(I) in addition 
to Cys12 and Cys15 (Banci et al., 2004a).  However, the recent crystal structures of 
ScAtx1 dimers clearly depict that His61 does not act as a direct Cu(I)-binding ligand 
(Figure 6) (Badarau et al., 2010).  Mutation of this residue was however shown to result 
in major conformational changes (Badarau et al., 2010), as discussed previously in 
section 1.2.2.4.  One of the aims of this study was to further investigate the precise role 
of this residue in mediating the interactions of ScAtx1 with CtaA MBD and PacS MBD. 
Badarau et al. (2010) have recently shown that while the transfer of Cu(I) 
from CtaA MBD to ScAtx1 is favourable in vitro, the subsequent transfer of Cu(I) from 
one Cu(I)-bound ScAtx1 dimer to PacS MBD is unfavourable.  Cu(I) was shown to 
transfer more readily from ScAtx1 to PacS MBD if the Cu(I) source was two Cu(I)-bound 
ScAtx1 dimer instead of one Cu(I)-bound ScAtx1 dimer (Badarau et al., 2010).  The 
dimerisation state of ScAtx1 can therefore be an important factor in determining Cu(I) 
transfer between these proteins (Badarau et al., 2010).  Further information regarding 
the interaction of ScAtx1 with PacS MBD can be gained from the HADDOCK model of 
the ScAtx1-Cu(I)-PacS MBD complex where the proteins were bridged by a single Cu(I) 
ion (Banci et al., 2006c).  The complex was proposed to be further stabilised by a 
network of electrostatic and hydrophobic interactions between the two interacting 
surfaces, although the surface charges of ScAtx1 and PacS MBD are not as 
pronounced as in the case of Atx1-Ccc2a or BsCopA-BsCopAb (Banci et al., 2006c).  
Unlike ScAtx1-PacS MBD there is no structural information available regarding the 
ScAtx1-CtaA MBD interaction.  The isolation of two different structural arrangements of 
Cu(I)-ScAtx1 homodimers (Figure 6) led the authors to suggest that these may 
represent different structural complexes regarding the interaction of ScAtx1 with each of 
its target MBDs (Badarau et al., 2010).  Since the HADDOCK model of ScAtx1-PacS 
MBD depicted it to be a side-to-side complex (Banci et al., 2006c) it is possible that the 
head-to-head conformation may be favoured for the ScAtx1-CtaA MBD complex 
formation (Badarau et al., 2010).  This hypothesis was further investigated in this study, 
as discussed in section 1.6. 
 
1.4.4 Interaction of CCS with SOD1 
Despite several studies, the exact mechanism underlying the CCS-dependent activation 
of SOD1 is not fully resolved.  The most popular model regarding CCS-mediated SOD1 
activation involves the “pivot, insert, release” pathway (Furukawa et al., 2004; Rae et 
al., 2001).  Based on this model the first step involves the interaction of CCS with the 
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disulfide reduced, zinc-bound form of SOD1.  However, there is some discrepancy 
regarding the identity of the oligomeric species between CCS and SOD1.  The Ccs1-
Sod1 crystal structure was found to be a dimer involving one monomer of SOD1 and 
one monomer of Ccs1 (Lamb et al., 2001).  An alternative theory regarding the CCS-
dependent activation of SOD1 proposes the formation of a hetero-tetramer between a 
dimer of CCS and a dimer of SOD1 (Hall et al., 2000).  Irrespective of the oligomeric 
species formed, the CCS-SOD1 interaction is mediated by a combination of 
electrostatic, hydrophobic and hydrogen-bonding mediated interactions between 
CCSD2 and SOD1 (Hall et al., 2000; Lamb et al., 2001).  The CCS-dependent 
activation of SOD1 requires the formation of the essential disulfide bond in SOD1 
between Cys57 and Cys146 and the incorporation of copper in the SOD1 copper-
binding site in the presence of oxygen, followed by the dissociation of the CCS-SOD1 
heterooligomer (Brown et al., 2004; Furukawa et al., 2004; Rae et al., 2001).  The 
transfer of Cu(I) from CCS to SOD1 has been shown to involve the formation of an 
intermolecular disulfide bond between the CXC motif in CCSD3 and SOD1 (Hall et al., 
2000; Lamb et al., 2001; Schmidt et al., 1999a).  An intermolecular disulfide bond is 
also evident between Sod1 Cys57 and Ccs1 Cys229 in the Ccs1-Sod1 crystal structure 
(Figure 11b).  It has further been proposed that the incorporation of copper in SOD1 
involves the transfer of Cu(I) from CCSD3 to SOD1 since Ccs1D1 was shown to be 
located too far away from the Sod1 active site in the Ccs1-Sod1 complex (Lamb et al., 
2001).  CCSD3 is likely the most flexible part of CCS and is located closer to the Sod1 
active site in the Ccs1-Sod1 complex than Ccs1D1.  It was therefore suggested that 
Cu(I) may be transferred from CCSD3 to SOD1 (Lamb et al., 2001).   
The role of CCSD1 in SOD1 activation is less clear and has been 
subsequently described as the most “enigmatic” region of CCS (Leitch et al., 2009b).  
There is evidence to indicate that the role of D1 may be species specific.  Studies in 
yeast documented Ccs1D1 to be important for SOD1 activation only when copper is 
limiting suggesting that under these conditions copper is initially bound by D1 and then 
transferred to D3 for incorporation into Sod1 (Schmidt et al., 1999a; Schmidt et al., 
2000).  Studies in mammalian cells have shown that CCSD1 is essential for the 
activation of SOD1 in both copper-limiting and copper-replete conditions (Caruano-
Yzermans et al., 2006).  In contrast, GST-purification assays have shown that the D1 of 
hCCS is not required for mediating the interaction with SOD1 (Casareno et al., 1998).  
Furthermore, the mutation of the Cu(I)-binding Cys residues in hCCSD1 did not 
abrogate the CCS-mediated activation of hSOD1 in vitro (Stasser et al., 2005; Stasser 
et al., 2007).  Hence, there is discrepancy regarding the role of hCCSD1 with respect to 
the interaction with and Cu(I) transfer to SOD1.  Stasser et al. also reported the 
formation of a Cu(I)-cluster involving Cu(I)-binding by the Cys244 and Cys246 residues 
of two hCCS monomers (Stasser et al., 2005; Stasser et al., 2007).  The authors 
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proposed that while apo-hCCS dimerises via interactions involving D2, upon the 
formation of the Cu(I)-cluster, hCCS can instead dimerise via D3 (Stasser et al., 2005; 
Stasser et al., 2007).  The D3-mediated dimerisation of hCCS would subsequently allow 
hCCS to interact with SOD1 via D2 (Stasser et al., 2005; Stasser et al., 2007).  
However, whether this cluster can form in vivo is currently not known.  One of the aims 
of this study was to elucidate the role of hCCS Cu(I)-binding residues in mediating the 
interaction with hSOD1 in vivo. 
 
1.5 The Role of Copper in Alzheimer’s disease 
AD is the most common form of dementia and is known to affect more than 29 million 
people in the world.  The major risk factor for AD remains age and it is usually 
diagnosed in over 65 year olds (van Es and van den Berg, 2009).  Irreversible 
neurodegeneration leads to memory loss and cognitive decline in the affected 
individuals.  Although AD was discovered more than 100 years ago, the cause of the 
disease in the majority of cases still remains unknown.  Approximately 1 % of AD cases 
are known to be familial and the mutations are traced to the genes involved in the 
production of Aβ peptide including the genes encoding for presenilin 1, presenilin 2 – 
components of the γ-secretase complex, and  the gene coding for APP (Goate et al., 
1991; Levy-Lahad et al., 1995; Sherrington et al., 1995; van Es and van den Berg, 
2009).  Another challenge in controlling AD is its late diagnosis.  To date, the most 
conclusive evidence for AD involves post-mortem analysis of the brain tissue (van Es 
and van den Berg, 2009).  Two distinct pathological hallmarks of AD are the presence 
of intracellular neurofibrillary tangles (NFTs) and extracellular senile plaques 
(Morrissette et al., 2009). 
 
1.5.1 Neuropathology of Alzheimer’s disease 
In the 1980s it was discovered that NFTs were composed of aggregated microtubule-
associated tau protein as a result of excessive and abnormal phosphorylation 
(Grundke-Iqbal et al., 1986; Kosik et al., 1986), whereas the major component of the 
senile plaques was identified as the Aβ peptide (Glenner and Wong, 1984; Masters et 
al., 1985).  Other pathological factors associated with AD include oxidative damage, 
synaptic injury and metal mis-homeostasis (Bush, 2003; Molina-Holgado et al., 2007).  
The major focus of AD research remains the aggregation of Aβ as described by the 
‘amyloid cascade hypothesis’ of AD (Hardy and Higgins, 1992).  Aβ is produced as a 
result of the endoproteolytic cleavage of APP (Kang et al., 1987) by a combination of 
secretases, shown in Figure 15.  The major component of senile plaques is the 42 
amino acid Aβ peptide (Aβ42) which is produced by the amyloidogenic processing of 
APP (Younkin, 1998).  The amyloidogenic pathway involves the cleavage of APP by 
BACE1 to generate the N-terminal end of Aβ followed by the intramembranous 
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cleavage of APP by the γ-secretase complex at the C-terminus leading to the release of 
Aβ (Figure 15).  In the non-amyloidogenic pathway, a truncated Aβ peptide is produced 
due to the cleavage of Aβ by the α-secretases instead of BACE1 (LaFerla et al., 2007), 
as shown in Figure 15.  The formation of the longer Aβ42 peptide and its subsequent 
aggregation is thought to be one of the major pathological causes of AD as described 
by the ‘amyloid cascade hypothesis’ (Hardy and Higgins, 1992). 
 
1.5.2 The ‘amyloid cascade hypothesis’ of Alzheimer’s disease 
The ‘amyloid cascade hypothesis’ was first proprosed by Hardy and Higgins in 1992.  
According to this hypothesis, the deposition of Aβ into senile plaques is the primary 
event leading to AD as a consequence of synaptic injury and neuronal loss (Hardy and 
Higgins, 1992).  Although the role of Aβ as a major contributor in AD pathogenesis is 
indisputable, the neurotoxicity of extracellular Aβ aggregates and their role as the main 
causative agent has been questioned due to the studies showing a lack of correlation 
between the deposition of senile plaques and the extent of the observed cognitive 
decline (Bush, 2003; Cuajungco et al., 2000; Hardy and Selkoe, 2002; Terry et al., 
1991).  In addition, Aβ was also found to be a component of the healthy human brain, 
although its exact function remains unknown (Haass et al., 1992).  However, in the 
healthy brain, Aβ is present in a soluble, monomeric form which is non-toxic, whereas 
the main constituent of senile plaques is the aggregated oligomeric form of Aβ (Piccini 
et al., 2005).  A more consistent biomarker appears to be the presence of soluble 
oligomers of Aβ (Hardy and Selkoe, 2002).  Several studies have shown a correlation 
between the presence of the soluble oligomeric form of Aβ and cognitive decline 
(Knobloch et al., 2007; Naslund et al., 2000; Oddo et al., 2003).  It has been postulated 
that the intracellular deposition of Aβ is an upstream event in AD pathogenesis as 
opposed to the presence of senile plaques which perhaps occurs at a relatively late 
stage of AD pathogenesis (LaFerla et al., 2007). The aggregation of Aβ has been 
closely associated with the mis-homeostasis of metals in AD, in particular copper, as 
discussed below.  
 
1.5.3 Copper mis-homeostasis in Alzheimer’s disease 
AD brains can contain up to 400 % more copper than the healthy human brain, and a 
high concentration of copper has also been detected in association with senile plaques 
(Lovell et al., 1998).  Copper mis-homeostasis in AD has an added complexity, as it 
appears to involve an imbalance between the extracellular and the intracellular 
concentration of copper (Filiz et al., 2008).  While excess extracellular copper is thought 
to be a strong contributor to oxidative stress, decreased intracellular copper 
concentration in AD is associated with reduced activity of cuproenzymes including 
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SOD1 and COX (Bayer et al., 2003; Maurer et al., 2000).  As mentioned previously 
(section 1.1.5), the brain is particularly vulnerable to metal-mediated toxicity which gets 
further aggravated by the age-dependent decline of the activity of the brain’s antioxidant 
enzymes.  In addition, Aβ, APP and BACE1, the main protein components involved in 
AD pathogenesis, have all been implicated in copper mis-homeostasis in AD. 
 
1.5.4 Amyloid-β and copper mis-homeostasis 
The Aβ peptide readily binds metals, in particular, copper and zinc (Faller, 2009).  
Copper-binding in Aβ has been shown to be coordinated by three His residues (His6, 
His13 and His14) and the carboxyl group of the N-terminus (Karr et al., 2005; Syme et 
al., 2004). In vitro experiments have reported Aβ to reduce Cu(II) to Cu(I) and the 
copper-bound Aβ complex has been shown to be more toxic than apo-Aβ as it can react 
with molecular oxygen to form hydrogen peroxide and further contribute to oxidative 
stress (Atwood et al., 2004; Huang et al., 1999).  In contrast, Aβ has also been shown 
to act as an anti-oxidant (Atwood et al., 2003; Kontush et al., 2001).  A study by 
Nakamura et al. (2007) reported decreased production of hydroxyl radicals in the 
presence of Aβ by free Cu(II).  Conflicting results have also been reported regarding 
copper-mediated aggregation of Aβ.  While some studies have shown copper to 
promote Aβ aggregation, other studies have reported Aβ oligomers to adopt a distorted 
structure in the presence of copper that is less prone to aggregation (Atwood et al., 
2004; Jiao and Yang, 2007).   
It has been proposed that metal-bound Aβ can act both as a pro-oxidant 
and as an anti-oxidant depending upon the oligomeric state of Aβ (Zou et al., 2002).  In 
its monomeric state, Aβ protects the neurons against metal-mediated oxidative 
damage, whereas in its aggregated state the presence of metals including copper, 
promotes oxidative damage.  Further studies are however required to determine the 
precise effect of copper-binding on Aβ conformation and the subsequent effects of 
copper-bound Aβ peptide in the pathogenesis of AD. 
 
1.5.5 The Role of Amyloid Precursor Protein in Copper homeostasis 
Amyloid precursor protein is a single-membrane spanning glycoprotein found in higher 
eukaryotic organisms including humans, rodents and worms (Coulson et al., 2000; 
Kang et al., 1987; Suazo et al., 2009).  There are several splice variants known for 
APP, but the most common form in the brain is the protein containing residues 1-695 
(Haass et al., 1991; Kong et al., 2008).  APP consists of a large extracellular domain, a 
transmembrane domain and a short intracellular domain, as shown in Figure 15.  The 
precise function of APP is not known although it has been implicated as a cell surface 
receptor involved in signal transduction and neurite growth (Jin et al., 1994; Kong et al., 
2008; Schubert et al., 1991).   
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Figure 15: Model depicting the proteolytic processing of the amyloid precursor 
protein (APP).  APP can be cleaved in the Aβ region by α-secretase (green arrow) and γ-
secretase (purple arrow) resulting in the release of a truncated Aβ peptide which is non-
amyloidogenic (Venugopal et al., 2008).  Alternatively, APP can be cleaved in either one of the 
two locations (blue arrows) by the β-secretase (BACE1) followed by γ-secretase leading to the 
release of longer Aβ fragments which are amyloidogenic (Gouras et al., 1998; Sinha and 
Lieberburg, 1999).  The extracellular copper-binding domain (CuBD) in APP is depicted as a red 
oval.  The numbers indicate the position of amino acids within APP (Faller and Hureau, 2009; 
Kong et al., 2008). 
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APP has also been implicated in the maintenance of neuronal copper homeostasis 
(Bellingham et al., 2004; Maynard et al., 2002; Suazo et al., 2009; Treiber et al., 2004; 
White et al., 1999).  APP contains two copper-binding sites with one of them located in 
the Aβ region and another in the extracellular portion (Atwood et al., 2000; Hesse et al., 
1994).  The extracellular copper-binding domain of APP (APP CuBD) has been shown 
to readily bind Cu(II) via two His residues (His147 and His151), a Tyr residue (Tyr168) 
and two water ligands (Kong et al., 2007a).  In vitro experiments have also highlighted 
the role of Cys144 and Met170 in the APP-mediated reduction of Cu(II) to Cu(I) (Ruiz et 
al., 1999).  Structural characterisation of APP CuBD by NMR spectroscopy (Barnham et 
al., 2003) and X-ray crystallography (Kong et al., 2007a; Kong et al., 2007b) revealed 
the copper-binding site to be relatively solvent-exposed in a similar way to the metal-
binding site of the copper metallochaperones Atx1 and CCS, leading to the hypothesis 
that APP may act as a neuronal copper metallochaperone (Barnham et al., 2003).   
The role of APP in copper homeostasis is further highlighted by several 
studies reporting changes in intracellular copper concentration with respect to APP 
expression levels, although these studies have provided contrasting results.  While 
some studies have highlighted the role of APP in copper export due to increased 
intracellular copper concentration when it is overexpressed and decreased intracellular 
copper concentration in mice lacking APP, others have shown an opposite effect 
(Bellingham et al., 2004; Maynard et al., 2002; White et al., 1999).  Overexpression of 
APP was also reported to result in increased intracellular copper concentration in 
human embryonic kidney (HEK) cells due to increased reduction of extracellular Cu(II) 
followed by greater uptake of Cu(I) (Suazo et al., 2009).  This was further supported by 
the subsequent increase in metallothionein levels, implicating APP in promoting the 
storage of excess copper.  Copper has also been shown to modulate APP processing 
and can result in decreased production of Aβ (Bayer et al., 2003; Borchardt et al., 
1999).  Further studies are required to conclusively determine the effect of copper-
binding to APP on Aβ production (Miller et al., 2006).      
 
1.5.6 β-secretase Amyloid Precursor Protein Cleaving Enzyme 1 and its Role in 
Copper homeostasis 
BACE1 is the rate-limiting enzyme involved in the production of Aβ by the proteolytic 
cleavage of APP at either the beginning of Aβ sequence (Asp1) or at Glu11 to liberate 
either Aβ42 or a truncated Aβ peptide following cleavage by γ-secretase, as shown in 
Figure 15 (Gouras et al., 1998; Sinha and Lieberburg, 1999).  The open reading frame 
of BACE1 constitutes a 501 amino acid membrane-bound protein comprising a 
proprotein domain, a large luminal domain, a transmembrane domain and a short 
cytosolic domain (CTD), as shown in Figure 16 (Hussain et al., 1999; Lin et al., 2000; 
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Sinha et al., 1999; Sinha and Lieberburg, 1999; Vassar et al., 1999; Yan et al., 1999).  
In the brain BACE1 has been implicated in myelination, neurotransmission, and in the 
maintenance of synaptic function (Cole and Vassar, 2007; Harrison et al., 2003; Willem 
et al., 2006).  BACE1 is also highly expressed in the pancreas albeit this isoform is 
devoid of β-secretase activity (Bodendorf et al., 2001; Ehehalt et al., 2002; Vassar et 
al., 1999).  The physiological function of pancreatic BACE1 is not known.  While the 
active site of BACE1 resides in the luminal portion, the cytosolic C-terminal domain 
(CTD) mediates the trafficking and intracellular localisation of BACE1 (Benjannet et al., 
2001; Capell et al., 2000; Huse et al., 2000; Walter et al., 2000).   
Human BACE1 CTD (hBACE1 CTD) contains a C482XXC485 motif which 
has been shown to bind Cu(I) in vitro (Angeletti et al., 2005).  In addition to Cys482 and 
Cys485, hBACE1 CTD also contains a third Cys residue at position 478.  Angeletti et al. 
(2005) reported that the binding of Cu(I) to hBACE1 CTD was mediated via Cys482 in 
association with either Cys478 or Cys485 and a third unidentified ligand.  In addition, 
Angeletti et al. (2005) also reported an interaction between hCCS and hBACE1 CTD 
ina yeast two-hybrid system which is mediated by D1 of hCCS.  This interaction was 
further confirmed by co-immunoprecipitation and glutathione-S-transferase (GST) pull-
down assays and co-localisation experiments.  The overexpression of BACE1 was 
shown to result in decreased SOD1 activity which could be rescued by increased 
expression of CCS, suggesting that BACE1 might play a role in neuronal copper 
homeostasis as a potential partner of CCS (Angeletti et al., 2005).  This is further 
supported by the studies in neuronal cells, where the deletion or depletion of CCS was 
shown to result in increased production of Aβ due to increased processing of APP via 
BACE1 (Gray et al., 2010).  However, the mechanism underlying the observed effects 
was not determined.  One of the aims of this study was to further characterise the 
hCCS-hBACE1 CTD interaction by determining the molecular basis of this interaction, 
as discussed further in section 0. 
 
1.5.7 Current Therapeutics Targeting Copper mis-homeostasis in Alzheimer’s 
disease 
Copper mis-homeostasis appears to be an integral part of AD pathology and may be 
one of the upstream factors in AD pathogenesis.  Although the exact role of Aβ, APP 
and BACE1 with respect to copper homeostasis is not yet established, there is sufficient 
evidence to suggest that targeting copper imbalance in AD is an attractive therapeutic 
strategy.  A key requirement for a copper-based therapeutic includes targeting the 
copper imbalance in the brain, that is, increased extracellular concentration of copper 
and decreased concentration of copper intracellularly, as discussed in section 1.5.3.  
This led to the use of 5-chloro-7-iodo-8-hydroxyquinoline commonly known as clioquinol 
as a metal-protein attenuating compound (MPAC) which can interact with the MBS of 
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the target protein (Bush, 2003; Cuajungco et al., 2000).  Clioquinol is a lipophilic 
compound that has relatively moderate (nanomolar) affinity for Cu(II) and Zn(II) (Bush, 
2003).  Studies with clioquinol in transgenic mouse models and clinical trials reported 
increased cognitive improvement and decreased deposition of Aβ in the brain (Cherny 
et al., 2001; White et al., 2006).  It was proposed that clioquinol was able to extract 
copper and zinc from the extracellular plaques resulting in disaggregation of Aβ.  
Copper-bound clioquinol was also reported to be able to traverse the cell membrane 
and due to its weak binding affinity for Cu(II), it was able to release Cu(II) inside the 
cells resulting in its redistribution inside the cell.  Increased intracellular concentration of 
copper also led to increased activation of matrix metalloproteinases which mediate the 
degradation of Aβ (Cherny et al., 2001; White et al., 2006).  However, this compound 
was withdrawn from clinical trials due to iodine-based contamination during its synthesis 
(Bush and Tanzi, 2008; Opazo et al., 2006).  A second 8-hydroxyquinoline derivate – 
PBT2 was synthesised which is not only more soluble than clioquinol but also lacks the 
iodine component and hence overcomes the iodine-mediated contamination problems 
(Adlard et al., 2008).  Studies in mice and phase II clinical trials have reported 
decreased Aβ load and improved cognition, however, larger scale studies are required 
to determine the full efficacy of this compound (Faux et al., 2010; Lannfelt et al., 2008). 
 
1.6 Copper homeostasis in S. cerevisiae 
This study used the yeast two-hybrid system to investigate the protein-protein 
interactions between metallochaperones and various binding partners.  Homologues of 
most of the copper-binding proteins investigated in this study are also present in S. 
cerevisiae.  Therefore, it is important to identify the proteins and pathways that can 
potentially be affected by the two-hybrid experiments carried out in this study.  While 
the individual components have been discussed previously, Figure 17 illustrates the 
main proteins that can be affected by the two-hybrid experiments. 
Similar to human cells, copper is present in the yeast cytoplasm in its 
reduced form as Cu(I) (as discussed in section 1.1.2).  In order to enter the cell, Cu(II) is 
reduced at the cell surface by the metalloreductases Fre1 and Fre2, as shown in Figure 
17.  The Fre1/Fre2 reductases are responsible for reducing Cu(II) and Fe(III) to Cu(I) 
and Fe(II) respectively (Dancis et al., 1992; Georgatsou et al., 1997; Hassett and 
Kosman, 1995).  Cu(I) is then transported through to the cytoplasm via the high-affinity 
copper transport proteins Ctr1 and Ctr3 (discussed in section 1.3.1).  A third Ctr protein, 
Ctr2, is located at the vacuolar membrane and is responsible for mobilising copper from 
the vacuole into the cytosol under conditions of copper deficiency (section 1.3.1).  
   
 59 
 
 
1 MAQALPWLLLWMGAGVLPAHGTQHGIRLPLRSGLGGAPLGLRLPRETDEE 
51 PEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFA 
101 VGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPH 
151 GPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDS 
201 LVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLW 
251 YTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKK 
301 VFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMG 
351 EVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIME 
401 GFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQT 
451 DESTLMTIAYVMAAICALFMLPLCLMVCQWRCLRCLRQQHDDFADDISLL 
501 K 
 
Figure 16: The amino acid sequence of human BACE1. The signal peptide is shown in 
purple, propeptide domain in green, protease domain in black, transmembrane domain in grey 
and the cytosolic C-terminal domain in blue.  The two catalytic motifs are highlighted in yellow 
and the predicted Cu(I)-binding residues are shown in red.  The numbers indicate the position of 
amino acids within human BACE1.  The sequence was obtained from GenBank accession 
number AF190725 (Vassar et al., 1999). 
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Figure 17: Copper homeostasis in S. cerevisiae.  The model depicts the proteins and 
pathways involved in copper homeostasis.  Cu(II) is reduced at the cell surface by the Fre1/Fre2 
reductases and is transported into the cell by Ctr1 and the Ctr3 transporters.  Once inside the 
cell, Cu(I) can be bound by the metallochaperones Ccs1, Atx1 and Cox17.  Ccs1 delivers Cu(I) 
to Sod1 which is localised in the cytosol, nucleus and the mitochondria.  Atx1 incorporates Cu(I) 
into Ccc2 which transports it to the Fet3/Ftr1 complex in the golgi.  Cu-bound Fet3/Ftr1 complex 
translocates to the plasma membrane to enable high-affinity iron uptake.  Cox17 binds Cu(I) in 
the cytosol and delivers it to the Sco1 and Cox11 proteins in the mitochondria which further 
transport Cu(I) to cytochrome c oxidase.  The copper-dependent transcription factors Mac1 and 
Ace1 regulate the induction of proteins involved in copper homeostasis, as discussed in section 
1.6.  Excess copper can be bound by the metallothionein proteins Cup1 and Crs5 or stored in 
the vacuole.  In conditions of copper deficiency, Ctr2 can mobilise copper from the vacuole into 
the cytoplasm.  Copper can also enter the cell via the divalent cation transporter Fet4. 
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Inside the cell, Cu(I) can bind to the copper metallochaperones Atx1 (section 1.3.2.4.1), 
Ccs1 (section 1.3.2.4.2) and Cox17 (section 1.3.2.4.3) which deliver Cu(I) to their 
respective target proteins.  Copper can also leak through the plasma membrane-bound 
low-affinity Fet4 transporter which is not specific for Fe(II) and can also transport other 
divalent cations including Cu(II) (Hassett et al., 2000).   
As discussed previously, copper homeostasis can also be regulated at the 
level of gene transcription.  While the copper-dependent transcription factor Mac1  
induces the transcription of proteins involved in copper uptake such as CTR1 and CTR3 
(section 1.3.1), the Ace1 transcription factor induces the transcription of proteins 
involved in preventing copper toxicity such as Sod1 and the metallothioneins Cup1 and 
Crs5 (Jensen et al., 1996; Pena et al., 1998; Strain and Culotta, 1996).  Figure 17, also 
illustrates the overlap between copper and iron homeostasis.  Both Cu(II) and Fe(III) 
are reduced by the Fre1/Fre2 reductases for high-affinity uptake into the cytosol.  The 
Fet3/Ftr1 complex requires the transport of Cu(I) from Ccc2 to the multicopper oxidase 
Fet3 in the golgi prior to its translocation to the cell surface for high-affinity iron uptake.  
In addition, the transcription of FRE1 is regulated by not only the iron-responsive 
transcription factor Aft1 but also Mac1 (Georgatsou et al., 1997; Labbe et al., 1997; 
Yamaguchi-Iwai et al., 1995; Yamaguchi-Iwai et al., 1996).   
 
1.7 Research Aims 
The goal of this study is to further the understanding of the molecular basis of the 
interaction of copper metallochaperones with their partner proteins.  The first aim of this 
study was to determine the molecular basis of the interaction between hCCS and 
hBACE1 CTD.  The recent evidence showing that CCS deficiency can result in 
enhanced Aβ production due to increased cleavage of APP by BACE1 (Gray et al., 
2010) demonstrates that the interaction of hCCS with hBACE1 CTD may be of 
relevance to AD pathology.  Moreover the increase in interaction between hCCS and 
hBACE1 CTD can also lead to decreased interaction of hCCS with hSOD1 (Angeletti et 
al., 2005).  Since hCCS and hBACE1 CTD can both bind Cu(I), one of the aims of this 
study was to determine the role of copper-binding in mediating the formation of a 
complex between them.  The complex formation was studied using a two-hybrid 
system.  To demonstrate a role for copper in complex formation, the interactions were 
tested in conditions of copper deficiency and copper excess.  This study also aimed to 
identify the amino acids involved in mediating the interaction of hCCS with hBACE1 
CTD.   
The complex formation of hCCS with hSOD1 was also studied using a 
yeast two-hybrid system.  As discussed in section 1.4.4, there is conflicting evidence 
regarding the role of D1 and D3 in the CCS-dependent activation of SOD1.  A lot of the 
information is based on the interaction of Ccs1 with Sod1.  However, it is now evident 
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that the CCS-dependent activation of SOD1 may vary depending upon the homologues 
studied (Leitch et al., 2009a; Leitch et al., 2009b).  This study aimed to investigate the 
effect of copper concentration and the role of Cu(I)-binding residues in hCCS in 
mediating the interaction with hSOD1.  As mentioned above, the interplay between the 
interactions of hCCS with hBACE1 CTD and hSOD1 may also be of relevance to AD 
pathology. 
The interaction of ScAtx1 with the MBDs of PacS and CtaA was also 
studied using a yeast two-hybrid system.  As discussed in section 1.4.3, cyanobacteria 
provide a rare example where the copper metallochaperone (ScAtx1) has been shown 
to interact with a proposed copper donor (CtaA) and copper acceptor (PacS) (Tottey et 
al., 2001; Tottey et al., 2002).  It has been shown that the complex formation of ScAtx1 
with its partner MBDs requires the Cu(I)-binding Cys ligands in ScAtx1.  This study 
aimed to investigate the effect of copper concentration on the interaction of ScAtx1 with 
the MBDs from PacS and CtaA.  Since there is comparatively little information available 
regarding the interaction of ScAtx1 with the CtaA MBD both in vitro and in vivo, this 
study aimed to provide vital information regarding the amino acids involved in mediating 
the complex formation between them.  Additionally, the role of these amino acids on the 
complex formation of ScAtx1 and PacS MBD was also demonstrated.  In light of the two 
different structural arrangements obtained by X-ray crystallography for the ScAtx1 
dimer (head-to-head and side-to-side), this study investigated the proposed idea that 
these arrangements may reflect the formation of structurally different complexes of 
ScAtx1 with PacS MBD and CtaA MBD (Badarau et al., 2010).   
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2. Materials and Methods 
2.1 Chemicals, Reagents and Equipment 
All chemicals were purchased from Sigma-Aldrich (Dorset, UK) except for growth 
medium components which were purchased from Formedium (Norfolk, UK), unless 
stated otherwise.  All restriction endonucleases were purchased from New England 
BioLabs (Herts, UK) while the Pfu DNA polymerase enzyme was purchased from 
Stratagene (Leicestershire, UK).  DNA oligomers were synthesised by Sigma-Genosys 
(Suffolk, UK).  The pGEMt_hCCS vector was received as a kind gift from Professor 
Colin Dingwall, King’s College London, UK.  The pCIneo_hSOD1 construct was 
generously provided by Professor Christopher Miller, King’s College London, UK.  The 
DNA oligomers used for S1 nuclease assays were kindly provided by Dr. Julian 
Rutherford, Newcastle University, UK. Deionized (dH2O) or double-dH2O (ddH2O) water 
purified using the Millipore Simplicity system (Millipore, UK) was used throughout.  For 
molecular biology purposes, ddH2O was sterilised by autoclaving at 121 
oC for 30 mins.  
All optical density (OD) readings were measured using a Perkin-Elmer lambda 35 UV-
Vis spectrophotometer. 
 
2.2 Strains 
2.2.1 E. coli 
All E. coli strains (Table 2) were maintained either on solid medium containing Luria-
Bertani (LB) medium (10 g/L tryptone, 10 g/L NaCl, 5 g/L yeast extract) (Sambrook and 
Russell, 2001) supplemented with 1.7 % (w/v) agar and the appropriate antibiotic at 4 
oC or as a cryo-stock containing 1.5 mL of pelleted bacterial culture resuspended in 250 
µL of 1 % (w/v) peptone and 250 µL of 50 % (v/v) glycerol, stored at -80 oC.   
 
2.2.2 S. cerevisiae 
All S. cerevisiae strains (Table 3) were maintained either on solid medium containing 1 
% (w/v) yeast extract, 2 % (w/v) peptone, 2 % (w/v) glucose or dextrose (YPD medium) 
supplemented with 2 % (w/v) agar at 4 oC or as a cryo-stock containing 1 mL of 
overnight cell culture with 1 mL of 30 % (v/v) glycerol and 80 µL dimethyl sulfoxide at -
80 oC.   
 
2.3 Molecular Biology in E. coli 
2.3.1 Preparation of competent E. coli cells 
An isolated colony of E. coli was inoculated in 5 mL LB medium overnight at 37 oC with 
shaking at 250 rpm in an orbital shaker (New Brunswick Scientific Co. Inc., USA).  The 
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culture was diluted 1:100 in LB medium (10 mL) the following day and grown for a 
further 2-3 hrs with shaking at 37 oC.  The cells were pelleted by centrifugation at 1600 
x g at 4 oC.  The pellet was resuspended in 1 mL ice-cold sterile TSS (85 % (v/v) LB, 10 
% (w/v) polyethylene glycol 8000 (PEG), 5 % (v/v) dimethyl sulfoxide, 50 mM 
magnesium chloride pH 6.5) and stored at 4 oC (Chung et al., 1989). 
 
Table 2: E. coli strains used in this study.   
 
Strain Genotype Purpose Source 
JM101 F- traD36 proA+B+ lacIq 
∆(lacZ)M15/ ∆(lac-proAB) glnV thi 
Cloning Lab stock 
XL-1 
Blue 
recA1 endA1 gyrA96 thi-1 hsdR17 
supE44 relA1 lac [F´ proAB+ 
lacIqZ∆M15 Tn10 (Tetr)] 
Site-directed 
mutagenesis 
Lab stock 
XL-1 
Blue 
MRF’ 
∆(mcrA)183 ∆(mcrCB-hsdSMR-
mrr)173 endA1 supE44 thi-1 
recA1 gyrA96 relA1 lac [F´ proAB 
lacIqZ∆M15. Tn10 (Tetr)] 
BacterioMatch® 
Bacterial 2-Hybrid 
Agilent 
Biotechnologies, 
UK 
BTH101 F-, cya-99, araD139, galE15, 
galK16, rpsL1 (Strr), hsdR2, 
mcrA1, mcrB1 
BACTH (Bacterial 
two-hybrid) system 
Euromedex, 
France 
 
 
Table 3: S. cerevisiae strains used in this study. 
 
 
2.3.2 Transformation in E. coli 
50 µL of competent E. coli cells were incubated with 1 µL of plasmid DNA and stored on 
ice for 20 mins.  The cells were heat-shocked by incubating them at 42 oC for 1 min, 
followed by 2 mins incubation on ice.  0.5 mL of LB medium was added to the cells and 
incubated at 37 oC with shaking for 1 hr.  100 µL of the transformed culture was spread 
on LB-agar plates with the appropriate antibiotics and incubated overnight at 37 oC 
(Sambrook and Russell, 2001). 
 
2.3.3 DNA manipulation 
All the vectors and DNA oligomers used in this study are listed in Table 4 and Table 5 
respectively. 
Strain Genotype Purpose Source 
EGY48 MATα his3 trp1 ura3-52 leu2: : pleu2-
LexAop6 
Yeast two-
hybrid 
K. Freeman, 
GSK, UK 
 
BY4741-
ccs1∆ 
 
MATα his3∆1 leu2∆0 met15∆0 
ura3∆0 ccs1∆: : KANR 
Deleting CCS1 
from the 
genome of 
EGY48 
Yeast genome 
collection, 
Research 
Genetics, USA 
SAY1 MAT, his3, trp. 1, ura3-52, leu2: : 
pleu2-LexAop6, ccs1∆: : KANR 
Yeast two-
hybrid 
This study 
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2.3.3.1 Extraction of DNA from E. coli cells 
Plasmid DNA was isolated from bacterial cultures using the Sigma GenElute Plasmid 
Miniprep kit according to the manufacturer’s instructions. 
 
2.3.3.2 Digestion of DNA using restriction endonucleases 
Plasmid DNA was digested by incubating the DNA at 37 oC with the appropriate 
restriction endonucleases for 1-2 hrs according to the manufacturer’s instructions and 
analysed by agarose gel electrophoresis.  
 
2.3.3.3 DNA analysis using agarose gels 
1 % (w/v) agarose was dissolved in 60 mL 1x TAE buffer (40 mM Tris-acetate, 1 mM 
EDTA pH 8.0) by boiling in a microwave, cooled to ~60 oC, poured into a gel cast (Bio-
Rad, UK) with 0.1 % (v/v) of 1 µg/mL ethidium bromide and left to set at room 
temperature.  Once set, the gel was placed inside a gel tank containing 1x TAE buffer, 
loaded with DNA samples containing 1x DNA-loading dye (0.4 % (w/v) bromophenol 
blue, 5 % (v/v) glycerol) and electrophoresed at 100 V for 30-60 mins.  Lambda DNA 
(Promega, UK) digested with PstI endonuclease was used as molecular weight 
markers.  Gels were photographed under UV irradiation (Bio-Rad Gel Doc 1000). 
 
2.3.3.4 Isolation of DNA from agarose gels 
The target band was excised using a scalpel from the agarose gel by visualising it 
under ultraviolet light using a transilluminator (UV Tec, UK).  The DNA was isolated 
from the gel slice using the Sigma GenElute Gel Extraction kit according to the 
manufacturer’s instructions. 
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Table 4: List of all the vectors used in this study. The details regarding the genes 
ligated into the multi-cloning site of the vectors are also provided including the amino acid 
residue numbers corresponding to the protein sequence. (-) indicates empty vector. 
 
Name of the Vector Gene ‘Insert’ Source 
Vectors used for cloning PCR products 
pGEMt - Promega, UK 
pJET - Fermentas, UK 
 
Source of hSOD1 gene 
pCIneo_hSOD1 Full-length hSOD1 Christopher Miller 
 
Source of hCCS gene 
pGEMt_hCCS Full-length hCCS Colin Dingwall 
   
BacterioMatch® Two-Hybrid system constructs 
pBT - Nigel Robinson 
pBT_ScAtx1 Full-length scAtx1 Nigel Robinson 
pTRG - Nigel Robinson 
pTRG_PacS95 PacS NTD (Res 1-95) Nigel Robinson 
pBT_hBACE1 CTD hBACE1 CTD
a 
This study 
pBT_hSOD1 Full-length hSOD1 This study 
pTRG_hCCS Full-length hCCS This study 
   
BACTH system constructs 
pUT18C - Richard Daniel 
pKT25 - Richard Daniel 
pUT18C_Zip Leucine zipper of GCN4 Richard Daniel 
pKT25_Zip Leucine zipper of GCN4 Richard Daniel 
pUT18C_hCCS Full-length hCCS This study 
pUT18C_hCCSD1 hCCS Domain 1
b 
This study 
pKT25_hBACE1 CTD hBACE1 CTD
a
 This study 
   
Yeast 2-Hybrid system constructs 
pMW112 - Katie Freeman 
pJG4.5 - Katie Freeman 
p423lexAkan - Katie Freeman 
pJG4.5_hCCS Full-length hCCS This study 
pJG4.5_hCCSD1 hCCS D1
b
 Katie Freeman 
pJG4.5_hCCSD2 hCCS D2
c 
Katie Freeman 
pJG4.5_hCCSD3 hCCS D3
d
 Katie Freeman 
pJG4.5_hCCS C22S Full-length hCCS This study 
pJG4.5_hCCS C25S Full-length hCCS This study 
pJG4.5_hCCS C22S,C25S Full-length hCCS This study 
pJG4.5_hCCS C224S Full-length hCCS This study 
pJG4.5_hCCS C224S,C226S Full-length hCCS This study 
pJG4.5_hCCSD1 C22S hCCS D1
b
 This study 
pJG4.5_hCCSD1 C25S hCCS D1
b
 This study 
pJG4.5_hCCSD1 C22S,C25S hCCS D1
b
 This study 
pJG4.5_hCCS R71A Full-length hCCS This study 
pJG4.5_hCCS R71E Full-length hCCS This study 
pJG4.5_hCCS R71K Full-length hCCS This study 
pJG4.5_hCCSD1 R71A hCCS D1
b
 This study 
pJG4.5_hCCSD1 R71E hCCS D1
b
 This study 
pJG4.5_hCCSD1 R71K hCCS D1
b
 This study 
pJG4.5_hSOD1 Full-length hSOD1 This study 
pJG4.5_HAH1 Full-length HAH1 Katie Freeman 
pJG4.5_Ccs1 Full-length CCS1 Katie Freeman 
pJG4.5_Ccs1 K66R Full-length CCS1 This study 
pJG4.5_ScAtx1 Full-length scAtx1 This study 
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pJG4.5_ScAtx1 A11K Full-length scAtx1 This study 
pJG4.5_ScAtx1 A11R Full-length scAtx1 This study 
pJG4.5_ScAtx1 E13A Full-length scAtx1 This study 
pJG4.5_ScAtx1 E13Q Full-length scAtx1 This study 
pJG4.5_ScAtx1 K21D Full-length scAtx1 This study 
pJG4.5_ScAtx1 N25R Full-length scAtx1 This study 
pJG4.5_ScAtx1 S58A Full-length scAtx1 This study 
pJG4.5_ScAtx1 H61A Full-length scAtx1 This study 
pJG4.5_ScAtx1 H61E Full-length scAtx1 This study 
pJG4.5_ScAtx1 H61F Full-length scAtx1 This study 
pJG4.5_ScAtx1 H61K Full-length scAtx1 This study 
pJG4.5_ScAtx1 H61Y Full-length scAtx1 This study 
p423lexAkan_hBACE1 CTD hBACE1 CTD
a
 This study 
p423lexAkan_hBACE1 CTD C478S hBACE1 CTD
a
 This study 
p423lexAkan_hBACE1 CTD W480M hBACE1 CTD
a
 This study 
p423lexAkan_hBACE1 CTD R481A hBACE1 CTD
a
 This study 
p423lexAkan_hBACE1 CTD R481E hBACE1 CTD
a
 This study 
p423lexAkan_hBACE1 CTD R481K hBACE1 CTD
a
 This study 
p423lexAkan_hBACE1 CTD C482S hBACE1 CTD
a
 This study 
p423lexAkan_hBACE1 CTD R484A hBACE1 CTD
a
 This study 
p423lexAkan_hBACE1 CTD C485S hBACE1 CTD
a
 This study 
p423lexAkan_hBACE1 CTD R487A hBACE1 CTD
a
 This study 
p423lexAkan_hBACE1 CTD 
D491A,D492A 
hBACE1 CTD
a
 This study 
p423lexAkan_hCCS Full-length hCCS This study 
p423lexAkan_hCCS C22S Full-length hCCS
 
This study 
p423lexAkan_hCCS C25S Full-length hCCS
 
This study 
p423lexAkan_hCCS C22S,C25S Full-length hCCS
 
This study 
p423lexAkan_hCCS C244S Full-length hCCS
 
This study 
p423lexAkan_hCCS C244S,C246S Full-length hCCS
 
This study 
p423lexAkan_hCCSD3 hCCS D3
d 
This study 
p423lexAkan_hCCS R71A Full-length hCCS This study 
p423lexAkan_hCCS R71E Full-length hCCS This study 
p423lexAkan_hCCS R71K Full-length hCCS This study 
p423lexAkan_Ccs1 Full-length yCCS This study 
p423lexAkan_Ccs1 K66R Full-length yCCS This study 
p423lexAkan_PacSN PacS NTD
e 
This study 
p423lexAkan_PacSN R13A PacS NTD
e
 This study 
p423lexAkan_PacSN Y65H PacS NTD
e
 This study 
p423lexAkan_CtaAN CtaA NTD
f 
This study 
p423lexAkan_CtaAN K34A CtaA NTD
f
 This study 
p423lexAkan_CtaAN F87H CtaA NTD
f
 This study 
p423lexAkan_CtaAN F87Y CtaA NTD
f
 This study 
p423lexAkan_CtaA111 CtaA NTD (Res 1-111) This study 
 
a hBACE1 CTD residues 478-501. 
b hCCS D1 residues 1-79. 
c hCCS D2 residues 79-231. 
d hCCSD3 residues 235-274. 
e PacS NTD residues 1-71. 
f CtaA NTD residues 1-92. 
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Table 5: List of all the DNA oligomers used in this study. 
 
No. Sequence (5’→3’) Purpose 
1 GCACTAGTGATTTTTGGATCCGCTTCGGATTCGGGG Cloning hCCS into 
pTRG 2 GGCCGCGGGATTTTTGAATTCTCAAAGGTGGGCAGGGG
G 
3 GGCCGCATGCCAGTGGCGTTGCCTGCGTTGCCTGCGTC
AGCAGCATGATGATTTTGCGGATGATATCAGCCTGCTGAA
ATAAG 
 
hBACE1 CTD for 
pBT 
4 AATTCTTATTTCAGCAGGCTGATATCATCCGCAAAATCAT
CATGCTGCTGACGCAGGCAACGCAGGCAACGCCACTGG
CATGC 
5 GAAGCGGCCGCGCGACGAAGGCCGTGTGCG Cloning hSOD1 into 
pBT 6 GAAGAATTCTTATTGGGCGATCCCAATTACACC 
7 CTGCCCCCAGATTCTGCAAGAATTCTTAGCCCATGCCCTT
GAGTACC 
Cloning hCCSD1 
into pTRG/pUT18C 
8 GGGATTCCACTAGTGATTTTGGATCCCGCTTCGGATTCG
GGG 
 
Cloning hCCS into 
pUT18C 9 CCCCGAATCCGAAGCGGGATCCAAAATCACTAGTGGAAT
CCC 
10 GCGTGCCAGTGGCGTTGCCTGCGTTGCCTGCGTCAGCA
GCATGATGATTTTGCGGATGATATCAGCCTGCTGAAATAA
GAG 
 
hBACE1 CTD for 
pKT25 
11 GATCCTCTTATTTCAGCAGGCTGATATCATCCGCAAAATC
ATCATGCTGCTGACGCAGGCAACGCAGGCAACGCCACTG
GCACGCTGCA 
12 GAAGAATTCATGGCTTCGGATTCGGGGAACCAGGGG Cloning hCCS into 
pJG4.5 13 GAACTCGAGTCAAAGGTGGGCAGGGGGCTGCGC 
14 GGTGCAGATGACCTCTCAGAGCTGTGTGG Creating hCCS 
C22S mutation 15 CCACACAGCTCTGAGAGGTCATCTGCACC 
16 CCTGTCAGAGCTCTGTGGACGCGGTGC Creating hCCS 
C25S mutation 17 GCACCGCGTCCACAGAGCTCTGACAGG 
18 GCAGATGACCTCTCAGAGCTCTGTGGACGCG Creating hCCS 
C22S,C25S 
mutation 
19 CGCGTCCACAGAGCTCTGAGAGGTCATCTGC 
20 GGCACGGGGGCGCAGGCGGTACTCAAGGGC Creating hCCS 
R71A mutation 21 GCCCTTGAGTACCGCCTGCGCCCCCGTGCC 
22 CCTTGAGTACCGCCTGTTCCCCCGTGCCTTCC Creating hCCS 
R71E mutation 23 GGAAGGCACGGGGGAACAGGCGGTACTCAAGG 
24 GGAAGGCACGGGGAAACAGGCGGTACTCAAGG Creating hCCS 
R71K mutation 25 CCTTGAGTACCGCCTGTTTCCCCGTGCCTTCC 
26 CCCAAGCAGATCTCCTCTTGCGATGGCC Creating hCCS 
C244S mutation 27 GGCCATCGCAAGAGGAGATCTGCTTGGG 
28 GGTGAGGCCATCGGAAGAGGAGATCTGCTTGG Creating hCCS 
C244S,C246S 
mutation 
29 CCAAGCAGATCTCCTCTTCCGATGGCCTCACC 
30 AATTCTGCCAATGGCGCTGCCTCCGCTGCCTGCGCCAGC
AGCATGATGACTTTGCTGATGACATCTCCCTGCTGAAGTG
AC 
 
hBACE1 CTD for 
p423lexAkan 
31 TCGAGTCACTTCAGCAGGGAGATGTCATCAGCAAAGTCA
TCATGCTGCTGGCGCAGGCAGCGGAGGCAGCGCCATTG
GCAG 
32 AATTCTCCCAATGGCGCTGCCTCCGCTGCCTGCGCCAGC
AGCATGATGACTTTGCTGATGACATCTCCCTGCTGAAGTG
AC 
 
hBACE1 CTD 
C478S for 
p423lexAkan 33 TCGAGTCACTTCAGCAGGGAGATGTCATCAGCAAAGTCA
TCATGCTGCTGGCGCAGGCAGCGGAGGCAGCGCCATTG
GGAG 
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34 AATTCTGCCAAATGCGCTGCCTCCGCTGCCTGCGCCAGC
AGCATGATGACTTTGCTGATGACATCTCCCTGCTGAAGTG
AC 
 
hBACE1 CTD 
W480M for 
p423lexAkan 35 TCGAGTCACTTCAGCAGGGAGATGTCATCAGCAAAGTCA
TCATGCTGCTGGCGCAGGCAGCGGAGGCAGCGCATTTG
GCA 
36 AATTCTGCCAATGGGCTTGCCTCCGCTGCCTGCGCCAGC
AGCATGATGACTTTGCTGATGACATCTCCCTGCTGAAGTG
AC 
 
hBACE1 CTD 
R481A for 
p423lexAkan 37 TCGAGTCACTTCAGCAGGGAGATGTCATCAGCAAAGTCA
TCATGCTGCTGGCGCAGGCAGCGGAGGCAAGCCCATTG
GCAG 
38 AATTCTGCCAATGGGAATGCCTCCGCTGCCTGCGCCAGC
AGCATGATGACTTTGCTGATGACATCTCCCTGCTGAAGTG
AC 
 
hBACE1 CTD 
R481E for 
p423lexAkan 39 TCGAGTCACTTCAGCAGGGAGATGTCATCAGCAAAGTCA
TCATGCTGCTGGCGCAGGCAGCGGAGGCATTCCCATTG
GCAG 
40 AATTCTGCCAATGGAAATGCCTCCGCTGCCTGCGCCAGC
AGCATGATGACTTTGCTGATGACATCTCCCTGCTGAAGTG
AC 
 
hBACE1 CTD 
R481K for 
p423lexAkan 41 TCGAGTCACTTCAGCAGGGAGATGTCATCAGCAAAGTCA
TCATGCTGCTGGCGCAGGCAGCGGAGGCATTTCCATTGG
CAG 
42 AATTCTGCCAATGGCGCTCCCTCCGCTGCCTGCGCCAGC
AGCATGATGACTTTGCTGATGACATCTCCCTGCTGAAGTG
AC 
 
hBACE1 CTD 
C482S for 
p423lexAkan 43 TCGAGTCACTTCAGCAGGGAGATGTCATCAGCAAAGTCA
TCATGCTGCTGGCGCAGGCAGCGGAGGGAGCGCCATTG
GCAG 
44 AATTCTGCCAATGGCGCTGCCTCGCTTGCCTGCGCCAGC
AGCATGATGACTTTGCTGATGACATCTCCCTGCTGAAGTG
AC 
 
hBACE1 CTD 
R484A for 
p423lexAkan 45 TCGAGTCACTTCAGCAGGGAGATGTCATCAGCAAAGTCA
TCATGCTGCTGGCGCAGGCAAGCGAGGCAGCGCCATTG
GCAG 
46 AATTCTGCCAATGGCGCTGCCTCCGCTCCCTGCGCCAGC
AGCATGATGACTTTGCTGATGACATCTCCCTGCTGAAGTG
AC 
 
hBACE1 CTD 
C485S for 
p423lexAkan 47 TCGAGTCACTTCAGCAGGGAGATGTCATCAGCAAAGTCA
TCATGCTGCTGGCGCAGGGAGCGGAGGCAGCGCCATTG
GCAG 
48 AATTCTGCCAATGGCGCTGCCTCCGCTGCCTGGCTCAGC
AGCATGATGACTTTGCTGATGACATCTCCCTGCTGAAGTG
AC 
 
hBACE1 CTD 
R487A for 
p423lexAkan 49 TCGAGTCACTTCAGCAGGGAGATGTCATCAGCAAAGTCA
TCATGCTGCTGAGCCAGGCAGCGGAGGCAGCGCCATTG
GCAG 
50 AATTCTGCCAATGGCGCTGCCTCCGCTGCCTGCGCCAGC
AGCATGCTGCTTTTGCTGATGACATCTCCCTGCTGAAGTG
AC 
 
hBACE1 CTD 
D491A,D492A for 
p423lexAkan 51 TCGAGTCACTTCAGCAGGGAGATGTCATCAGCAAAAGCA
GCATGCTGCTGGCGCAGGCAGCGGAGGCAGCGCCATTG
GCAG 
52 CCGCGGGATTAAGCGAATTCGCGACGAAGGCCGTGTG Cloning hSOD1 into 
p423lexAkan 53 GCCGCACTAGTGATTGAACTCGAGTTATTGGGCGATCCC 
54 GCGAAACTGTGGTAGAGACGCCATCATAAGAGG Creating Ccs1 
K66R mutation 55 CCTCTTATGATGGCGTCTCTACCACAGTTTCGC 
56 GGAAGAGGGTAAAAATTCATTGTTCGG PCR of KANR (from 
BY4741-ccs1∆) 57 ATTGCCACATGCGTATGTACATGTCCG 
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58 GTTCCTGCGCCGGTTGCATTCGATTCC Verifying ccs1∆ 
genomic deletion 59 GATGGTGTCAAGAACCGGCTTGGCTGC 
60 GAAGAATTCATGACTATTCAACTAACTGTACC Cloning ScAtx1 into 
pJG4.5 61 GAACTCGAGTCACTCAACTTCATGGCCCGCCG 
62 CTGTACCCACCATTAAATGTGAAGCCTGTGC Creating ScAtx1 
A11K mutation 63 GCACAGGCTTCACATTTAATGGTGGGTACAG 
64 CTGTACCCACCATTAGATGTGAAGCCTGTGC Creating ScAtx1 
A11R mutation 65 GCACAGGCTTCACATCTAATGGTGGGTACAG 
66 CCACCATTGCCTGTGCTGCCTGTGCCGAAGC Creating ScAtx1 
E13A mutation 67 GCTTCGGCACAGGCAGCACAGGCAATGGTGG 
68 CCACCATTGCCTGTCAAGCCTGTGCCGAAGC Creating ScAtx1 
E13Q mutation 69 GCTTCGGCACAGGCTTGACAGGCAATGGTGG 
70 CGAAGCTGTGACCGATGCCGTGCAAAATGAGG Creating ScAtx1 
K21D mutation 71 CCTCATTTTGCACGGCATCGGTCACAGCTTCG 
72 CCAAAGCCGTGCAAAGAGAGGATGCCCAAGC Creating ScAtx1 
N25R mutation 73 GCTTGGGCATCCTCTCTTTGCACGGCTTTGG 
74 CGAACGGCGATCGCCGCTGCGGGCCATGAAGTTG Creating ScAtx1 
S58A mutation 75 CAACTTCATGGCCCGCAGCGGCGATCGCCGTTCG 
76 CTCACTCAACTTCAGCGCCCGCCGAGGCG Creating ScAtx1 
H61A mutation 77 CGCCTCGGCGGGCGCTGAAGTTGAGTGAG 
78 GCCTCGGCGGGCGAAGAAGTTGAGTG Creating ScAtx1 
H61E mutation 79 CACTCAACTTCTTCGCCCGCCGAGGC 
80 GCCTCGGCGGGCTTTGAAGTTGAGTG Creating ScAtx1 
H61F mutation 81 CACTCAACTTCAAAGCCCGCCGAGGC 
82 GCCTCGGCGGGCAAAGAAGTTGAGTG Creating ScAtx1 
H61K mutation 83 CACTCAACTTCTTTGCCCGCCGAGGC 
84 CGCCTCGGCGGGCTATGAAGTTGAGTGAG Creating ScAtx1 
H61Y mutation 85 CTCACTCAACTTCATAGCCCGCCGAGGCG 
86 GAAGAATTCATGGCCCAAACCATCAATCTGC Cloning PacSN into 
p423lexAkan 87 GAACTCGAGTCATTTAAGCACCCTAGCGTGG 
88 GCAACTAGAGGGAATGGCTTGTGCGGCCTGTGC Creating PacSN 
R13A mutation 89 GCACAGGCCGCACAAGCCATTCCCTCTAGTTGC 
90 GGAGCGAGCGGGTCACCACGCTAGGGTGC Creating PacSN 
Y65H mutation 91 GCACCCTAGCGTGGTGACCCGCTCGCTCC 
92 GAAGAATTCATGGTTCAACTTTCCCCGACCCC Cloning CtaAN into 
p423lexAkan 93 GAACTCGAGTCAACGAATCTGACTGGGAAATCCC 
94 CGTGGGGGGCATGGCTTGTGCCGGTTGTGTGG Creating CtaAN 
K34A mutation 95 CCACACAACCGGCACAAGCCATGCCCCCCACG 
96 GAGTCAGCGGGGACATCCCAGTCAGATTCG Creating CtaAN 
F87H mutation 97 CGAATCTGACTGGGATGTCCCCGCTGACTC 
98 GAGTCAGCGGGGATATCCCAGTCAGATTCG Creating CtaAN 
F87Y mutation 99 CGAATCTGACTGGGATATCCCCGCTGACTC 
100a GGGCAAAGGCTTCTTTGAATTCAGCAATTTGTTCTTCGGT
GGTGCC 
CMD1 primer for 
S1 nuclease assay 
101a CCCCGTTGGGCAGCTACATGATTTTTGGCATTGTTCATTA
TTTTTGCAGCTACCACATTGATGCCA 
CUP1 primer for S1 
nuclease assay 
102a CGCCATACTCGATGCTACTGTCTTGGATGCACTAGACATG
GCGTCCATATTCATGCTGTTTGC 
CTR1 primer for S1 
nuclease assay 
 
a These oligomers were received as a kind gift from Dr. Julian Rutherford, University of 
Newcastle, UK. 
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2.3.3.5 DNA Ligation 
50 ng of the desired vector was digested with the appropriate restriction endonucleases 
and electrophoresed on an agarose gel.  The desired DNA band was purified from the 
gel as discussed in section 2.3.3.4. The purified digested vector was subsequently 
ligated with the insert DNA using the T4 DNA ligase (Fermentas, UK) according to the 
manufacturer’s instructions.  An exceptional strategy was used for the ligation of the 
DNA oligomers coding for hBACE1 CTD into the desired vector. The double-stranded 
hBACE1 CTD DNA oligomers comprised two individual complementary single-stranded 
DNA oligomers coding for hBACE1 CTD (Table 5).  The single-stranded DNA oligomers 
underwent an ‘annealing’ step prior to ligation into the desired vector, involving the 
incubation of a mixture containing 0.75 % (v/v) of 2 ng/µL of each single-stranded DNA 
oligomer, 0.125 % (v/v) TE buffer (10 mM Tris-HCl pH 8.0, 1 mM EDTA pH 8.0) and 
0.125 % of 25 mM MgCl2, at 94 
oC for 90 secs in a PCR machine, followed by 15 mins 
incubation at room temperature.  Successful ligation was verified by the digestion of the 
ligated vector with the appropriate restriction endonucleases followed by agarose gel 
electrophoresis and by obtaining the DNA sequence of the ligated vector using the DNA 
sequencing silver service, Beckman-Coulter Genomics, UK. 
 
2.3.3.6 Polymerase chain reaction 
Polymerase chain reactions (PCR) were prepared in 0.5 mL eppendorf tubes containing 
2 ng template DNA, 0.4 mM  deoxyribonucleotide triphosphates (dNTPs) mix (Promega, 
UK),  50 pmol/µL of each primer, 1 µL of 2.5 U/µL Pfu polymerase (Stratagene, UK), 5 
µL 10x Pfu buffer and sterile dH2O.  The PCR conditions were modified according to the 
manufacturer’s instructions. 
 
2.3.3.7 Site-directed mutagenesis 
Mutations in DNA were created by preparing a 50 µL reaction mixture consisting of 15-
20 ng template DNA, 125 ng of each DNA oligomer, 0.5 mM dNTPs mix, 5 µL 10x Pfu 
polymerase buffer, 1 µL of 2.5U/µL Pfu polymerase and sterile dH2O.  The reaction 
mixture was incubated in a PCR machine according to the conditions specified in the 
protocol for Stratagene’s QuikChange® Site-directed mutagenesis kit (Stratagene, UK). 
2.4 Bacterial 2-Hybrid 
2.4.1 BacterioMatch® Two-Hybrid System (Stratagene, UK) 
An overview of the principles underlying the BacterioMatch® two-hybrid system is 
provided in Figure 18.  Some of the vectors used in this system (Table 4) were received 
as a kind gift from Professor Nigel Robinson (Newcastle University, UK). 
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Figure 18: Overview of the BacterioMatch® Bacterial Two-Hybrid System.  Ligation 
of any genes – X and Y into the multi-cloning site of the vectors pTRG and pBT results in the 
expression of the fusion proteins α-X (α domain of RNA polymerase (RNAP)-X) and λcI-Y 
respectively, when co-expressed in the reporter strain XL-1 Blue MRF’.  When λcI binds to the 
λcI operator, an interaction between X and Y promotes the binding of α to RNAP resulting in the 
stable recruitment of RNAP to the promoter leading to the transcription of the reporter genes – 
amp
r
 and lacZ. 
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2.4.1.1 Cloning & Co-transformation 
All constructs were cloned into the BacteroMatch® vectors – pTRG and pBT.  The 
constructs created in this study were cloned into the BamHI and EcoRI sites of pTRG 
and into the NotI and EcoRI sites of pBT.  10 ng of each vector was co-transformed into 
the XL-Blue MRF’ cells based on the procedure discussed in section 2.3.2. 
 
2.4.1.2 Spreading co-transformed cells onto LB-agar plates 
XL-1 Blue MRF’ cells co-transformed with pTRG_X and pBT_Y (where X and Y 
represent the presence of a fusion gene) were plated onto LB-agar plates containing 
tetracycline, chloramphenicol and kanamycin (LB-TCK) and incubated at 30 oC for 3 
days. 
 
2.4.1.3 β-galactosidase Assay 
The protocol used for β-galactosidase assay was based on the method detailed in 
Bowness (2004).  A colony of XL-1 Blue MRF’ cells co-transformed with pTRG_X and 
pBT_Y was grown in 5 mL LB-TCK medium at 30 oC overnight with shaking at 250 rpm.  
The following day, 0.5 mL of exponentially growing cells (OD595 ~0.15-0.3) were 
pelleted by centrifugation at 16000 x g for 1 min.  The pellet was resuspended in 0.5 mL 
ice-cold Z-buffer (60 mM K2HPO4.3H2O, 40 mM KH2PO4, 10 mM KCl, 1 mM 
MgSO4.7H2O) with 0.3 % (v/v) β-mercaptoethanol.  50 µL of 1 % (w/v) SDS and 100 µL 
chloroform was added to the resuspended cells and vortexed at maximum speed for 30 
secs to ensure lysis.  The tubes were incubated at room temperature for ~20 mins to 
allow for the chloroform to settle.  176 µL of the aqueous layer was added to a 96-well 
microtitre plate containing 35 µL of 4 mg/mL (in 0.1 M potassium phosphate buffer, pH 
7.0) o-nitrophenyl-β-D-galactopyranoside (ONPG) and incubated at room temperature 
for ~70 mins or until a yellow colour developed.  The reaction was stopped by the 
addition of 88 µL of 1 M sodium carbonate.  The time between the addition of cell lysate 
and sodium carbonate was recorded as the reaction time (t).  As a control (t0) a well 
containing 35 µL ONPG and 176 µL dH2O was also incubated and stopped with all the 
other reaction samples by the addition of 88 µL of 1 M sodium carbonate.  The OD414 of 
the reaction samples was measured using a microtitre plate reader, and the β-
galactosidase activity was calculated using Equation 5 (Bowness, 2004). 
     nmoles ONP min-1 mg-1 protein = 300 (OD414 (t) – OD414 (t0))/ 1.83 (t x V x OD595)   [5] 
where, OD414(t) = absorbance measured at 414 nm in the sample well, OD414(t0) = 
absorbance measured at 414 nm in the control well, OD595 = absorbance measured 
at 595 nm of initial cell culture (cell density),  t = reaction time (mins), V = volume of 
cells used (mL); since, OD414 of 300 nmoles ONP solution = 1, ~1 mg/mL of total 
   
 74 
protein is obtained from OD595 of cell culture = 1/1.83 (Bowness, 2004).  
  
2.4.2 Bacterial Adenylate Cyclase Two-Hybrid System (EuroMedex, France) 
An overview of the principles underlying the bacterial adenylate cyclase two-hybrid 
(BACTH) system is provided in Figure 19.  The BACTH system strain, BTH101 and the 
vectors (Table 2 and Table 4) were received as a kind gift from Dr. Richard Daniel 
(Newcastle University, UK). 
 
2.4.2.1 Cloning & Co-transformation 
All constructs were cloned into the BACTH vectors – pKT25 and pUT18C (Table 4), and 
co-transformed into the BTH101 cells, according to the manufacturer’s instructions. 
2.4.2.2 Spreading co-transformed cells onto Minimal Medium-agar plates 
BTH101 cells co-transformed with pKT25_X and pUT18C_Y (where X and Y represent 
the presence of a fusion gene) were washed twice with minimal medium (MM) before 
spreading them onto MM-agar plates.  MM-agar plates were prepared by autoclaving a 
solution containing 3.6 µM FeCl3.6H2O, 40 µM MgCl2.6H2O, 100 µM MnCl2.4H2O, 10 
mM NH4Cl, 0.7 mM Na2SO4, 0.5 mM KH2PO4, 1.2 mM NH4NO3 and 1 % (w/v) agar at 
121 oC for 30 mins followed by the addition of 0.8 % (w/v) filter-sterile glucose, 0.4 % 
(w/v) casamino acids, 0.004 % (w/v) 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside 
(X-Gal), 25 µg/mL kanamycin, 100 µg/mL ampicillin, 3 µM thiamine and 0.1 mM 
isopropyl-β-D-1-thiogalactopyranoside (IPTG) after the medium had cooled to ~40 oC. 
The plates were incubated at 30 oC for 3 days. 
 
2.4.2.3 β-galactosidase Assay 
A colony of BTH101 cells co-transformed with pKT25_X and pUT18C_Y was grown in 5 
mL LB-medium with the appropriate amino acids at 30 oC overnight with shaking at 250 
rpm.  The following day, 0.5 mL of exponentially growing cells (OD595 ~0.15-0.3) was 
pelleted and assayed for β-galactosidase activity as detailed in section 2.4.1.3.   
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Figure 19: Overview of the BACTH system.  Ligation of any genes – X and Y into the 
multi-cloning site of the vectors pKT25 and pUT18C results in the expression of the fusion 
proteins T25-X and T18-Y when co-expressed in the reporter strain BTH101.  Interaction 
between X and Y brings T25 and T18, components of the catalytic domain of adenylate cyclase, 
into close proximity.  Functional complementation of T25 and T18 results in the synthesis of 
cyclic AMP (cAMP) by adenylate cyclase which forms a complex with the catabolite activator 
protein, CAP and binds to the promoter resulting in the transcription of the reporter genes for 
lac/mal allowing for growth on medium lacking lactose/maltose and lacZ. 
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2.5  Manipulation of S. cerevisiae 
2.5.1 Preparation of competent S. cerevisiae cells 
A few isolated colonies of either untransformed S. cerevisiae cells were inoculated in 5 
mL YPD or a few isolated colonies of transformed S. cerevisiae cells were inoculated in 
5 mL synthetic-dextrose (SD)-glucose medium (0.17 % (w/v) yeast nitrogen base, 0.5 % 
(w/v) ammonium sulphate, 2 % (w/v) glucose and the appropriate amino acids) 
overnight and incubated at 30 oC with shaking at 250 rpm in an orbital shaker.  The 
following day the cells were diluted 1:50 in fresh 50 mL YPD or SD medium 
respectively, and incubated at 30 oC with shaking at 300 rpm until absorbance at 600 
nm was ~0.8.  Cells were pelleted by centrifugation at 1000 x g at 4 oC.  The 
supernatant was discarded and the pellet was washed three times with 1mL sterile 
ddH2O with centrifugation at 3000 x g.  The pellet was resuspended in 300 µL of filter-
sterilised 100 mM lithium acetate and stored at 4 oC (Ausubel et al., 2002). 
 
2.5.2 DNA transformation in S. cerevisiae 
50 µL of competent S. cerevisiae cells were added to a 1.5 mL eppendorf tube 
containing 240 µL of filter-sterilised 50 % (w/v) PEG 4000 and 10 µL of 10 mg/mL 
salmon-sperm DNA followed by the addition of ~800 ng of plasmid DNA and mixed by 
gently vortexing the tube.  32 µL of filter-sterilised 1 M lithium acetate was added to the 
tube and incubated at 30 oC for 20 mins followed by heat-shock at 42 oC for 15 mins.  
The cells were pelleted and washed with 1 mL sterile ddH2O by centrifugation at 1000 x 
g.  The pellet was resuspended in 300 µL of sterile ddH2O and stored at 4 
oC (Ausubel 
et al., 2002).  150 µL of the resuspended pellet was spread on YPD- or SD-agar plates, 
as appropriate.   
 
2.5.3 Isolation of genomic DNA from S. cerevisiae 
A few isolated colonies of the strain were grown in 10 mL YPD medium overnight at 30 
oC with shaking at 250 rpm.  5 mL of the cell culture was centrifuged at 1200 x g and 
the pellet was washed with sterile ddH2O.  The cells were briefly vortexed at 1800 rpm 
to remove any residual medium.  The pellet was resuspended in 200 µL breaking buffer 
(1 % (w/v) SDS, 2 % (v/v) Triton X-100, 100 mM NaCl, 10 mM Tris-HCl pH 8.0, 1 mM 
EDTA pH 8.0) followed by the addition of 0.3 g glass beads and 200 µL of 
phenol/chloroform/isoamyl alcohol mixture and vortexed at 2400 rpm for 3 mins.  200 
µL of TE buffer was added to the lysed cells and vortexed briefly.  The cell lysate 
(aqueous layer) was separated from the cell debris by centrifugation at 16000 x g for 5 
mins and transferred to a 1.5 mL tube.  1 mL of 100 % ethanol was added to the cell 
lysate and mixed by inversion.  The tube was centrifuged at 16000 x g for 3 mins and 
the pellet was resuspended in 0.4 mL TE buffer.  The lysate was incubated with 0.075 
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% (v/v) TE buffer containing 0.7 µg/µL RNase A at 37 oC for 15 mins, followed by the 
addition of 0.025 % (v/v) of 4 M ammonium acetate and 1 mL of 100 % ethanol.  The 
genomic DNA was pelleted by centrifugation at 16000 x g for 3 mins.  The supernatant 
was discarded and any remaining ethanol was removed by drying the pellet at 60 oC for 
10 mins.  The genomic DNA pellet was resuspended in 100 µL TE buffer and stored at -
20 oC (Ausubel et al., 2002). 
 
2.5.4 Isolation of RNA from S. cerevisiae 
S. cerevisiae cells were grown in the appropriate medium as required and pelleted by 
centrifugation at 1000 x g at 4 oC.  The pellet was resuspended in 400 µL TES buffer 
(10 mM Tris-HCl pH 7.5, 10 mM EDTA, 0.5 % (w/v) SDS) followed by the addition of 
400 µL acid phenol.  The mixture was vortexed briefly at 2400 rpm and incubated at 65 
oC for 60 mins with intermittent vortexing.  The mixture was cooled to 4 oC and 
centrifuged at 16000 x g for 5 mins at 4 oC.  The aqueous layer was isolated in a 1.5 mL 
tube and equivalent volume of acid-phenol was added to it followed by vortexing at 
2400 rpm for ~30 secs and centrifugation at 16000 x g for 5 mins at 4 oC.  The aqueous 
layer was isolated in a 1.5 mL tube and the RNA was precipitated by the addition of 
0.07 % (v/v) of 3 M sodium acetate pH 5.3 and 1 mL of ice-cold 100 % ethanol by 
incubation at -20 oC for ~60 mins.  RNA was pelleted by centrifugation at 16000 x g for 
5 mins at 4 oC.  The pellet was washed with ice-cold 70 % ethanol and centrifuged at 
16000 x g for 5 mins at 4 oC.  The RNA pellet was resuspended in 100 µL sterile ddH2O 
and stored at -20 oC (Ausubel et al., 2002). 
 
2.5.5 Whole cell protein extraction 
S. cerevisiae cells were grown in the appropriate medium and pelleted by centrifugation 
at 1000 x g at 4 oC.  The pellet was resuspended in 500 µL ice-cold resuspension buffer 
containing 20 mM Tris-HCl pH 8.0, 50 mM ammonium acetate, 2 mM EDTA and added 
to a 1.5 mL tube containing ~0.3 g 0.5 mM glass beads and 500 µL of ice-cold 20 % 
trichloroacetic acid (TCA).  The cells were lysed by five cycles of ribolysation for 30 
secs followed by 1 min incubation on ice.  The liquid phase was isolated into a fresh 1.5 
mL tube and stored on ice.  500 µL of a mixture containing 50 % (v/v) resuspension 
buffer and 50 % (v/v) 20 % TCA was added to the tube containing the glass beads, and 
was ribolysed for an additional 30 secs followed by 1 min incubation on ice.  The 
aqueous phase was isolated and added to the previously extracted supernatant and 
centrifuged at 16000 x g for 10 mins at 4 oC.  The pellet was resuspended in 300 µL 
loading buffer (120 mM Tris base 3.5 % (w/v) SDS, 14 % (v/v) glycerol, 80 mM EDTA, 
0.02 % (w/v) bromophenol blue and 12 % (v/v) 1M DTT).  The cell lysate was incubated 
at 100 oC for 10 mins followed by centrifugation at 16000 x g for 10 mins.  The 
supernatant was isolated and stored at -20 oC. 
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2.6 Yeast two-hybrid 
An overview of the principles underlying the yeast two-hybrid system is provided in 
Figure 20.  The yeast two-hybrid strain EGY48, the vectors pJG4.5 and p423lexAkan, 
and some of the constructs used in this study (Table 4) were generously provided by 
Dr. Katie Freeman, GlaxoSmithKline (GSK), UK. 
 
2.6.1 Transformation of EGY48 with reporter plasmid pMW112 
Competent EGY48 cells were prepared and transformed with the reporter plasmid 
pMW112 containing the reporter genes for leucine (leu) and β-galactosidase, as 
detailed in sections 2.5.1 and 2.5.2 respectively. 
 
2.6.2 Cloning into Yeast two-hybrid vectors 
All genes were cloned into the unique EcoRI and XhoI sites of the pJG4.5 and 
p423lexAkan vectors, according to the standard procedures discussed above. 
 
2.6.3 Co-transformation in EGY48 
EGY48 cells transformed with pMW112 vector (EGY48_pMW112) were further co-
transformed with the yeast two-hybrid vectors pJG4.5_X and p423lexAkan_Y (where X 
and Y represent the presence of a fusion gene) as discussed in section 2.5.2. 
 
2.6.4 β-galactosidase assays 
A few isolated colonies containing EGY48_pMW112 cells co-transformed with 
pJG4.5_X and p423lexAkan_Y vectors were inoculated in 5mL SD-gluclose-leu 
medium (0.84 % (v/v) 7.2 mg/mL leu) and incubated overnight at 30 oC with shaking at 
250 rpm.  The following day the cells were diluted into fresh 5 mL SD-galactose (gal; 2 
%, w/v)-raffinose (raff; 1 %, w/v)-leu medium such that the initial absorbance at 600 nm 
was ~0.4, and grown at 30 oC with shaking at 300 rpm for 3-5 hrs until absorbance at 
600 nm was ~0.5-0.8 (exact OD600 was recorded).  1.5 mL of the cells were pelleted by 
centrifugation at 16000 x g and washed twice with 1.5 mL ice-cold Z-buffer (section 
2.4.1.3).  The pelleted cells were finally resuspended in 0.5 mL ice-cold Z-buffer.  100µL 
of the resuspended cells were lysed by three freeze-thaw cycles constituting flash-
freezing in liquid nitrogen followed by thawing at 37 oC for 2 mins.  0.7 mL of ice-cold Z-
buffer containing 0.3 % (v/v) β-mercaptoethanol was added to the lysed cells followed 
by 0.16 mL of ONPG (section 2.4.1.3).  The tubes were incubated inside a 30 oC 
incubator (dark environment) for ~60 mins or until yellow colour developed.  The 
reaction was stopped by the addition of 0.4 mL of 1 M sodium carbonate.  The time 
between the addition of ONPG and sodium carbonate was recorded as the reaction 
time (t).  The cell debris was pelleted by centrifugation at 16000 x g and the OD420 of 
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the supernatant was recorded.  The β-galactosidase activity of the reaction mixture was 
measured using Equation 6 adapted from Miller (1972). 
β-galactosidase Activity (Miller Units) = 1000 x OD420/ (t x V x OD600)       [6] 
where, t = reaction time (mins), V = volume of cells (mL) x concentration factor (3), 
OD600 = absorbance measured at 600 nm of initial cell culture (cell density), OD420 = 
absorbance at 420 nm.   
 
2.6.5 Studying the role of copper using the yeast two-hybrid system 
The effect of Cu concentration on interactions was studied by growing the desired 
EGY48_pMW112 with pJG4.5_X and p423lexAkan_Y co-transformants in SD growth 
medium containing 0.17 % (w/v) Cu-depleted yeast nitrogen base without amino acids 
and ammonium sulfate, 0.5 % (w/v) ammonium sulphate, 2 % (w/v) glucose, 0.84 % 
(v/v) 7.2 mg/mL leu and other amino acids, as appropriate with varying amounts of 
filter-sterilised copper sulfate (CuSO4) and/or filter-sterilised bathocuproinedisulfonic 
acid disodium salt (BCS) solution, as required and assayed for β-galactosidase activity 
according to 2.6.4. 
 
2.6.5.1 Growth Curves 
EGY48_pMW112 cells + pJG4.5 and p423lexAkan were grown in SD-Gal-Raff-leu 
medium with and without CuSO4 and BCS.  The OD600 was recorded at various time 
intervals and the data points were plotted on a line graph.  
 
2.6.5.2 Determination of intracellular copper content using inductively coupled 
plasma - mass spectrometry 
The Cu content of the EGY48_pMW112 cells + pJG4.5 and p423lexAkan was 
determined by measuring the Cu concentration of the whole cell lysate using inductively 
coupled plasma-mass spectrometry (ICP-MS).  Exponentially growing cells (OD600 0.5-
0.8), such that the final OD at 600 nm was ~30 in SD-gal-raff-leu medium with and 
without CuSO4 and BCS, were harvested by centrifugation at 1000 x g at 4 
oC.  The 
pellet was washed with sterile ddH2O and flash-frozen in liquid nitrogen.  After thawing 
the pellet at room temperature, the cells were lysed by the addition of 1 mL of 65 % 
(v/v) Suprapur® HNO3 (Merck, UK) and incubated at 30 
oC for 3 nights.  1 mL of ddH2O 
was added to the lysed cells and the cell debris was pelleted by centrifugation at 1000 x 
g for 10 mins at 4 oC.  Samples for ICP-MS were prepared by adding 0.3 mL of the 
supernatant to 1.2 mL of ddH2O.  Cu standard solutions in the range of 0-400 µg/L were 
prepared by the dilution of stock Cu solution (987 µg/mL in 1.2 % HNO3; Sigma, UK) in 
3 % (v/v) Suprapur® HNO3.   
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Figure 20: Overview of the Yeast two-hybrid system. Ligation of any genes X and Y 
into the multi-cloning site of the vectors pJG4.5 and p423lexAkan results in the expression of the 
fusion proteins AD_X (Activation Domain of B42_X) and DNA-BD_Y (DNA binding domain of 
LexA_Y) respectively when co-expressed in the reporter strain EGY48 transformed with the 
reporter vector pMW112.  When DNA-BD binds to the LexA operator, an interaction between X 
and Y can stabilize the binding of RNAP to the promoter via its interaction with AD resulting in 
the transcription of the reporter genes – LEU2 and LACZ. 
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All samples and standards were analysed by the peak jump method, averaged over 100 
reads per sample in triplicate using an auto-tuned Thermo X-series ICP-MS.  The 
copper content was defined as the amount of copper atoms per cell, calculated on the 
basis that OD600 of 1 is equivalent to ~3 x 10
7 cells/mL (Treco and Lundblad, 1993). 
 
2.6.5.3 Studying the expression of nuclear proteins by S1 nuclease assays 
The effect of copper concentration on the expression of nuclear proteins was studied by 
monitoring the expression levels of the CTR1 and CUP1 genes in EGY48_pMW112 
with pJG4.5_X and p423lexAkan_Y co-transformants.  RNA was extracted from a pellet 
constituting exponentially growing cells (OD600 0.5-0.8), such that the final absorbance 
at 600 nm was ~40 in SD-gal-raff-leu medium with and without CuSO4 and BCS as 
discussed in section 2.5.4. 
2.6.5.3.1 Labeling S1 probes with ATP-[γ- 32P] 
The S1 probes were prepared by labeling the CTR1 and CUP1 DNA oligomers (Table 
5) with ATP-[γ-32P] (6000 Ci/mmol; Perkin-Elmer, UK).  This involved the incubation of a 
25 µL reaction mixture containing 20 % (v/v) of 1 pmol/µL of CTR1 (or CUP1) oligomer, 
20 % (v/v) of 1 pmol/µL of a calmodulin-binding DNA oligomer (CMD1) with 10 % (v/v) 
10x T4 polynucleotide kinase (PNK) buffer (Promega, UK), 0.04 % (v/v) T4 PNK 
enzyme (Promega, UK) and 0.04 % (v/v) ATP-[γ-32P] at 37 oC for 30 mins.  The reaction 
was stopped by the addition of 50 % (v/v) TE buffer.  The labeled probe was isolated 
and purified using the IllustraTM ProbeQuant G-50 Micro Columns Radiolabeled Probe 
Purification kit (GE Healthcare, UK) according to the manufacturer’s instructions.   
2.6.5.3.2 Hybridization and purification of labeled S1 probes with RNA 
A 50 µL reaction mixture containing 0.02 % (v/v) of the labeled S1 probe, 0.8 % (v/v) of 
700 ng/µL RNA (from the desired co-transformants), 0.15 % (v/v) of hybridization buffer 
(257 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid sodium salt (HEPES) pH 
7.0, 6.8 mM EDTA pH 7.5, 2 mM NaCl and 0.7 % (v/v) Triton X-100) was incubated at 
55 oC overnight.  The following day, samples were cooled to room temperature and 
incubated with 0.45 mL of S1 reaction mixture containing (0.0001 % (v/v) S1 nuclease 
(Promega, UK), 333 mM NaCl, 2.2 mM ZnCl2, 66 mM sodium acetate pH 4.6) at 37 
oC 
for 30 mins.  3 µL of 10 µg/mL tRNA was added to the side of the tubes, vortexed and 
centrifuged at 16000 x g for 30 secs.  0.9 mL of ice-cold 100 % ethanol was added to 
the tubes and incubated at -20 oC for 90 mins to precipitate the DNA-RNA hybrid.  The 
hybrid was pelleted by centrifuging the tubes at 16000 x g for 10 mins and washed with 
70 % ethanol.  The supernatant was discarded and any remaining ethanol was 
removed by incubating the pellet at 65 oC for 20 mins.  The pellet was resuspended in 
10 µL S1 loading buffer containing 90 % (v/v) formamide, 0.5x TBE buffer (44.5 mM 
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Tris-base, 44.5 mM Boric acid, 2 mM EDTA pH 8.0) and 0.5 µL of 6x loading dye (0.25 
% (w/v) bromophenol blue, 30 % (v/v) glycerol) and incubated at 65 oC for 10 mins.  
The tubes were centrifuged at 16000 x g for 15 secs and stored on ice.  Subsequently 
the samples were electrophoresed on a polyacrylamide-urea based gel. 
 
2.6.5.3.3 Analysis of the S1 samples by polyacrylamide-urea gel electrophoresis 
The polyacrylamide-urea gel constituted 50 % (w/v) urea, 20 % (v/v) of 40 % 
acrylamide/bis-acrylamide solution (19:1) in 1x TBE buffer polymerized by the addition 
of 0.07 % ammonium persulfate (APS) and 0.03 % N,N,N',N'-
Tetramethylethylenediamine (TEMED).  The gel mixture was poured into a gel cast 
(Bio-Rad, UK) followed by the insertion of a plastic comb to create individual lanes and 
left to polymerise at room temperature for 90 mins.  Prior to loading the samples, the 
polyacrylamide-urea gel was pre-run by loading 10 µL of 6x loading dye (mentioned 
above) and electrophoresed in 1x TBE buffer at 200 V for 60 mins.  After loading the 
samples, the gel was electrophoresed at 200 V for 2.5-3 hrs.  Following electrophoresis, 
the gel was incubated in fixing solution (10 % (v/v) methanol, 10 % (v/v) acetic acid) for 
1 hr with rocking and lifted onto a piece of 3MM Whatman® paper (Fisher, UK).  The 
gels were dried using a gel drier (Drygel Sr. Slab Gel Dryer Model SE 1160) at 80 oC for 
2 hrs.  The dried gels were incubated with a standard X-ray film overnight at room 
temperature or at -80 oC (for higher intensity), and developed using an auto-developer 
(Konica Minolta SRX-101A). 
 
2.6.5.4 Phosphorimaging 
The expression of messenger RNA (mRNA) was quantified by incubating the X-ray film 
pre-exposed to the S1 gel (section 2.6.5.3.3) with a phophorimaging screen at room 
temperature for 30-60 mins.  The screen was scanned using the rolling ball method of 
the Typhoon TRIO Variable Mode Imager (GE Healthcare, UK). 
 
2.6.6 Sodium dodecyl sulfate-Polyacrylamide gel electrophoresis  
The expression of proteins was studied using sodium dodecyl sulfate-polyacrylamide 
gel electrophoresis (SDS-PAGE).  The gels consisted of a 5 % acrylamide/bis-
acrylamide stacking gel poured above a layer of 10 % or 15 % acrylamide/bis-
acrylamide separation gel with a plastic comb to produce the ridges in the gel.  The 
stacking gel was prepared by adding 0.05 % (w/v) APS and 0.1 % (v/v) TEMED to a 
solution containing 125 mM Tris-HCl pH 6.8 and 0.1 % (w/v) SDS.  The running gel was 
prepared by adding 0.05 % (w/v) APS, 0.05 % (v/v) TEMED) to a solution containing 
375 mM Tris-HCl pH 8.8, 0.1 % (w/v) SDS and 10 % (v/v) glycerol.  Once the gels had 
polymerized 20 µL of the protein samples (section 2.5.5) were loaded on to the gel, 
along with a broad range (2.3 kDa – 200 kDa) molecular weight markers or pre-stained 
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markers (20 kDa – 6.5 kDa; Bio-Rad, UK).  All electrophoresis experiments were carried 
out using a Mini-Protein II Cell (Bio-Rad, UK) containing 1x SDS-PAGE buffer (25 mM 
Tris-HCl pH 8.8, 200 mM glycine, 0.1% (w/v) SDS) at a constant voltage of 200 V for 
60-90 mins until the dye front reached the bottom of the separation gel.     
    
2.6.7 Western Blotting 
The expression of fusion proteins in EGY48_pMW112 cells + pJG4.5_X and 
p423lexAkan_Y was verified by immunoblotting.  Whole cell extract from exponentially 
growing cells (OD600 0.5-0.8), such that the final absorbance at 600 nm was ~2.5 in SD-
gal-raff-leu medium was prepared as detailed in section 2.5.5.  20 µL of the cell extract 
was loaded on to 15 % SDS-PAGE gels (see section 2.6.6) along with 5 µL of pre-
stained protein molecular weight markers and electrophoresed at 200 V until the dye-
front reached the bottom of the gel.  The gel was subsequently placed on a piece of 
blotting card (Sigma, UK) with a foam pad underneath inside a plastic cast.  A piece of 
HybondTM ECLTM nitrocellulose membrane (GE Healthcare, UK) was placed on top of 
the gel followed by another piece of blotting card and a foam pad.  The blotting cards, 
foam pads and the nitrocellulose membrane were all pre-soaked in the transfer buffer 
(0.5x SDS-PAGE buffer without SDS (see section 2.6.6), 20 % (v/v) methanol) and after 
assembly were firmly pressed from the centre towards the sides to remove trapped air 
bubbles before the cast was sealed and placed inside a Mini-Protean II Cell (Bio-Rad, 
UK) containing 1x transfer buffer.  Transfer was achieved by applying a constant 
current at 270 mA for 90 mins.  The membrane was subsequently removed and rinsed 
with TBST buffer (10 mM Tris-HCl pH 7.4, 150 mM NaCl, 0.05 % Tween 20) followed by 
30 mins incubation in Ponceau S staining solution (0.25 % (w/v) Ponceau S, 5 % (v/v) 
acetic acid).  The membrane was rinsed several times with water until the background 
was clear.  The membrane was photographed and rinsed with TBST buffer before 
blocking it in 1x TBST buffer containing 25 % (w/v) blot-qualified bovine serum albumin 
(BSA; Promega, UK) for 60 mins with gentle rocking.  The blocking solution was 
discarded and the membrane was incubated overnight in 1x TBST buffer containing 25 
% (w/v) blot-qualified BSA and either 1 in 1000 dilution of rabbit anti-HA primary 
antibody (Sigma-Aldrich, UK) or 1 in 25000 dilution of rabbit anti-LexA primary antibody 
(Abcam, UK) at 4 oC with gentle rocking.   
The following day the membrane was washed three times with TBST 
buffer and incubated for 1 hr with 1x TBST buffer containing 7 % (v/v) of goat anti-rabbit 
alkaline phosphatase (AP) secondary antibody (Promega, UK) at room temperature 
with gentle rocking.  Subsequently the membrane was washed with AP buffer (100 mM 
Tris-HCl pH 9.5, 100 mM NaCl, 5 mM MgCl2) and incubated with 20 mL AP buffer 
containing 0.44 % (v/v) nitro blue tetrazolium (Promega, UK) and 0.32 % (v/v) 5-bromo-
4-chloro-3-indolyl phosphate (Promega, UK) for 3-20 mins in a dark environment until 
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protein bands were visible on the membrane.  The reaction was stopped by washing 
the membrane with dH2O and photographed. 
 
2.6.8 Creation of the ccs1∆-knockout mutant of EGY48  
Genomic DNA (section 2.5.3) was isolated from the BY4741-ccs1∆ strain (Table 3) and 
used as a template for amplifying the KANR gene which is present in place of CCS1 in 
this strain.  The S. cerevisiae genome sequence was obtained from the online 
Sachharomyces Genome Database resource (SGD) in order to design DNA oligomers 
homologous to the region ~100 bp before the start and end of the CCS1 gene (Table 5).  
A 50 µL PCR reaction was prepared in a 0.5 mL eppendorf tube comprising 100 ng 
BY4741- ccs1∆ genomic DNA template, 0.4 mM dNTPs mix, 50 pmol/µL of each 
primer, 1 µL of 2.5 U/µL Pfu polymerase, 5 µL 10x Pfu buffer and sterile ddH2O and 
incubated in a PCR machine according to the conditions stated in Table 6.  The PCR 
product was subsequently electrophoresed on a 1.5 % agarose gel and the desired 
band was isolated according to sections 2.3.3.3 and 2.3.3.4.   
The purified PCR product consisting of the KanR gene from the BY4741- 
ccs1∆ strain was transformed into EGY48 (section 2.5.2) to enable the removal or 
‘knocking-out’ of CCS1 from the EGY48 genome and the insertion of the KANR gene in 
place of it.  This strain would subsequently be denoted as SAY1.  200 µL of the 
transformation mixture was inoculated in 5 mL YPD and incubated overnight at 30 oC 
with shaking at 250 rpm.  The following day, the transformants were spread on to YPD-
agar plates containing 400 µg/mL of the G-418 antibiotic (Formedium, UK) and 
incubated for 1-2 days at 30 oC.  Since only the cells containing KANR should grow on 
YPD-agar plates containing G-418, all of the colonies evident on these plates should 
contain the desired SAY1 strain.   A diagnostic PCR was also performed to verify the 
success of homologous recombination resulting in the replacement of CCS1 with KANR.   
Two DNA primers were designed where one primer was homologous to 
KANR while the other primer was homologous to a portion of the S. cerevisiae genome 
~150 bp downstream of the CCS1 gene (that is, ~50 bp upstream of DNA oligomer no. 
57, Table 5).  Two PCR reactions, similar to the reactions mentioned above, were 
prepared with either EGY48 or SAY1 genomic DNA as the template, and incubated 
according to the conditions stated in Table 6.  The PCR samples were loaded on to 1.5 
% agarose gels and the presence of a band at the appropriate size in the lane 
containing the PCR product from the SAY1 strain only confirmed the successful 
knockout of CCS1 from EGY48. 
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Table 6: PCR conditions used for amplifying the KanR gene from BY4741-ccs1∆. 
 
Purpose Incubation 
Temperature (oC) 
Incubation 
Time 
Number 
of cycles 
DNA denaturation 99 5 mins 1 
DNA denaturation 95 40 sec  
35 Annealing of DNA primer to the 
template 
Tm – 5 
oCa 30 sec 
Primer extension 68 2 mins 
Completion 68 5 mins 1 
 
a The melting temperature (Tm) of the DNA oligomer. 
2.7 Bioinformatics 
The ClustalW2 software was used to align amino acid sequences of proteins using the 
default settings (http://www.ebi.ac.uk/Tools/clustalw/).  The figures depicting crystal 
structures of proteins were created using PyMol (PyMol molecular graphics system, 
Version 1.3, Schrodinger, LLC).  The models of ScAtx1-PacSN and ScAtx1-CtaAN were 
created in PyMol by superimposing and aligning a monomer of PacSN or CtaAN on the 
appropriate ScAtx1 dimer.  While the PacSN monomer was selected from the 2xmw 
structure in the PDB database, the CtaAN monomer was obtained by using the Swiss 
PDB modelling software.  The sequence of CtaAN was submitted into the Swiss PDB 
modelling software and the automated mode was used to obtain a model of it 
(http://swissmodel.expasy.org).  The structural alignment of hCCSD1 and CcsD1 shown 
in Figure 12, was performed in PyMol by selecting the CcsD1 sequence from the 1qup 
structure in the PDB database and superimposing it on the hCCSD1 structure (PDB 
accession code: 2crl) using the default settings. 
2.8 Statistical Analysis 
The significance of difference between the β-galactosidase activity of the WT and 
mutant proteins was determined by analyzing the data by one-way analysis of variance 
and the Bonferroni post hoc test.  Significance level of 0.05 was used, such that P< 
0.05 implied a significant difference whereas P> 0.05 implied the lack of significant 
difference in β-galactosidase activities.  
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3. Results 
3.1 Investigating the molecular basis of the interaction between copper 
metallochaperones and hBACE1 CTD  
Initially the bacterial two-hybrid systems were utilised to study the interaction between 
hBACE1 CTD and hCCS.  Bacterial two-hybrid systems provide the advantage of 
minimising the potential interference by endogenous copper-binding proteins on the 
interaction of hBACE1 CTD with hCCS since there are no known Cu(I)-binding proteins 
in the cytosol of E. coli (Tottey et al., 2005), the site of bacterial two-hybrid interactions.    
The interaction of hBACE1 CTD with hCCS was first studied using the BacterioMatch® 
bacterial two-hybrid system, which is a well-established system for investigating the 
interaction of copper metallochaperones with their target proteins.  Some of the 
previously explored interactions using this system include the interaction of BsCopZ 
with the MBDs of BsCopA (Radford et al., 2003) and the interaction of ScAtx1 with the 
MBDs of PacS and CtaA (Banci et al., 2006c; Banci et al., 2010b; Borrelly et al., 2004; 
Tottey et al., 2002).  The interaction of ScAtx1 with the MBD of PacS comprising 
residues 1-95 (PacS95) was used as the positive control for this system.  Empty pBT 
and pTRG, that is vectors lacking the proteins under investigation (for example ScAtx1, 
PacS95 or hCCS) as the translational fusions, were used as the negative controls.  As 
shown in Figure 21, a significant interaction (P<0.05) was detected between ScAtx1 
and PacS95, consistent with previous reports (Borrelly et al., 2004; Tottey et al., 2002).  
However, a significant interaction was not observed between hBACE1 CTD and hCCS 
(P>0.05) (Figure 22a).  Since, the interaction of hCCS with hBACE1 CTD has 
previously been shown to be mediated by D1 of hCCS (Angeletti et al., 2005), the 
interaction of hBACE1 CTD with isolated D1 of hCCS was also tested.  However, no 
significant interaction was evident between hBACE1 CTD and hCCSD1 either (Figure 
22b).  It was hypothesised that the lack of interactions may be because the tertiary 
protein structure of hCCS and hCCSD1 may not be optimal for interacting with hBACE1 
CTD due to their expression as fusion proteins with the components of the 
BacterioMatch® two-hybrid system.  In order to address this issue, the BACTH two-
hybrid system was used to study the interaction of hBACE1 CTD with hCCS and 
hCCSD1.  Significant interactions were not detected between hBACE1 CTD and full-
length hCCS (Figure 23) or hCCSD1 (Figure 24) in this system either.  Since neither of 
the two bacterial two-hybrid systems yield a significant interaction between hBACE1 
CTD and hCCS or hCCSD1, it was proposed that these proteins may not be able to fold 
properly in the bacterial cytoplasm due to their eukaryotic origins.  Hence the 
interactions were investigated using the yeast two-hybrid system instead.  
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Figure 21: β-galactosidase activity assays of ScAtx1 with PacS95 using the 
BacterioMatch® two-hybrid system.  XL-1 Blue MRF’ cells were co-transformed with pBT 
and pTRG with or without scAtx1 and pacS95 respectively, as the translational fusions.  Data 
from three independent co-transformants are presented in black, grey or white.  Each data bar 
represents the average of a co-transformant assayed in triplicate + SD. 
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Figure 22: β-galactosidase activity assays of hBACE1 CTD with hCCS and 
hCCSD1 using the BacterioMatch® two-hybrid system.  XL-1 Blue MRF’ cells were co-
transformed with pBT and pTRG with or without hBACE1 CTD and hCCS (A) or hCCSD1 (B) 
respectively, as the translational fusions.  Data from three independent co-transformants are 
presented in black, grey or white.  Each data bar represents the average of a co-transformant 
assayed in triplicate + SD. 
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Figure 23: β-galactosidase activity assays of hBACE1 CTD with hCCS using the 
BACTH two-hybrid system.  BTH101 cells were co-transformed with pKT25 and pUT18C 
with or without the constructs mentioned above as the translational fusions.  Data from three 
independent co-transformants are presented in black, grey or white.  Each data bar represents 
the average of a co-transformant assayed in triplicate + SD. 
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Figure 24: β-galactosidase activity assays of hBACE1 CTD with hCCSD1 using 
the BACTH two-hybrid system.  BTH101 cells were co-transformed with pKT25 and 
pUT18C with or without the constructs mentioned above as the translational fusions.  Data from 
three independent co-transformants are presented in black, grey or white.  Each data bar 
represents the average of a co-transformant assayed in triplicate + SD. 
pKT
25-
zip/
pUT
18C
-zip
hBA
CE
1 C
TD/
hCC
SD
1
pKT
25-
zip/
pUT
18C
hBA
CE
1 C
TD/
pUT
18C
pKT
25/
pUT
18C
-zip
pKT
25/
hCC
SD
1
pKT
25/
pUT
18C
0
500
1000
1500
2000
2500
 
β
-g
a
la
c
to
s
id
a
s
e
 A
c
ti
v
it
y
 
(n
m
o
l 
O
N
P
 m
g
-1
 p
ro
te
in
 m
in
-1
)
hBA
CE
1 C
TD/
hCC
SD
1
pKT
25-
zip/
pUT
18C
hBA
CE
1 C
TD/
pUT
18C
pKT
25/
pUT
18C
-zip
pKT
25/
hCC
SD
1
pKT
25/
pUT
18C
0
5
10
15
20
25
30
35
40
45
 
β
-g
a
la
c
to
s
id
a
s
e
 A
c
ti
v
it
y
 
(n
m
o
l 
O
N
P
 m
g
-1
 p
ro
te
in
 m
in
-1
)
   
 91 
A significant interaction was detected between hCCS and hBACE1 CTD (Figure 25) 
using the yeast two-hybrid system, consistent with the results reported previously by 
Angeletti et al. (2005).  Also in agreement with previous reports (Angeletti et al., 2005), 
a significant interaction was only detected between hCCSD1 and hBACE1 CTD but not 
between hCCSD2 and hBACE1 CTD or between hCCSD3 and hBACE1 CTD (Figure 
26).  However, the interaction of hCCSD1 with hBACE1 CTD was ~ 5-fold weaker in 
comparison to the interaction of full-length hCCS with hBACE1 CTD (Figure 26).  While 
a significant interaction was not detected between Ccs1 and hBACE1 CTD, a significant 
interaction was consistently observed between HAH1 and hBACE1 CTD (Figure 27).   
3.1.1 Effect of copper concentration on the interactions of copper 
metallochaperones with hBACE1 CTD 
Since hCCS, HAH1, and hBACE1 CTD can all bind Cu(I) (Angeletti et al., 2005; Eisses 
et al., 2000; Wernimont et al., 2000), it was hypothesised that the interactions of hCCS 
and HAH1 with hBACE1 CTD may be dependent upon the formation of a Cu(I)-bridged 
complex.  This hypothesis is supported by previous studies where interactions between 
copper metallochaperones and their target proteins were shown to be dependent upon 
the presence of copper.  These include the interactions of Atx1 with Ccc2 MBDs (Banci 
et al., 2006b; Portnoy et al., 1999; Pufahl et al., 1997), HAH1 with the MBDs of ATP7A 
or ATP7B (Hamza et al., 1999; Larin et al., 1999; van Dongen et al., 2004) and the 
interaction of BsCopZ with BsCopAb (Banci et al., 2003a).  To demonstrate a role for 
copper in mediating the interaction of hCCS with hBACE1 CTD, the co-transformants 
were cultured in minimal yeast medium containing copper-depleted yeast nitrogen base 
with BCS or CuSO4 added to it.  To verify that the presence of CuSO4 or BCS in the 
growth medium results in altered copper content in the nucleus of the co-transformed 
cells, the site of yeast two-hybrid interactions, the transcription of CTR1 and CUP1 
mRNAs were studied by S1 nuclease assays.  The mRNA level of CMD1, the gene 
coding for the calmodulin protein, was also measured to ensure equivalent sample 
loading, based on the methods used previously by Keller et al. (2000).  To ensure that 
the changes in nuclear copper content were not due to the presence of the hCCS and 
hBACE1 CTD fusions, co-transformants containing empty pJG4.5 and p423lexAkan 
vectors, that is, vectors lacking the hCCS and hBACE1 CTD proteins were also 
assayed for CTR1, CUP1 and CMD1 mRNA levels.   
Previous studies have established that the transcription of CTR1 is 
dependent upon the activity of the transcription factor Mac1 which induces the 
transcription of its target genes, including CTR1, under copper-limiting conditions 
(Labbe et al., 1997; Yamaguchi-Iwai et al., 1997; Zhu et al., 1998).  S1 nuclease assays 
indicate that the addition of 500 µM BCS to the growth medium induce the transcription 
of CTR1 while no CTR1 transcription was detected in the samples obtained from the co-
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transformants cultured in basal medium (medium lacking BCS or CuSO4) or in the 
presence of 10 µM CuSO4 (Figure 28a).  Similarly, the addition of 10 µM CuSO4 was 
shown to induce the transcription of CUP1, the gene coding for the metallothionein 
protein CUP1 (Figure 28b).  The transcription of CUP1 has been shown to be regulated 
by the Ace1 transcription factor under copper-replete conditions (Thiele, 1988).  
Interestingly, residual CUP1 expression was also evident in the samples obtained from 
the co-transformants cultured in 500 µM BCS (Figure 28b).  Since the addition of 500 
µM BCS results in increased transcription of CTR1 (Figure 28a), this may subsequently 
lead to a rapid copper influx in the cell.  In order to ensure that this influx does not result 
in free copper atoms in the cell, CUP1 may be constitutively expressed at low levels 
even in the presence of BCS.   
The mRNA levels of CTR1 and CMD1 were quantified using 
phosphorimaging analysis, as shown in Figure 28c.  Approximately 2-fold higher levels 
of CTR1 mRNA levels are evident in the co-transformants containing empty vectors in 
comparison to the co-transformants containing vectors with hCCS and hBACE1 CTD as 
the translational fusions cultured in the presence of 500 µM BCS (Figure 28c).  Unlike 
the data obtained with the addition of 500 µM BCS (Figure 28c), similar CUP1 mRNA 
levels are evident for the co-transformants cultured in the presence of 10 µM CuSO4 
containing either empty vectors or hCCS and hBACE1 CTD (Figure 28d).  The latter 
results are in agreement with the copper content data determined by ICP-MS which 
reveal an ~ 20-fold increase in the copper content of all of the co-transformants cultured 
in 10 µM CuSO4 compared to the co-transformants incubated in the basal medium 
(Figure 28e-f).  Similar copper content is also evident for all of the co-transformants 
cultured in the presence of 500 µM BCS (Figure 28e-f).  However, the copper content of 
the co-transformants containing hCCS and hBACE1 CTD was ~ 2-fold higher than the 
co-transformants containing the empty vectors when grown in basal medium (Figure 
28e-f).  Therefore, the presence of 500 µM BCS results in ~ 4-fold or ~2-fold decrease 
in the copper content of the co-transformants containing hCCS and hBACE1 CTD or 
empty vectors, respectively, compared to the co-transformants cultured in basal 
medium.   
β-galactosidase activity assays indicate that the addition of 500 µM BCS 
significantly decreases the interaction of hCCS with hBACE1 CTD compared to the co-
transformants cultured in the basal medium (Figure 28e).  However, the addition of 10 
µM CuSO4 to the basal medium does not have a significant effect on the β-
galactosidase activity of the hCCS/hBACE1 CTD co-transformants (Figure 28e).  No 
significant effect of 500 µM BCS or 10 µM CuSO4 is evident on the β-galactosidase 
activitiy of the co-transformants containing empty vectors (Figure 28f). 
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Figure 25: β-galactosidase activity assays of hCCS with hBACE1 CTD using the 
yeast two-hybrid system.  EGY48 cells were co-transformed with pJG4.5 and p423lexAkan 
vectors with or without hCCS and hBACE1 CTD respectively, as the translational fusions.  Data 
from three independent co-transformants are presented in black, grey or white.  Each data bar 
represents the average of a co-transformant assayed in triplicate + SD.  
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Figure 26: β-galactosidase activity assays of the individual domains of hCCS with 
hBACE1 CTD using the yeast two-hybrid system.  EGY48 cells were co-transformed 
with pJG4.5 and p423lexAkan with or without the constructs mentioned above as the 
translational fusions.  Each data bar represents the average of three co-transformants assayed 
in triplicate + SD. 
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Figure 27: β-galactosidase activity assays of hCCS, Ccs1 and HAH1 with hBACE1 
CTD using the yeast two-hybrid system.  EGY48 cells were co-transformed with pJG4.5 
and p423lexAkan with or without the constructs mentioned above as the translational fusions.  
Each data bar represents the average of three co-transformants assayed in triplicate + SD. 
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Figure 28: S1 nuclease protection assays, β-galactosidase activity assays and 
copper content analyses of the pJG4.5/p423lexAkan and hCCS/hBACE1 CTD co-
transformants cultured in different copper conditions.  EGY48 cells co-transformed 
with pJG4.5 and p423lexAkan with or without hCCS and hBACE1 CTD respectively, as the 
translational fusions were grown in basal medium with or without 10 µM CuSO4 and 500 µM 
BCS.  The expression levels of CMD1 in addition to CTR1 (A) and CUP1 (B) were determined 
by S1 nuclease protection assays.  The mRNA level of CMD1, quantified by phophorimaging 
analysis, was compared with the mRNA level of CTR1 or CUP1 as shown in (C) and (D) 
respectively.  β-galactosidase activity assays of the co-transformants containing pJG4.5_hCCS 
and p423lexAkan_hBACE1 CTD (E) or pJG4.5 and p423lexAkan (F) using the yeast two-hybrid 
system are also shown.  In (E) and (F) the black bar represents the average β-galactosidase 
activity of the co-transformants assayed in triplicate + SD, whereas the white bar represents the 
copper content determined by ICP-MS. 
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To determine if higher concentrations of BCS or CuSO4 can have a greater effect on the 
hCCS/hBACE1 CTD interaction, the co-transformants were incubated in the presence 
of 30 µM – 3 mM BCS or 0.3 – 300 µM CuSO4.  The growth rates of the co-
transformants cultured in the highest concentrations of BCS and CuSO4 were compared 
to the growth rates of the co-transformants cultured in the basal medium.  As shown in 
Figure 29, the growth rates for all of the co-transformants were very similar up to 6 
hours of incubation confirming that the presence of 3 mM BCS or 300 µM CuSO4 do not 
impair the growth of the co-transformants during the exponential phase of the growth 
curve.  Western blot analysis was used to ensure that the change in copper 
concentration due to the presence of CuSO4 or BCS did not affect the protein 
expression levels compared to the co-transformants grown in the basal medium.  Cell 
lysates from hCCS/hBACE1 CTD co-transformants grown in the presence of CuSO4 or 
BCS were immunoblotted with the anti-HA (for the pJG4.5 constructs) and the anti-LexA 
(for the p423lexAkan constructs) antibodies.  The protein expression levels from these 
co-transformants were compared with the cell lysates from the co-transformants grown 
in the basal medium.  Prior to immunoblotting, the nitrocellulose membranes were 
stained with Ponceau S to determine equivalent protein loading in all lanes.  The 
expression levels of endogenous proteins were used as loading controls, since due to 
the relatively low expression levels of the desired fusion proteins they could not be 
detected by the Ponceau S stain.  As shown in Figure 30 and Figure 31, the addition of 
BCS or CuSO4 does not result in aberrant changes in protein expression as equivalent 
protein expression levels were detected for all of the co-transformants.  While the 
addition of 30 µM or 100 µM BCS does not result in a significant change in the copper 
content compared to the co-transformants cultured in basal medium, the addition of 500 
µM and 1 mM BCS results in ~ 2-fold and ~ 5-fold reduction in cellular copper content, 
respectively (Figure 32).  The presence of 3 mM BCS results in greater than 200-fold 
decrease in the cellular copper content compared to the co-transformants incubated in 
the basal medium (Figure 32).   
Consistent with the copper content data, the addition of 30 µM or 100 µM 
BCS does not have a significant effect on the interaction of hCCS with hBACE1 CTD, 
as determined by β-galactosidase activity assays (Figure 32).  The addition of 500 µM 
BCS significantly decreases the interaction between hCCS and hBACE1 CTD 
compared to the β-galactosidase activity of the co-transformants cultured in basal 
medium (Figure 32).  Despite the difference in copper content between the co-
transformants incubated in 500 µM, 1 mM and 3 mM BCS, the addition of 1 mM or 3 
mM BCS does not decrease the interaction further compared to the results obtained 
with the addition of 500 µM BCS (Figure 32).  The data therefore indicate that although 
the hCCS and hBACE1 CTD interaction decreases in a copper-deficient environment, it 
is nevertheless not abolished completely.  Unlike the results obtained with copper 
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depletion, the β-galactosidase activity assays do not indicate a significant effect of 
increased copper content on the interaction of hCCS with hBACE1 CTD (Figure 33).  
Despite an ~ 50-fold increase in cellular copper content with the addition of 300 µM 
CuSO4, the interaction between hCCS and hBACE1 CTD remains similar to the co-
transformants cultured in the basal medium (Figure 33).  The effect of copper 
concentration on the interaction of hCCSD1 and HAH1 with hBACE1 CTD was also 
studied.  As shown in Figure 34 and Figure 35, neither the addition of BCS nor the 
presence of CuSO4 had a significant effect on the hCCSD1/hBACE1 CTD or 
HAH1/hBACE1 CTD interactions.  Surprisingly, the addition of 100 µM BCS to the 
growth medium results in ~ 2-fold increase in the HAH1/hBACE1 CTD interaction 
compared to the co-transformants cultured in basal medium (Figure 35). 
 
3.1.2 The role of Cu(I)-binding residues in hCCS in mediating the interaction 
with hBACE1 CTD 
Since copper depletion decreases the interaction of hCCS with hBACE1 CTD (Figure 
28e and Figure 32), it was hypothesised that this interaction may require the copper-
binding Cys residues in hCCS.  As the interaction between these proteins is associated 
with D1 of hCCS (Figure 26), the copper-binding Cys residues (Cys22 and Cys25) in 
this domain, present in a CXXC-motif, were mutated to Ser.  Mutation of either Cys22 or 
Cys25 to Ser in hCCS results in ~ 8-9-fold weaker interaction with hBACE1 CTD 
compared to the interaction of hCCS wild-type (WT) protein with hBACE1 CTD (Figure 
36).  Mutation of both of the D1 Cys residues in hCCS completely abolishes the 
interaction with hBACE1 CTD (Figure 36).  Similarly, the mutation of both Cys22 and 
Cys25 in hCCSD1 also abolishes the interaction with hBACE1 CTD (Figure 37).  While 
the mutation of either Cys22 or Cys25 in hCCSD1 significantly decreases the 
interaction with hBACE1 CTD, the difference compared with the interaction of hCCSD1 
WT protein with hBACE1 CTD is only ~ 2-fold (Figure 37) unlike the single mutations in 
full-length hCCS where the difference is ~ 9-fold (Figure 36).  The data therefore 
indicate that both Cys22 and Cys25 are important for the hCCS/hBACE1 CTD and 
hCCSD1/hBACE1 CTD interactions.  Western blot and Ponceau S analyses (Figure 38) 
indicate similar protein expression levels for the hCCS and hCCSD1 WT and mutant 
proteins suggesting that the effects of Cys mutations observed on the interaction with 
hBACE1 CTD are not due to aberrant changes in protein expression levels.  
Rae et al. (2001) proposed that Cu(I)-binding in hCCSD1 may induce 
structural changes in Arg71 resulting in the orientation of this residue towards the 
metal-binding site.  Analogous residues in Atx1 and HAH1 have been shown to be 
important for mediating the interactions with their respective target proteins (Arnesano 
et al., 2001a; Arnesano et al., 2004; Hussain et al., 2008; Portnoy et al., 1999; 
Wernimont et al., 2000).  To investigate the role of this residue in mediating the 
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interaction of hCCS with hBACE1 CTD, Arg71 was mutated to Ala, Glu or Lys.  While all 
three mutations in full-length hCCS result in a significant decrease in the interaction 
with hBACE1 CTD, the most dramatic effects were obtained with the hCCS Arg71Glu 
and Arg71Lys mutations (Figure 39).  The hCCS Arg71Glu and Arg71Lys mutations 
both result in an ~ 10-fold decrease in the interaction with hBACE1 CTD compared with 
the interaction of hCCS WT protein with hBACE1 CTD (Figure 39).  The mutation of 
Arg71 in hCCSD1 also results in a significant decrease in the interaction with hBACE1 
CTD (Figure 40).  Unlike the results obtained with the full-length hCCS Arg mutations 
where Arg71Glu and Arg71Lys mutations had a greater effect than the Arg71Ala 
mutation, all three Arg71 mutations in hCCSD1 result in very similar interactions with 
hBACE1 CTD (~3-fold lower than hCCSD1 WT/hBACE1 CTD).  No aberrant effect of 
the Arg71 mutations in hCCS and hCCSD1 was observed on protein expression levels 
(Figure 41).   
Similar to hCCSD1, Ccs1D1 also contains a positively charged residue in 
loop 5 in the analogous location to Arg71 in hCCSD1, although this residue is 
substituted by Lys in Ccs1 (Lys65) (Figure 9b).  In light of the evidence that the 
mutation of hCCS Arg71 to Lys significantly decreases the interaction with hBACE1 
CTD, it was hypothesised that the incorporation of an Arg residue in the analogous 
position in Ccs1 may enhance its interaction with hBACE1 CTD.  While the data 
indicate a slight increase in interaction between Ccs1 Lys66Arg and hBACE1 CTD 
compared to the Ccs1 WT/hBACE1 CTD interaction, this increase was not found to be 
significant (Figure 42).  Western blot and Ponceau S analyses indicate similar protein 
expression levels for both Ccs1 Lys66Arg and Ccs1 WT proteins (Figure 43).   
In addition to Cys22 and Cys25, hCCS can also bind Cu(I) via the 
Cys244 and Cys246 residues in D3 (Caruano-Yzermans et al., 2006; Eisses et al., 
2000; Rae et al., 2001).  To investigate the role of Cys244 and Cys246 residues in 
mediating the interaction of hCCS with hBACE1 CTD, these residues were mutated to 
Ser.  However, neither the mutation of Cys244 nor the mutation of both Cys244 and 
Cys246 had a significant effect on the interaction with hBACE1 CTD compared to the 
interaction of hBACE1 CTD with hCCS WT protein (Figure 44).  The data therefore 
suggest that the Cu(I)-binding Cys residues in hCCSD3 are not required for the 
interaction between hCCS and hBACE1 CTD.  Western blot and Ponceau S analyses 
indicate equivalent expression levels for hCCS WT, hCCS Cys244Ser and hCCS 
Cys244Ser,Cys246Ser proteins (Figure 45). 
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Figure 29: Growth curves for the co-transformants containing hCCS and hBACE1 
CTD cultured in basal medium and in medium containing 300 µM CuSO4, 500 µM 
BCS or 3 mM BCS.  EGY48 cells co-transformed with pJG4.5_hCCS and 
p423lexAkan_hBACE1 CTD were grown in basal medium (■) or in medium containing 300 µM 
CuSO4 (○), 500 µM BCS (▲) or 3 mM BCS (□) over a course of 7 hrs.   
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Figure 30: Western blot and Ponceau S analyses of the co-transformants 
containing hCCS and hBACE1 CTD cultured in varying concentrations of BCS.  
Whole cell extracts from EGY48 cells co-transformed with pJG4.5_hCCS and 
p423lexAkan_hBACE1 CTD grown in different concentrations of BCS were analysed with the 
anti-HA antibody by western blot analysis and show intense bands at ~42 kDa for the hCCS 
translational fusions (A).  The co-transformants were also analysed with the anti-LexA antibody 
and show intense bands at ~27 kDa for the hBACE1 CTD translational fusions (B).  The 
nitrocellulose membranes were stained with Ponceau S to determine equivalent protein loading 
in each lane (C).  The position of the protein molecular weight markers in (C) are shown on the 
left in kDa. 
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Figure 31: Western blot and Ponceau S analyses of the co-transformants 
containing hCCS and hBACE1 CTD cultured in varying concentrations of CuSO4.  
Whole cell extracts from EGY48 cells co-transformed with pJG4.5_hCCS and 
p423lexAkan_hBACE1 CTD grown in different concentrations of CuSO4 were analysed with the 
anti-HA antibody and show intense bands at ~42 kDa for the hCCS translational fusions (A).  
The co-transformants were also analysed with the anti-LexA antibody and show intense bands 
at ~27 kDa for the hBACE1 CTD translational fusions (B).  The nitrocellulose membranes were 
stained with Ponceau S to determine equivalent protein loading in each lane (C).  The position of 
the protein molecular weight markers in (C) are shown on the left in kDa. 
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Figure 32: β-galactosidase activity assays using the yeast two-hybrid system and 
the copper content of the co-transformants containing hCCS and hBACE1 CTD 
cultured in basal medium or in varying concentration of BCS.  EGY48 cells co-
transformed with pJG4.5_hCCS and p423lexAkan_hBACE1 CTD were grown in various 
concentrations of BCS and assayed for β-galactosidase activity.   The black bar represents the 
average β-galactosidase activity for the co-transformants assayed in triplicate + SD.  The white 
bar represents the cellular copper content determined using ICP-MS. 
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Figure 33: β-galactosidase activity assays using the yeast two-hybrid system and 
the copper content of the co-transformants containing hCCS and hBACE1 CTD 
cultured in basal medium or in varying concentration of CuSO4.  EGY48 cells co-
transformed with pJG4.5_hCCS and p423lexAkan_hBACE1 CTD were grown in various 
concentrations of CuSO4 and assayed for β-galactosidase activity.   The black bar represents 
the average β-galactosidase activity for the co-transformants assayed in triplicate + SD.  The 
white bar represents the cellular copper content determined using ICP-MS. 
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Figure 34: β-galactosidase activity assays using the yeast two-hybrid system for 
the co-transformants containing hCCSD1 and hBACE1 CTD cultured in basal 
medium or in medium containing BCS or CuSO4.  EGY48 cells co-transformed with 
pJG4.5_hCCSD1 and p423lexAkan_hBACE1 CTD were grown with or without (-) added CuSO4 
or BCS at the concentrations shown above and assayed for β-galactosidase activity.  Each data 
bar represents the average of three co-transformants assayed in triplicate + SD. 
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Figure 35: β-galactosidase activity assays using the yeast two-hybrid system for 
the co-transformants containing HAH1 and hBACE1 CTD cultured in basal 
medium or in medium containing BCS or CuSO4.  EGY48 cells co-transformed with 
pJG4.5_HAH1 and p423lexAkan_hBACE1 CTD were grown with or without (-) added CuSO4 or 
BCS at the concentrations shown above and assayed for β-galactosidase activity.  Each data 
bar represents the average of three co-transformants assayed in triplicate + SD. 
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Figure 36: β-galactosidase activity assays showing the effects of hCCS Cys22 
and Cys25 mutations on the interaction with hBACE1 CTD using the yeast two-
hybrid system.  EGY48 cells were co-transformed with pJG4.5 and p423lexAkan with or 
without the constructs mentioned above as the translational fusions.  Each data bar represents 
the average of three co-transformants assayed in triplicate + SD. 
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Figure 37: β-galactosidase activity assays showing the effect of hCCSD1 Cys22 
and Cys25 mutations on the interaction with hBACE1 CTD using the yeast two-
hybrid system.  EGY48 cells were co-transformed with pJG4.5 and p423lexAkan with or 
without the constructs mentioned above as the translational fusions.  Each data bar represents 
the average of three co-transformants assayed in triplicate + SD. 
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Figure 38: Western blot and Ponceau S analyses of hCCS and hCCSD1 WT, 
Cys22Ser, Cys25Ser and Cys22Ser,Cys25Ser proteins with the anti-HA antibody.  
Whole cell extracts from EGY48 cells co-transformed with p423lexAkan_hBACE1 CTD and 
pJG4.5 with the hCCS (A) or hCCSD1 (B) constructs as the translational fusions were analysed 
with the anti-HA antibody by western blot analysis.  The intense bands shown in (A) at ~42 kDa 
represent the hCCS translational fusion, while the intense bands at ~ 20 kDa in (B) represent the 
hCCSD1 translational fusions. The nitrocellulose membranes shown in (A) and (B) were stained 
with Ponceau S prior to immunoblotting to determine equivalent protein loading in each lane, as 
shown in (C) and (D) respectively.  The position of the protein molecular weight markers in (C) 
and (D) are shown on the left in kDa. 
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Figure 39: β-galactosidase activity assays showing the effect of hCCS Arg71 
mutations on the interaction with hBACE1 CTD using the yeast two-hybrid 
system.  EGY48 cells were co-transformed with pJG4.5 and p423lexAkan with or without the 
constructs mentioned above as the translational fusions.  Each data bar represents the average 
of three co-transformants assayed in triplicate + SD. 
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Figure 40: β-galactosidase activity assays showing the effect of hCCSD1 Arg71 
mutations on the interaction with hBACE1 CTD using the yeast two-hybrid 
system.  EGY48 cells were co-transformed with pJG4.5 and p423lexAkan with or without the 
constructs mentioned above as the translational fusions.  Each data bar represents the average 
of three co-transformants assayed in triplicate + S.D. 
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Figure 41: Western blot and Ponceau S analyses of hCCS and hCCSD1 WT, 
Arg71Ala, Arg71Glu and Arg71Lys proteins with the anti-HA antibody.  Whole cell 
extracts from EGY48 cells co-transformed with p423lexAkan_hBACE1 CTD and pJG4.5 with 
hCCS (A) or hCCSD1 (B) constructs as the translational fusions were analysed with the anti-HA 
antibody by western blot analysis.  The intense bands in (A) at ~42 kDa represent the hCCS 
translational fusion, while the intense bands at ~ 20 kDa in (B) represent the hCCSD1 
translational fusions. The nitrocellulose membranes shown in (A) and (B) were stained with 
Ponceau S prior to immunoblotting to determine equivalent protein loading in each lane, as 
shown in (C) and (D) respectively.  The position of the protein molecular weight markers in (C) 
and (D) are shown on the left in kDa. 
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Figure 42: β-galactosidase activity assays showing the effect of Ccs1 Lys66Arg 
mutation on the interaction with hBACE1 CTD using the yeast two-hybrid system.  
EGY48 cells were co-transformed with pJG4.5 and p423lexAkan with or without the constructs 
mentioned above as the translational fusions.  Each data bar represents the average of three co-
transformants assayed in triplicate + SD. 
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Figure 43: Western blot and Ponceau S analyses of Ccs1 WT and Lys66Arg 
proteins with the anti-HA antibody.  Whole cell extracts from EGY48 cells co-transformed 
with p423lexAkan_hBACE1 CTD and pJG4.5 with CCS1 WT or CCS1 lys66arg as the 
translational fusions were analysed with the anti-HA antibody by western blot analysis and show 
intense bands at ~ 39 kDa for the Ccs1 translational fusions (A).  The nitrocellulose membrane 
was stained with Ponceau S to determine equivalent protein loading in each lane (B).  The 
position of the protein molecular weight markers in (B) are shown on the left in kDa. 
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Figure 44: β-galactosidase activity assays showing the effect of hCCS Cys244Ser 
and Cys244Ser,Cys246Ser mutations on the interaction with hBACE1 CTD using 
the yeast two-hybrid system.  EGY48 cells were co-transformed with pJG4.5 and 
p423lexAkan with or without the constructs mentioned above as the translational fusions.  Each 
data bar represents the average of three co-transformants assayed in triplicate + SD. 
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Figure 45: Western blot and Ponceau S analyses of hCCS WT, Cys244Ser and 
Cys244Ser,Cys246Ser proteins with the anti-HA antibody.  Whole cell extracts from 
EGY48 cells co-transformed with p423lexAkan_hBACE1 CTD and pJG4.5 with the hCCS 
constructs shown above as the translational fusions were analysed with the anti-HA antibody by 
western blot analysis and show intense bands at ~42 kDa for the hCCS translational fusions (A).  
The nitrocellulose membrane was stained with Ponceau S to determine equivalent protein 
loading in each lane (B).  The position of the protein molecular weight markers in (B) are shown 
on the left in kDa. 
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3.1.3 The role of Cu(I)-binding Cys residues in hBACE1 CTD in mediating the 
interaction with copper metallochaperones 
Since the mutation of the Cu(I)-binding Cys residues in D1 of hCCS abolishes the 
interaction with hBACE1 CTD (Figure 36 and Figure 37), the Cu(I)-binding residues 
Cys478, Cys482 and Cys485 in hBACE1 CTD (Angeletti et al., 2005) were also 
mutated to Ser to determine their roles in the interactions with hCCS and HAH1.  As 
shown in Figure 46, the mutation of Cys478 to Ser results in significantly increased 
interactions of hBACE1 CTD with hCCS, hCCSD1 and HAH1.  In contrast, the mutation 
of either Cys482 (Figure 47) or Cys485 (Figure 48) abolishes the interaction of hBACE1 
CTD with hCCS, hCCSD1 and HAH1.  The data therefore indicate that the Cys residues 
in the CXXC motif of both hBACE1 CTD and hCCS are vital for their interaction.  
Western blot and Ponceau S analyses indicate that the hBACE1 CTD Cys mutations do 
not have an aberrant effect on protein expression levels as equivalent protein levels 
were observed for all of the mutation proteins compared to the hBACE1 CTD WT 
protein (Figure 49).   
3.1.4 Identifying additional residues in hBACE1 CTD involved in mediating the 
interactions with hCCS and HAH1 
The data shown in Figure 47 and Figure 48 clearly demonstrate that the Cys residues in 
the CXXC motif of hBACE1 CTD are essential for the interactions with hCCS and 
HAH1.  It was subsequently hypothesised that the residues surrounding the CXXC motif 
in hBACE1 CTD may also be involved in the interaction of hBACE1 CTD with copper 
metallochaperones.  To investigate this further, some of the residues located close to 
the CXXC-motif were mutated to study the effects of those mutations on the interactions 
of hBACE1 CTD with hCCS and HAH1.   
The Trp480 residue is located two residues upstream of Cys482 in 
hBACE1 CTD.  In the analogous position, most of the copper metallochaperones and 
the cognate MBDs possess a Met residue (Arnesano et al., 2002).  This Met residue 
has been shown to be important for maintaining the hydrophobic core of the ferredoxin-
fold (Banci et al., 2001b; Hearnshaw et al., 2009; Poger et al., 2005; Wernimont et al., 
2000).  While hBACE1 CTD is too short to form a ferredoxin-fold, it is possible that 
Trp480 may also play a structural role in the organisation of the CXXC motif for Cu(I)-
binding in hBACE1 CTD.  Therefore, the Trp480 residue was mutated to Met to 
determine its effect on the interaction of hBACE1 CTD with hCCS and HAH1.  As 
shown in Figure 50, the Trp480Met mutation significantly decreases the interaction of 
hBACE1 CTD with hCCS and almost abolishes the interactions with hCCSD1 and 
HAH1, suggesting that this residue is important for mediating the interactions with 
copper metallochaperones.   
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Figure 46: β-galactosidase activity assays showing the effect of hBACE1 CTD 
Cys478Ser mutation on the interactions with hCCS, hCCSD1 and HAH1 using the 
yeast two-hybrid system.  EGY48 cells were co-transformed with pJG4.5 and p423lexAkan 
with or without the constructs mentioned above as the translational fusions.  Each data bar 
represents the average of three co-transformants assayed in triplicate + SD.  The amino acid 
sequence of hBACE1 CTD is shown and the residue mutated is underlined.   
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Figure 47: β-galactosidase activity assays showing the effect of hBACE1 CTD 
Cys482Ser mutation on the interactions with hCCS, hCCSD1 and HAH1 using the 
yeast two-hybrid system.  EGY48 cells were co-transformed with pJG4.5 and p423lexAkan 
with or without the constructs mentioned above as the translational fusions.  Each data bar 
represents the average of three co-transformants assayed in triplicate + SD.  The amino acid 
sequence of hBACE1 CTD is shown and the residue mutated is underlined.   
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Figure 48: β-galactosidase activity assays showing the effect of hBACE1 CTD 
Cys485Ser mutation on the interactions with hCCS, hCCSD1 and HAH1 using the 
yeast two-hybrid system.  EGY48 cells were co-transformed with pJG4.5 and p423lexAkan 
with or without the constructs mentioned above as the translational fusions.  Each data bar 
represents the average of three co-transformants assayed in triplicate + SD.  The amino acid 
sequence of hBACE1 CTD is shown and the residue mutated is underlined.   
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Figure 49: Western blot and Ponceau S analyses of hBACE1 CTD WT, Cys478Ser, 
Cys482Ser and Cys485Ser proteins with the anti-LexA antibody.  Whole cell extracts 
from EGY48 cells co-transformed with pJG4.5_hCCS and p423lexAkan with the hBACE1 CTD 
constructs shown above as the translational fusions were analysed with the anti-LexA antibody 
by western blot analysis and show intense bands at ~27 kDa for the hBACE1 CTD translational 
fusions (A). The nitrocellulose membrane was stained with Ponceau S to determine equivalent 
protein loading in each lane (B).  The position of the protein molecular weight markers in (B) are 
shown on the left in kDa.  
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Figure 50: β-galactosidase activity assays showing the effect of hBACE1 CTD 
Trp480Met mutation on the interactions with hCCS, hCCSD1 and HAH1 using the 
yeast two-hybrid system.  EGY48 cells were co-transformed with pJG4.5 and p423lexAkan 
with or without the constructs mentioned above as the translational fusions.  Each data bar 
represents the average of three co-transformants assayed in triplicate + SD.  The amino acid 
sequence of hBACE1 CTD is shown and the residue mutated is underlined.   
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Arg481 is one of the three Arg residues surrounding the CXXC motif in hBACE1 CTD.  
Arg481 was mutated to Ala to determine its influence on the interactions of hBACE1 
CTD with hCCS, hCCSD1 and HAH1.  As shown in Figure 51, the Arg481Ala mutation 
significantly decreases the interaction of hBACE1 CTD with hCCS and HAH1, and 
abolishes the interaction with hCCSD1.  To determine if the decrease in interactions is 
due to the loss of positive charge in this position, the Arg481 residue was also mutated 
to Glu and Lys.  The results obtained with the Arg481Glu mutation are similar to the 
Arg481Ala data, where the interactions of hBACE1 CTD with hCCS and HAH1 are 
significantly lower while the interaction with hCCSD1 is completely abolished (Figure 
52).  However, the Arg481Lys mutation leads to an ~ 2-fold increase in the interactions 
of hBACE1 CTD with hCCS and hCCSD1 and abolishes the interaction of hBACE1 
CTD with HAH1 (Figure 51).   In contrast to the results obtained with the Arg481Ala 
mutation, the mutation of Arg484 or Arg487 to Ala in hBACE1 CTD results in 
significantly increased interactions with hCCS and HAH1 (Figure 53 and Figure 54).  
While the Arg484Ala mutation significantly increases the interaction of hBACE1 CTD 
with hCCSD1 (Figure 53), the increase in β-galactosidase activity with the Arg487Ala 
mutant with hCCSD1 was not found to be significant (Figure 54).   
All of the residues studied in hBACE1 CTD were located around the N-
terminal region of the hBACE1 CTD due to their proximity to the CXXC motif.  
Furthermore, it has been proposed that the interaction of hCCS with hBACE1 CTD is 
likely mediated by the residues located in the N-terminal region of hBACE1 CTD 
(Rentmeister et al., 2006).  The C-terminal region of hBACE1 CTD – in particular the 
residues between Asp495 and Lys501 have been implicated in regulating the 
intracellular localisation of hBACE1 by undergoing post-translational modifications and 
interactions with other proteins (Benjannet et al., 2001; Huse et al., 2000; Walter et al., 
2001).  However, there are two consecutive Asp residues in hBACE1 CTD, Asp491 and 
492, which are located between the CXXC motif and the Asp495-Lys501 residues.  To 
investigate whether the negative charge of these residues is important for the 
interactions of hBACE1 CTD with copper metallochaperones, both of these residues 
were mutated to Ala.  As shown in Figure 55, mutation of Asp491 and 492 to Ala does 
not have a significant effect on the interactions with hCCS or hCCSD1.  In contrast, the 
Asp491Ala,Asp492Ala mutation abolishes the interaction of hBACE1 CTD with HAH1 
suggesting that these residues may be required for the interaction with HAH1 but not 
with hCCS (or hCCSD1).  Equivalent protein expression levels are observed for all of 
the hBACE1 CTD mutant proteins compared to the hBACE1 CTD WT protein (Figure 
56). 
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Figure 51: β-galactosidase activity assays showing the effect of hBACE1 CTD 
Arg481Ala and Arg481Lys mutations on the interactions with hCCS, hCCSD1 and 
HAH1 using the yeast two-hybrid system.  EGY48 cells were co-transformed with pJG4.5 
and p423lexAkan with or without the constructs mentioned above as the translational fusions.  
Each data bar represents the average of three co-transformants assayed in triplicate + SD.  The 
amino acid sequence of hBACE1 CTD is shown and the residue mutated is underlined.  
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Figure 52: β-galactosidase activity assays showing the effect of hBACE1 CTD 
Arg481Glu mutation on the interactions with hCCS, hCCSD1 and HAH1 using the 
yeast two-hybrid system.  EGY48 cells were co-transformed with pJG4.5 and p423lexAkan 
with or without the constructs mentioned above as the translational fusions.  Each data bar 
represents the average of three co-transformants assayed in triplicate + SD.  The amino acid 
sequence of hBACE1 CTD is shown and the residue mutated is underlined.   
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Figure 53: β-galactosidase activity assays showing the effect of hBACE1 CTD 
Arg484Ala mutation on the interactions with hCCS, hCCSD1 and HAH1 using the 
yeast two-hybrid system.  EGY48 cells were co-transformed with pJG4.5 and p423lexAkan 
with or without the constructs mentioned above as the translational fusions.  Each data bar 
represents the average of three co-transformants assayed in triplicate + SD.  The amino acid 
sequence of hBACE1 CTD is shown and the residue mutated is underlined.   
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Figure 54: β-galactosidase activity assays showing the effect of hBACE1 CTD 
Arg487Ala mutation on the interactions with hCCS, hCCSD1 and HAH1 using the 
yeast two-hybrid system.  EGY48 cells were co-transformed with pJG4.5 and p423lexAkan 
with or without the constructs mentioned above as the translational fusions.  Each data bar 
represents the average of three co-transformants assayed in triplicate + SD.  The amino acid 
sequence of hBACE1 CTD is shown and the residue mutated is underlined.   
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Figure 55: β-galactosidase activity assays showing the effect of hBACE1 CTD 
Asp491Ala,Asp492Ala mutation on the interactions with hCCS, hCCSD1 and 
HAH1 using the yeast two-hybrid system.  EGY48 cells were co-transformed with pJG4.5 
and p423lexAkan with or without the constructs mentioned above as the translational fusions.  
Each data bar represents the average of three co-transformants assayed in triplicate + SD.  The 
amino acid sequence of hBACE1 CTD is shown and the residues mutated are underlined.   
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Figure 56: Western blot and Ponceau S analyses of hBACE1 CTD WT, Arg484Ala, 
Arg487Lys, Trp480Met, Arg481Ala, Arg481Lys, Arg481Glu and 
Asp491Ala,Asp492Ala proteins with the anti-LexA antibody.  Whole cell extracts from 
EGY48 cells co-transformed with pJG4.5_hCCS and p423lexAkan with the hBACE1 CTD 
constructs shown above as the translational fusions were analysed with the anti-LexA antibody 
by western blot analysis.  (A) and (C) show intense bands at ~27 kDa for the hBACE1 CTD 
translational fusions.  The nitrocellulose membranes shown in (A) and (C) were stained with 
Ponceau S prior to immunoblotting to determine equivalent protein loading in each lane, as 
shown in (B) and (D) respectively.  The position of the protein molecular weight markers in (B) 
and (D) are shown on the left in kDa. 
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3.2 Investigating the interaction of hSOD1 with hCCS 
The yeast two-hybrid system was also used to further the understanding of the 
interaction of hSOD1 with hCCS.  Unexpectedly, no significant interaction was 
observed between hSOD1 and hCCS as shown in Figure 57.  Since hCCS has been 
shown to interact with Ccs1 and Sod1 in S. cerevisiae (Schmidt et al., 2000), it was 
hypothesised that the lack of interaction between hSOD1 and hCCS may be due to 
interference by endogenous Ccs1 or Sod1.  Hence, an EGY48 ccs1∆ strain, denoted as 
SAY1, was created where the CCS1 gene was substituted with the KANR gene by 
homologous recombination.  PCR analysis confirmed the successful substitution of 
CCS1 with KANR in the SAY1 strain (Figure 58).  pJG4.5_hSOD1 and 
p423lexAkan_hCCS were subsequently co-transformed in the SAY1 strain.  As shown 
in Figure 59, a significant interaction was detected between hSOD1 and hCCS in this 
strain, consistent with the hypothesis that endogenous Ccs1 can interfere with the yeast 
two-hybrid interaction between hSOD1 and hCCS.  All subsequent experiments were 
therefore carried out in the SAY1 strain. 
3.2.1 The effect of copper concentration on the interaction of hSOD1 with hCCS  
To investigate the effect of copper concentration on the interaction of hCCS with 
hSOD1, the co-transformants were cultured in minimal yeast medium containing 
copper-depleted yeast nitrogen base with BCS or CuSO4 added to it.  As shown in 
Figure 60, the presence of excess copper in the growth medium does not have a 
significant effect on the hSOD1/hCCS interaction.  However, a two-fold increase in 
interaction is observed in copper-deficient conditions compared to the co-transformants 
cultured in basal medium.  Since copper concentration can have a significant effect on 
the hSOD1/hCCS interaction, it was proposed that the Cu(I)-binding residues in hCCS 
may also be required for the interaction of hSOD1 with hCCS, as discussed below. 
3.2.2 The role of hCCSD1 and hCCSD3 in mediating the interaction of hCCS with 
hSOD1 
A previous study investigating the role of each domain in Ccs1 suggested that D1 and 
D3 of Ccs1 can interact with each other (Schmidt et al., 1999a).  The authors studied 
the interactions in a ccs1∆ strain which is auxotrophic for Lys and Met during aerobic 
growth due to the lack of Sod1 activity (Culotta et al., 1997).  The expression of Ccs1 in 
the ccs1∆ strain was shown to recover Sod1 activity and complement for these 
auxotrophies (Culotta et al., 1997).  Schmidt et al. (1999a) found that CcsD1 when co-
expressed with a construct containing CcsD2 and CcsD3 (CcsD2,D3) increased the 
complementation of the Lys auxotrophy of the ccs1∆ strain in comparison to when 
CcsD1 was not co-expressed with the CcsD2,D3 construct (Schmidt et al., 1999a).  In 
addition, the “pivot, insert, release” mechanism of the CCS-dependent SOD1 activation 
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pathway proposes that Cu(I) is transferred from CCSD1 to CCSD3, further suggesting 
that CCSD1 and CCSD3 can transiently interact with each other (Rae et al., 2001).  To 
investigate this hypothesis further p423lexAkan_hCCSD3 was co-transformed with 
either pJG4.5_hCCS or pJG4.5_hCCSD1.  However, significant interactions were not 
detected between either full-length hCCS and hCCSD3 or between hCCSD1 and 
hCCSD3 (Figure 61).   
Two studies reported the formation of a Cu(I)-cluster involving the Cys 
residues in the CXC-motif of hCCSD3 (Stasser et al., 2005; Stasser et al., 2007).  
Stasser et al. (2007) also proposed that in the absence of cluster formation hCCS 
dimerises via intersubunit interactions between D2 of each monomer.  However, the 
formation of D3-mediated Cu(I)-cluster in hCCS when the concentration of Cu(I) was ~ 
2-fold higher than the protein concentration, was suggested by the authors to induce 
dimerisation via the D3 Cys residues instead of D2 (Stasser et al., 2007).  This change 
in the dimeric arrangement of hCCS was proposed to increase the availability of D2 for 
interaction with hSOD1 (Stasser et al., 2007).  On the basis of these data it was 
hypothesised that the copper-binding Cys residues in D3 of hCCS may contribute to the 
complex formation with hSOD1.  To test this hypothesis, hSOD1 was co-transformed 
with the hCCSD3 Cys mutation proteins.  As shown in Figure 62, hCCS Cys244Ser and 
Cys244Ser,Cys246Ser mutations do not have a significant effect on the interaction of 
hCCS with hSOD1.  Since Cys22 and Cys25 residues in hCCS can also bind Cu(I) 
(Eisses et al., 2000; Stasser et al., 2005), the role of these residues in mediating the 
interaction with hSOD1 was also explored.  The Cys22Ser and Cys25Ser mutations in 
hCCS result in slightly increased interactions with hSOD1, although these differences 
were not found to be significant (Figure 62).  Western blot and Ponceau S analyses 
indicate equivalent protein expression levels for hCCS WT and mutant proteins (Figure 
63).   
 
3.2.3 The role of hCCS Arg71 in mediating the interaction with hSOD1 
As discussed in section 3.1.2, Cu(I)-binding in hCCSD1 has been proposed to induce 
the movement of Arg71 in hCCS towards the bound metal ion.  To determine the role of 
Arg71 in the interaction with hSOD1 the effects of mutating it to Ala, Lys or Glu were 
also explored.  As shown in Figure 64, the presence of either Ala or Lys at this position 
does not have a significant effect on the interaction of hCCS with hSOD1.  However, 
the mutation of Arg71 to Glu results in a significant decrease in the interaction with 
hSOD1 suggesting that a negatively charged residue in this position is not favourable 
for interaction.  Western blot and Ponceau S analyses indicate similar expression levels 
for hCCS WT and Arg71 mutant proteins (Figure 63c-d).   
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Figure 57: β-galactosidase activity assays of hSOD1 with hCCS using the yeast 
two-hybrid system.  EGY48 cells were co-transformed with pJG4.5 and p423lexAkan with or 
without hSOD1 and hCCS respectively, as the translational fusions.  Each data bar represents 
the average of three co-transformants assayed in triplicate + SD. 
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Figure 58: Agarose gel confirming the successful deletion of CCS1 from the 
EGY48 strain.  The SAY1 strain was created by replacing ccs1 in EGY48 with the KANR gene 
by homologous recombination.  A diagnostic PCR was performed where the genomic DNA from 
EGY48 and SAY1 strains were incubated with a DNA oligomer homologous to the CCS1 
promoter and a DNA oligomer homologous to KAN
R
, as detailed in section 2.  The presence of a 
DNA band at 887 bp in the lane containing genomic DNA from the SAY1 strain and the absence 
of a band in the lane containing genomic DNA from the EGY48 strain confirmed the successful 
deletion of ccs1 from the genome.  The sizes of the molecular weight markers (MW) in bp are 
shown above.  
   
 134 
 
 
 
 
 
Figure 59: β-galactosidase activity assays of hSOD1 with hCCS using the yeast 
two-hybrid system.  SAY1 cells were co-transformed with pJG4.5 and p423lexAkan with or 
without hSOD1 and hCCS respectively, as the translational fusions.  Each data bar represents 
the average of three co-transformants assayed in triplicate + SD. 
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Figure 60: β-galactosidase activity assays using the yeast two-hybrid system for 
the co-transformants containing hSOD1 and hCCS cultured in basal medium or in 
medium containing CuSO4 or BCS.  SAY1 cells co-transformed with pJG4.5_hSOD1 and 
p423lexAkan_hCCS were grown with or without (-) added CuSO4 or BCS at the concentrations 
shown above and assayed for β-galactosidase activity.  Each data bar represents the average of 
two co-transformants assayed in triplicate + SD.   
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Figure 61: β-galactosidase activity assays of hCCS and hCCSD1 with hCCSD3 
using the yeast two-hybrid system.  EGY48 cells were co-transformed with pJG4.5 and 
p423lexAkan with or without the constructs mentioned above as the translational fusions.  Each 
data bar represents the average of three co-transformants assayed in triplicate + SD cells. 
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Figure 62: β-galactosidase activity assays showing the effect of hCCS Cys 
mutations on the interaction with hSOD1 using the yeast two-hybrid system.  
SAY1 cells were co-transformed with pJG4.5 and p423lexAkan with or without the constructs 
mentioned above as the translational fusions.  Each data bar represents the average of three co-
transformants assayed in triplicate + SD. 
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Figure 63: Western blot and Ponceau S analyses of hCCS WT, Cys22Ser, 
Cys25Ser, Arg71Ala, Arg71Glu, Arg71Lys, Cys244Ser and Cys244Ser,Cys246Ser 
proteins with the anti-LexA antibody.  Whole cell extracts from SAY1 cells co-transformed 
with pJG4.5_hSOD1 and p423lexAkan with the hCCS constructs mentioned above as the 
translational fusions were analysed with the anti-LexA antibody by western blot analysis.  (A) 
and (C) show intense bands at ~53 kDa for the hCCS translational fusions. The nitrocellulose 
membranes shown in (A) and (C) were stained with Ponceau S prior to immunoblotting to 
determine equivalent protein loading in each lane, as shown in (B) and (D) respectively.  The 
position of the protein molecular weight markers in (B) and (D) are shown on the left in kDa. 
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Figure 64: β-galactosidase activity assays showing the interaction of hSOD1 with 
hCCS WT, hCCS Arg71 mutation proteins and Ccs1 using the yeast two-hybrid 
system.  SAY1 cells were co-transformed with pJG4.5 and p423lexAkan with or without the 
constructs mentioned above as the translational fusions.  Each data bar represents the average 
of three co-transformants assayed in triplicate + SD. 
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In agreement with the study by Schmidt et al. (2000), a significant interaction was also 
detected between hSOD1 and Ccs1 although it is ~ 2-fold weaker than the interaction of 
hSOD1 with hCCS (Figure 64 and Figure 65).  While the hCCS Arg71Lys mutation does 
not have a significant effect on the interaction with hSOD1 (Figure 64), the mutation of 
the analogous residue to Arg in Ccs1 (Lys66Arg) significantly increases its interaction 
with hSOD1 compared to the interaction of hSOD1 with Ccs1 WT protein (Figure 65).  
Western blot and Ponceau S analyses indicate equivalent protein expression levels for 
Ccs1 WT and Lys66Arg proteins (Figure 66).  The results therefore suggest that the 
loop 5 residue in D1 of CCS may contribute in mediating the interactions with hSOD1. 
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Figure 65: β-galactosidase activity assays showing the interaction of hSOD1 with 
hCCS, Ccs1 WT and Ccs1 Lys66Arg using the yeast two-hybrid system.  SAY1 
cells were co-transformed with pJG4.5 and p423lexAkan with or without the constructs 
mentioned above as the translational fusions.  Each data bar represents the average of three co-
transformants assayed in triplicate + SD. 
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   A 
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Figure 66: Western blot and Ponceau S analyses of Ccs1 WT and Lys66Arg 
proteins with the anti-LexA antibody.  Whole cell extracts from SAY1 cells co-transformed 
with pJG4.5_hSOD1 and p423lexAkan with CCS1 (WT) or CCS1 lys66arg as the translational 
fusions were analysed with the anti-LexA antibody by western blot analysis and show intense 
bands at ~ 52 kDa for the Ccs1 translational fusions (A).  The nitrocellulose membrane was 
stained with Ponceau S to determine equivalent protein loading in each lane (B).  The position of 
the protein molecular weight markers in (B) are shown on the left in kDa.  
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3.3 Studying the interaction of ScAtx1 with the metal-binding domains of PacS 
and CtaA 
Since the BacterioMatch® bacterial two-hybrid system has successfully been used 
previously to study the interaction of ScAtx1 with the MBDs of PacS (PacS95) and CtaA 
(Borrelly et al., 2004; Tottey et al., 2002), the initial aim was to utilise the same system 
for studying these interactions further.  While a significant interaction was detected 
between ScAtx1 and PacS95, the difference between the ScAtx1/PacS95 interaction 
and the negative controls was observed to be only ~ 2-fold (Figure 21).  This difference 
was considered insufficient for effectively distinguishing between the effects of mutating 
a wide variety of amino acids in ScAtx1, PacS MBD and CtaA MBD on protein-protein 
interactions.  Hence, the interactions of ScAtx1 with the MBDs of PacS and CtaA were 
explored using the yeast two-hybrid system instead.  Precedents for studying the 
interactions between bacterial proteins using the yeast two-hybrid system are available 
(Lei et al., 1999; Martinez-Argudo and Contreras, 2002; Pawlowski et al., 2003). 
3.3.1 Establishing the yeast two-hybrid system to study the interactions of 
ScAtx1 with the MBDs of PacS and CtaA 
In order to establish the yeast two-hybrid system for studying the interaction of ScAtx1 
with the PacS MBD, ScAtx1 was cloned in both pJG4.5 and p423lexAkan vectors.  The 
structures of apo- (Banci et al., 2006c) and Cu(I)-PacS MBD (Badarau et al., 2010) 
show that the first 71 amino acids of PacS represent the ferredoxin-fold.  Hence, only 
residues 1-71 of PacS, denoted here as PacSN, were cloned into the yeast two-hybrid 
vectors.  As shown in Figure 67, a significant interaction was detected between ScAtx1 
and PacSN when ScAtx1 was cloned into the pJG4.5 vector and PacSN was cloned into 
the p423lexAkan vector, but not when cloned in the reverse order.  Such “directionality” 
when studying protein-protein interactions using the yeast two-hybrid system has been 
reported previously.  It is usually attributed to potential differences in protein folding due 
to the expression of the desired protein as a fusion complex with the two-hybrid DNA-
binding and activation domain components (Estojak et al., 1995; Kaufmann et al., 
2005).  Subsequent experiments were performed by cloning all of the ScAtx1 constructs 
in pJG4.5 and PacSN constructs in p423lexAkan.  To use ScAtx1 in the pJG4.5 vector, 
CtaA MBD was cloned into the p423lexAkan vector, as for PacSN.  Initially a CtaA MBD 
construct comprising residues 1-111 (CtaA111), similar to the construct used by Tottey 
et al. (2002) for bacterial two-hybrid studies, was cloned in the p423lexAkan vector.  
However, no significant interaction was detected between ScAtx1 and CtaA111 (Figure 
68).  The submission of the CtaA111 sequence into the Swiss PDB modelling software 
(http://swissmodel.expasy.org) revealed that only residues 25-91 are involved in 
forming the ferredoxin-fold.  Therefore, a truncated construct containing CtaA residues 
1-92 (CtaA92) was cloned in the p423lexAkan vector.  As shown in Figure 68, a 
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significant interaction is observed between ScAtx1 and CtaA92.  Hence, the CtaA92 
construct, hereon denoted as CtaAN, was used for all subsequent experiments in this 
study. 
 
3.3.2 The effect of copper concentration on the interactions of ScAtx1 with 
PacSN and CtaAN 
Tottey et al. (2002) have previously shown that the bacterial two-hybrid interaction of 
ScAtx1 with PacS95 and CtaA111 is dependent upon the Cys residues in the CXXC 
motif of ScAtx1.  In addition, Banci et al. (2006c) found that the addition of 1 mM BCS 
dissociated the ScAtx1-Cu(I)-PacS95 complex into apo-proteins.  As mentioned 
previously (section 3.1), the interactions between homologous proteins have also been 
shown to be dependent on the presence of Cu(I).  These data led to the hypothesis that 
the interactions of ScAtx1 with PacSN and CtaAN may also be dependent upon the 
intracellular Cu(I) concentration.  To investigate the effect of copper concentration on 
the protein-protein interactions, the co-transformants containing ScAtx1 and PacSN or 
ScAtx1 and CtaAN were incubated in various concentrations of CuSO4 or BCS and 
assayed for β-galactosidase activity.  As shown in Figure 69, the addition of 30 µM or 
300 µM CuSO4 results in a small, albeit significant decrease in the interaction of ScAtx1 
with PacSN compared to the co-transformants incubated in the basal medium.  The 
interaction of ScAtx1 with PacSN also decreases significantly in the presence of 500 µM 
BCS compared to the co-transformants incubated in the basal medium.  However, no 
significant change was evident in the β-galactosidase activity between the 
ScAtx1/PacSN co-transformants cultured in higher concentrations of BCS (1 mM or 3 
mM) in comparison to the co-transformants incubated in the basal medium.   
In contrast to ScAtx1/PacSN interaction, the addition of BCS results in 
increased interaction between ScAtx1 and CtaAN (Figure 70).  The addition of 300 µM 
CuSO4 to the growth medium also results in a significant decrease in the interaction 
between ScAtx1 and CtaAN compared to the co-transformants grown in the basal 
medium (Figure 70).  The data therefore indicate that the interaction of ScAtx1 with both 
PacSN and CtaAN decreases in the presence of high concentration of added CuSO4 
(300 µM).  While the addition of BCS significantly increases the interaction between 
ScAtx1 and CtaAN, the effect of low copper concentration on the interaction of ScAtx1 
and PacSN is inconclusive since this interaction was only disrupted in the presence of 
500 µM BCS.   
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Figure 67: β-galactosidase activity assays of ScAtx1 with PacSN using the yeast 
two-hybrid system.  EGY48 cells were co-transformed with pJG4.5 and p423lexAkan with or 
without the constructs mentioned above as the translational fusions.  Each data bar represents 
the average of three co-transformants assayed in triplicate + SD. 
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Figure 68: β-galactosidase activity assays of ScAtx1 with CtaA92 or CtaA111 
using the yeast two-hybrid system.  EGY48 cells were co-transformed with pJG4.5 and 
p423lexAkan with or without the constructs mentioned above as the translational fusions.  Each 
data bar represents the average of three co-transformants assayed in triplicate + SD. 
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Figure 69: β-galactosidase activity assays using the yeast two-hybrid system for 
the co-transformants containing ScAtx1 and PacSN cultured in basal medium or 
in medium containing BCS or CuSO4.  EGY48 cells co-transformed with pJG4.5_ScAtx1 
and p423lexAkan_PacSN were grown with or without (-) added CuSO4 or BCS at the 
concentrations shown above and assayed for β-galactosidase activity.  Each data bar represents 
the average of two co-transformants assayed in triplicate + SD. 
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Figure 70: β-galactosidase activity assays using the yeast two-hybrid system for 
the co-transformants containing ScAtx1 and CtaAN cultured in basal medium or 
in medium containing BCS or CuSO4.  EGY48 cells co-transformed with pJG4.5_ScAtx1 
and p423lexAkan_CtaAN were grown with or without (-) added CuSO4 or BCS at the 
concentrations shown above and assayed for β-galactosidase activity.  Each data bar represents 
the average of two co-transformants assayed in triplicate + SD. 
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3.3.3 The role of residues surrounding the CXXC motif of ScAtx1, PacSN and 
CtaAN in mediating protein-protein interactions 
Since the copper-binding Cys ligands in the CXXC motif of ScAtx1 have been shown to 
be essential for the interaction with PacSN and CtaAN (Tottey et al., 2002), it was 
proposed that the residues located close to the CXXC motif in these proteins may also 
influence the interactions between these proteins.  This hypothesis is further supported 
by the HADDOCK model of the ScAtx1-PacS95 complex which indicates that the 
residues around the metal-binding sites may be involved in complex formation (Banci et 
al., 2006c).  To investigate this hypothesis some of the residues adjacent to the CXXC 
motifs of ScAtx1, PacSN and CtaAN were mutated to determine their roles in protein-
protein interactions.  Arg13 in PacSN has been shown to be important for mediating the 
interaction with ScAtx1 (Banci et al., 2010b).  The Arg13Asp mutation in PacSN 
abolished the bacterial two-hybrid interaction with ScAtx1 (Banci et al., 2010b).  The 
corresponding residue is Ala in ScAtx1 (Ala11), as shown in Figure 71.  To determine 
the effect of a positive charge in that position, PacSN Arg13 was mutated to Ala.  The 
PacSN Arg13Ala mutation results in ~ 5-fold decrease in the interaction with ScAtx1 
compared to the interaction of PacSN WT protein with ScAtx1 (Figure 72).  The mutation 
of the analogous residue in CtaAN, Lys34 to Ala abolishes the interaction with ScAtx1 
(Figure 73).  The mutation of ScAtx1 Ala11 to either Lys or Arg also results in 
significantly decreased interactions with PacSN and CtaAN (Figure 74).   
The presence of an intermolecular hydrogen bond between the side 
chains of Glu13 in ScAtx1 and Cys14 in PacS95 was also reported in the modelled 
complex (Banci et al., 2006c).  The mutation of ScAtx1 Glu13 to either Ala or Gln was 
found to abolish the bacterial two-hybrid interaction with PacS95 (Banci et al., 2006c).  
To determine if ScAtx1 Glu13 is also involved in mediating the interaction of ScAtx1 
with CtaAN, this residue was mutated to either Ala or Gln.  For comparative purposes 
the effects of these mutations on the interaction with PacSN was also studied.  In 
agreement with the previous findings, the mutation of Glu13 to either Ala or Gln results 
in significantly decreased interaction of ScAtx1 with PacSN (Figure 75a) confirming that 
the results obtained with the yeast two-hybrid system are comparable with the bacterial 
two-hybrid data.  Unlike the previous study (Banci et al., 2006c), significant differences 
are evident between the effects of the two mutations on the interaction with PacSN.  
While the ScAtx1 Glu13Ala mutation results in ~ 4-fold decrease, the Glu13Gln 
mutation leads to only ~ 2-fold decrease in the interaction with PacSN compared to the 
interaction with ScAtx1 WT protein (Figure 75).  Similarly, the ScAtx1 Glu13Gln 
mutation results in ~ 3-fold decrease in interaction, whereas the Glu13Ala mutation 
abolishes the interaction of ScAtx1 with CtaAN (Figure 76).  Western blot and Ponceau 
S analyses indicate that the mutation of the above mentioned residues does not have 
an aberrant effect on the protein expression levels (Figure 77 and Figure 78).    
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 PacSN    ---------------------MAQTINLQLEGMRCAACASSIERAIAKVPGVQSCQVNFALEQAVVSYHG-ETTPQILTDAVERAGYHARVLK  71 
 CtaAN    MVQLSPTPASTLTYKDANGQNRTASLTLDVGGMKCAGCVAAVERQLDQLTGVTDSCVNLVTAVAVVRYEPEKIQPQAIAEHLSQRGFPSQIR-  92 
ScAtx1   -----------------------MTIQLTVPTIACEACAEAVTKAVQNEDAQATVQVDLTSKKVTITS---ALGEEQLRTAIASAGHEVE---  64 
 
 
Figure 71: Sequence alignment of the PacSN, CtaAN and ScAtx1 yeast two-hybrid constructs investigated in this study.  Shown above is the 
amino acid sequence alignment for PacSN, CtaAN and ScAtx1.  Cys residues in the CXXC motif are highlighted in black while the other residues mutated in this 
study are shown in blue. 
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Figure 72: β-galactosidase activity assays showing the effects of PacSN Arg13Ala 
mutation on the interaction with ScAtx1 using the yeast two-hybrid system. 
EGY48 cells were co-transformed with pJG4.5 and p423lexAkan, with or without the constructs 
mentioned above, as the translational fusions.  Each data bar represents the average of three 
co-transformants assayed in triplicate + SD. 
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Figure 73: β-galactosidase activity assays showing the effects of CtaAN Lys34Ala 
mutation on the interaction with ScAtx1 using the yeast two-hybrid system. 
EGY48 cells were co-transformed with pJG4.5 and p423lexAkan with or without the constructs 
mentioned above as the translational fusions.  Each data bar represents the average of three co-
transformants assayed in triplicate + SD. 
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Figure 74: β-galactosidase activity assays showing the effects of ScAtx1 Ala11 
mutations on the interactions with PacSN and CtaAN using the yeast two-hybrid 
system.  EGY48 cells were co-transformed with pJG4.5 with or without the scAtx1 constructs 
mentioned above and p423lexAkan with or without pacSN (A) or ctaAN (B) as the translational 
fusions.  Each data bar represents the average of three co-transformants assayed in triplicate + 
SD. 
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Figure 75: β-galactosidase activity assays showing the effects of ScAtx1 Glu13 
mutations on the interactions with PacSN using the yeast two-hybrid system.  
EGY48 cells were co-transformed with p423lexAkan with or without pacSN and pJG4.5 with or 
without scAtx1, scAtx1 glu13ala (A) or scAtx1 glu13gln (B) as the translational fusions.  Each 
data bar represents the average of three co-transformants assayed in triplicate + SD. 
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Figure 76: β-galactosidase activity assays showing the effect of ScAtx1 Glu13 
mutation on the interaction with CtaAN using the yeast two-hybrid system.  EGY48 
cells were co-transformed with pJG4.5 and p423lexAkan with or without the constructs 
mentioned above as the translational fusions.  Each data bar represents the average of three co-
transformants assayed in triplicate + SD. 
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A      B 
 
C      D 
 
 
Figure 77: Western blot and Ponceau S analyses of PacSN WT and Arg13Ala, and 
CtaAN WT and Lys34Ala proteins with the anti-LexA antibody.  Whole cell extracts 
from EGY48 cells co-transformed with pJG4.5_ScAtx1 and p423lexAkan with the pacSN (A) or 
ctaAN (B) constructs as the translational fusions were analysed with the anti-LexA antibody by 
western blot analysis.  The intense bands in (A) at ~32 kDa represent the PacSN translational 
fusions, while the intense bands at ~ 34 kDa in (B) represent the CtaAN translational fusions. The 
nitrocellulose membranes from (A) and (B) were stained with Ponceau S prior to immunoblotting 
to determine equivalent protein loading in each lane, as shown in (C) and (D) respectively.  The 
position of the protein molecular weight markers in (C) and (D) are shown on the left in kDa. 
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Figure 78: Western blot and Ponceau S analyses of ScAtx1 WT, Ala11Lys, 
Ala11Arg, Glu13Ala and Glu13Gln proteins with the anti-HA antibody.  Whole cell 
extracts from EGY48 cells co-transformed with p423lexAkan_PacSN and pJG4.5 with the scAtx1 
constructs shown above as the translational fusions were analysed with the anti-HA antibody by 
western blot analysis, and show intense bands at ~ 18 kDa for the ScAtx1 translational fusions in 
(A).  The nitrocellulose membrane was stained with Ponceau S to determine equivalent protein 
loading in each lane (B).  The position of the protein molecular weight markers in (B) are shown 
on the left in kDa. 
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3.3.4 Determining the role of the key loop 5 residues in ScAtx1 (His61), PacSN 
(Tyr65) and CtaAN (Phe87) in mediating protein-protein interactions 
The ScAtx1 His61 residue, albeit distant in sequence from the CXXC motif, is located 
close to the metal-binding region in the structures of ScAtx1 (Badarau et al., 2010; 
Banci et al., 2004a).  His61 has been proposed to act as a third Cu(I)-binding ligand in 
ScAtx1 in addition to Cys12 and Cys15 (Banci et al., 2004a).  However, in the crystal 
structures of the two Cu(I)-bound head-to-head ScAtx1 dimer and in the four Cu(I)-
bound side-to-side ScAtx1 dimer, His61 was shown to be important for mediating 
hydrogen-bonding interactions rather than as a Cu(I)-binding ligand (Badarau et al., 
2010).  Apart from its postulated role in metal-binding, this residue is of particular 
interest to this study with respect to its possible role in mediating the interactions with 
PacSN and CtaAN.  The analogous residue in Atx1 has been shown to be important for 
the yeast two-hybrid interaction with the MBDs of Ccc2 (Portnoy et al., 1999).  In 
addition, the mutation of the analogous residue in HAH1, Lys60 to either Ala or Tyr 
impaired the formation of a complex with ATP7B MBD4, as determined by gel filtration 
and circular dichroism experiments (Hussain et al., 2009).  Hence, ScAtx1 His61 and 
the analogous residues in the loop 5 of PacSN and CtaAN (Tyr65 and Phe87 
respectively, as shown in Figure 71) were mutated, to determine the role of these 
residues on protein-protein interactions. 
The mutation of ScAtx1 His61 to Ala significantly decreases the 
interaction with PacSN (Figure 79a), and abolishes the interaction with CtaAN (Figure 
79b).  To mimic the residues found in the MBDs of the target proteins, His61 was also 
mutated to Tyr or Phe.  Both mutations abolish the interaction of ScAtx1 with PacSN 
(Figure 79a and Figure 80a).  While the ScAtx1 His61Tyr mutation des not have a 
significant effect on the interaction with CtaAN (Figure 79b), the ScAtx1 His61Phe 
mutation significantly decreases the interaction with CtaAN (Figure 80b).  The data 
therefore indicate that the presence of an aromatic residue in place of His61 abolishes 
the interaction of ScAtx1 with PacSN but does not have an equally drastic effect on the 
interaction of ScAtx1 with CtaAN.  The mutation of the residue in the analogous position 
in PacSN, Tyr65 to His almost abolishes the interaction with ScAtx1 (Figure 81).  
However, ScAtx1 His61Ala shows a greater interaction with PacSN Tyr65His than the 
ScAtx1 WT protein (Figure 81).  The level of interaction between ScAtx1 His61Ala and 
PacSN Tyr65His is similar to that between the WT proteins (Figure 81).  The His61Tyr 
mutation does not have a similar effect as the His61Ala variant of ScAtx1 when co-
transformed with PacSN Tyr65His construct.  No significant interaction is observed 
between ScAtx1 His61Tyr and PacSN Tyr65His (Figure 81).  The mutation of Phe87 in 
CtaAN (analogous position to His61 in ScAtx1) to His or Tyr also results in a significant 
decrease in the interaction with ScAtx1 compared to the interaction with CtaAN WT 
protein, albeit the interactions are not abolished completely (Figure 82).   
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Figure 79: β-galactosidase activity assays showing the effects of ScAtx1 
His61Ala and His61Tyr mutations on the interactions with PacSN and CtaAN using 
the yeast two-hybrid system.  EGY48 cells were co-transformed with pJG4.5 with or 
without the scAtx1 constructs mentioned above and p423lexAkan with or without pacSN (A) or 
ctaAN (B) as the translational fusions.  Each data bar represents the average of three co-
transformants assayed in triplicate + SD. 
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Figure 80: β-galactosidase activity assays showing the effects of ScAtx1 
His61Glu and His61Phe mutations on the interactions with PacSN and CtaAN 
using the yeast two-hybrid system.  EGY48 cells were co-transformed with pJG4.5 with or 
without the scAtx1 constructs mentioned above and p423lexAkan with or without pacSN (A) or 
ctaAN (B) as the translational fusions.  Each data bar represents the average of three co-
transformants assayed in triplicate + SD. 
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Figure 81: β-galactosidase activity assays showing the interaction of WT and 
His61Ala ScAtx1 with WT and Tyr65His PacSN using the yeast two-hybrid system.  
EGY48 cells were co-transformed with pJG4.5 and p423lexAkan with or without the constructs 
mentioned above as the translational fusions.  Each data bar represents the average of three co-
transformants assayed in triplicate + SD. 
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Figure 82: β-galactosidase activity assays showing the effect of CtaAN Phe87 
mutations on the interaction with ScAtx1 using the yeast two-hybrid system.  
EGY48 cells were co-transformed with pJG4.5 and p423lexAkan with or without the constructs 
mentioned above as the translational fusions.  Each data bar represents the average of three co-
transformants assayed in triplicate + SD. 
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The results therefore indicate that the swapping around of the key loop 5 residues in 
ScAtx1, PacSN and CtaAN is not favourable for the interactions of ScAtx1 with PacSN or 
CtaAN.  The analogous residue in loop 5 of the ferredoxin-fold in eukaryotic homologues 
of ScAtx1 is found to be Lys (Arnesano et al., 2002).  To mimic the residue in eukaryotic 
copper metallochaperones, ScAtx1 His61 was mutated to Lys.  In addition, His61 in 
ScAtx1 was also mutated to Glu to investigate the effect of a negative charge in this 
position on the interactions with PacSN and CtaAN.  While the ScAtx1 His61Glu 
mutation abolishes the interaction with both PacSN and CtaAN (Figure 80), the ScAtx1 
His61Lys mutation yields different results with PacSN and CtaAN (Figure 83).  The 
ScAtx1 His61Lys mutation results in ~ 2-fold decrease in the interaction with PacSN but 
almost abolishes the interaction with CtaAN (Figure 83).  Western blot and Ponceau S 
analyses indicate that the mutations in ScAtx1 His61 and CtaAN Phe87 do not have an 
aberrant effect on protein expression (Figure 84 and Figure 85a).  Slightly higher 
expression levels are observed for PacSN Tyr65His protein compared to the PacSN WT 
protein by visual inspection (Figure 85b).  However, despite increased protein levels of 
PacSN Tyr65His protein, no significant interaction is evident with the ScAtx1 WT protein 
(Figure 81). 
  
3.3.5 Determination of the structural arrangement of the complex formation of 
ScAtx1 with PacSN and CtaAN  
One of the aims of this study was to investigate if ScAtx1 can form structurally distinct 
complexes with PacSN and CtaAN.  This is based on the idea proposed by Badarau et 
al. (2010) that the two different structural arrangements obtained for the ScAtx1 dimers 
might be a reflection of the complex formation between ScAtx1 and its target MBDs.  
The models of the two different structural arrangements are the two Cu(I)-bound head-
to-head dimer and the four Cu(I)-bound side-to-side dimer, shown in Figure 6.  The four 
Cu(I)-bound side-to-side ScAtx1 dimer (Figure 6b) was observed to be very similar to 
the modelled complex of ScAtx1 and PacS95 (Banci et al., 2006c).  This structure is 
also very similar to the complexes reported for Atx1-Cu(I)-Ccc2a (Banci et al., 2006b), 
HAH1-Cu(I)-ATP7A MBD1 (Banci et al., 2009) and HAH1-Cu(I)-ATP7B MBD4 (Hussain 
et al., 2009).  In the absence of structural information regarding the complex between 
ScAtx1 and CtaAN, it was suggested that while ScAtx1 and PacSN likely form a side-to-
side complex, ScAtx1 and CtaAN may form a head-to-head complex.  To investigate this 
further three residues in ScAtx1 were mutated in an attempt to solely disrupt the side-
to-side complexes unlike the previously discussed mutations in ScAtx1 which may 
disrupt the formation of both side-to-side and head-to-head complexes.  Based on the 
above mentioned crystal structures of the ScAtx1 dimers, the mutation of Lys21, Asn25 
or Ser58 residues in ScAtx1 should not impair potential head-to-head complex 
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formation between ScAtx1 and its target MBDs, as shown in Appendix A.  Western blot 
and Ponceau S analyses indicate that the mutation of these residues does not have an 
aberrant effect on protein expression (Figure 86). 
ScAtx1 Lys21 was reported to be one of the key residues involved in 
mediating electrostatic interactions with PacS95 in the ScAtx1-PacS95 modelled 
complex (Banci et al., 2006c).  The superimposition of a Cu(I)-bound PacSN monomer 
against the four Cu(I)-bound side-to-side ScAtx1 dimer (Appendix B) indicates that the 
side chain of ScAtx1 Lys21 can potentially interact with the side chain of Glu61 in 
PacSN.  In an attempt to disrupt the formation of the ScAtx1-PacSN complex, Lys21 in 
ScAtx1 was mutated to Asp.  As shown in Figure 87a, the ScAtx1 Lys21Asp mutation 
abolishes the interaction with PacSN consistent with the hypothesis that the Asp side 
chain can result in repulsion with the side chain of PacSN Glu61.  In contrast to the 
ScAtx1 Lys21Asp mutation, the ScAtx1 Asn25Arg mutation does not have a significant 
effect on the interaction of ScAtx1 with PacSN (Figure 88a).  Asn25 in ScAtx1 was 
mutated to Arg in an attempt to disrupt the formation of a side-to-side complex as a 
consequence of steric clashes due to the presence of the bulky side chain of Arg.  
However, the model presented in Appendix B shows that the side chain of Asn25 is 
also located close to the side chain of PacSN Glu61.  The lack of significant effect of the 
Asn25Arg mutation on the interaction of ScAtx1 with PacSN is therefore consistent with 
the hypothesis that the Asn25Arg mutation can result in a favourable electrostatic 
interaction between the side chains of ScAtx1 Arg25 and PacS71 Glu61 if the proteins 
form a side-to-side complex.  Ser58 in ScAtx1 was reported to interact with the side 
chains of Arg23 and Arg62 in PacS95 in the ScAtx1-PacS95 modelled complex (Banci 
et al., 2006c).  This residue was therefore mutated to Ala to disrupt the formation of 
hydrogen-bonding interactions with the residues in PacSN.  As shown in Figure 89a, the 
Ser58Ala mutation significantly decreases the interaction of ScAtx1 with PacSN but 
does not completely abolish it.  These data are therefore consistent with the hypothesis 
that ScAtx1 and PacSN can form a side-to-side complexe which involve interactions 
between several residues in both of the proteins.  Unlike the results obtained with 
PacSN, all three ScAtx1 mutations (Lys21Asp, Asn25Arg and Ser58Ala) significantly 
decrease the interaction of ScAtx1 with CtaAN but do not completely abolish it (Figure 
87b, Figure 88b and Figure 89b).  These results are in contrast to the proposed 
hypothesis that ScAtx1 and CtaAN may form a head-to-head complex instead of a side-
to-side complex and indicate that ScAtx1/CtaAN can also form a side-to-side complex 
similar to ScAtx1/PacSN.   
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Figure 83: β-galactosidase activity assays showing the effects of ScAtx1 
His61Lys mutation on the interactions with PacSN and CtaAN using the yeast two-
hybrid system.  EGY48 cells were co-transformed with pJG4.5 with or without the scAtx1 
constructs mentioned above and p423lexAkan with or without pacSN (A) or ctaAN (B) as the 
translational fusions.  Each data bar represents the average of three co-transformants assayed 
in triplicate + SD. 
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Figure 84: Western blot and Ponceau S analyses of ScAtx1 WT, His61Ala, 
His61Glu, His61Phe, His61Lys and His61Tyr proteins with the anti-HA antibody.  
Whole cell extracts from EGY48 cells co-transformed with p423lexAkan_PacSN and pJG4.5 with 
the scAtx1 constructs shown above as the translational fusions were analysed with the anti-HA 
antibody by western blot analysis and show intense bands at ~ 18 kDa for the ScAtx1 
translational fusions in (A).  The nitrocellulose membrane was stained with Ponceau S to 
determine equivalent protein loading in each lane (B).  The position of the protein molecular 
weight markers in (B) are shown on the left in kDa. 
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Figure 85: Western blot and Ponceau S analyses of PacSN WT and Tyr65His, and 
CtaAN WT, Phe87His and Phe87Tyr proteins with the anti-LexA antibody.  Whole 
cell extracts from EGY48 cells co-transformed with pJG4.5_ScAtx1 and p423lexAkan with the 
ctaAN (A) or pacSN (B) constructs as the translational fusions were analysed with the anti-LexA 
antibody by western blot analysis.  The intense bands in (A) at ~32 kDa represent the PacSN 
translational fusion, while the intense bands at ~ 34 kDa in (B) represent the CtaAN translational 
fusions. The nitrocellulose membranes from (A) and (B) were stained with Ponceau S prior to 
immunoblotting to determine equivalent protein loading in each lane, as shown in (C) and (D) 
respectively.  The position of the protein molecular weight markers in (C) and (D) are shown on 
the left in kDa. 
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Figure 86: Western blot and Ponceau S analyses of ScAtx1 WT, Asn25Arg, 
Lys21Asp and Ser58Ala proteins with the anti-HA antibody.  Whole cell extracts from 
EGY48 cells co-transformed with pJG4.5_ScAtx1 and p423lexAkan_PacSN were analysed with 
the anti-HA antibody by western blot analysis.  The intense bands in (A) and (B) at ~18 kDa 
represent the ScAtx1 translational fusion.  The nitrocellulose membranes from (A) and (B) were 
stained with Ponceau S prior to immunoblotting to determine equivalent protein loading in each 
lane, as shown in (C) and (D) respectively.  The position of the protein molecular weight markers 
in (C) and (D) are shown on the left in kDa. 
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Figure 87: β-galactosidase activity assays showing the effect of ScAtx1 Lys21Asp 
mutation on the interactions with PacSN and CtaAN using the yeast two-hybrid 
system.  EGY48 cells were co-transformed with pJG4.5 with or without the scAtx1 constructs 
mentioned above and p423lexAkan with or without pacSN (A) or ctaAN (B) as the translational 
fusions.  Each data bar represents the average of three co-transformants assayed in triplicate + 
SD. 
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Figure 88: β-galactosidase activity assays showing the effect of ScAtx1 Asn25Arg 
mutation on the interaction with PacSN and CtaAN using the yeast two-hybrid 
system.  EGY48 cells were co-transformed with pJG4.5 with or without the scAtx1 constructs 
mentioned above and p423lexAkan with or without pacSN (A) or ctaAN (B) as the translational 
fusions.  Each data bar represents the average of three co-transformants assayed in triplicate + 
SD. 
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Figure 89: β-galactosidase activity assays showing the effect of ScAtx1 Ser58Ala 
mutation on the interaction with PacSN and CtaAN using the yeast two-hybrid 
system.  EGY48 cells were co-transformed with pJG4.5 with or without the scAtx1 constructs 
mentioned above and p423lexAkan with or without pacSN (A) or ctaAN (B) as the translational 
fusions.  Each data bar represents the average of three co-transformants assayed in triplicate + 
SD. 
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4. Discussion 
Copper metallochaperones play an important role in maintaining intracellular copper 
homeostasis by delivering Cu(I) to their specific target proteins which are important for a 
wide variety of functions including superoxide dismutation, photosynthesis and 
respiration.   Interest in copper metallochaperones has increased as additional 
functions have been associated with them.  For example, HAH1 can act as a 
transcription factor (Itoh et al., 2008) and CCS deficiency can result in increased 
production of Aβ in neuronal cells (Gray et al., 2010).  These studies suggest that 
copper metallochaperones may serve as potential targets in therapies aiming to restore 
copper homeostasis in some of the diseases where copper mis-homeostasis is an 
integral part of the disease pathology including AD and PD.   
Since some of the known copper metallochaperones can interact with 
multiple proteins (for example, HAH1, hCCS, EhCopZ and ScAtx1), a key challenge is 
to determine the factors that mediate the interaction of a copper metallochaperone with 
a specific protein.  Favourable protein-protein interactions play a fundamental role in 
ensuring metal selectivity and its delivery to the correct target protein which prevents 
toxicity due to inappropriate metal-binding (Banci et al., 2010c).  The aim of this study 
was to further the understanding of the molecular basis of the interactions of copper 
metallochaperones with their partner proteins.  This was investigated by studying two 
very different systems.  In the first, the interactions of hCCS with hBACE1 CTD and 
hSOD1 were analysed.  In the second system, the interaction of ScAtx1 with the MBDs 
of PacS and CtaA were studied.  The strategy used to determine the molecular basis of 
these interactions involved the mutagenesis of metal-binding amino acids or surface 
residues potentially mediating interactions.  The effects of mutations were studied using 
the yeast two-hybrid system.  The role of copper concentration on protein-protein 
interactions was also investigated by analysing the effect of varying concentrations of 
CuSO4 or BCS on β-galactosidase activity. 
Yeast is one of the model organisms for studying protein-protein 
interactions especially of the human origin, since it contains homologues of most 
proteins and pathways, is much more convenient to manipulate but less complicated 
than human cells.  As discussed in section 1.6, pathways of copper homeostasis are 
quite well preserved in yeast and humans.  However, these advantages can also act as 
potential limiations of the yeast two-hybrid system in this study.  One of the problems in 
studying hCCS-based interactions using the yeast two-hybrid system is the fact that a 
proportion both Ccs1 and Sod1 have been shown to be localised in the nucleus of S. 
cerevisae (Wood and Thiele, 2009), the site of yeast two-hybrid interactions.  
Consequently there is always a possibility that changes in interaction of hCCS with 
hBACE1 CTD or hSOD1 in this study (when testing the effect of a mutation or copper 
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concentration effect), is as a result of altered interactions with endogenous Ccs1 or 
Sod1.  While Ccs1 and Sod1 have both been detected in the nucleus, the proportion of 
these proteins that resides in the nucleus is currently not known (Wood and Thiele, 
2009).  Considering that the fusion proteins are overexpressed in the yeast two-hybrid 
system, it is possible that intereference with endogenous proteins may not have a 
significant impact on the observed output.  Due to time constraints, this issue could not 
be fully addressed in this study, but measures of how this could be investigated are 
discussed in chapter 5. 
An added problem regarding the potential interactions of hCCS or 
hSOD1 with endogenous Ccs1 or Sod1 is the effect this may have on Mac1 activity.  It 
has been shown that catalytically active Sod1 is required in the nucleus for Mac1 
activity which induces the transcription of several proteins involved in copper and iron 
homeostasis including CTR1 (Wood and Thiele, 2009).  This is particularly relevant for 
the experiments investigating the interaction of hCCS with hSOD1, which were carried 
out in the SAY1 strain (which lacks Ccs1), as discussed further in section 4.2.  
However, these issues should not pose a problem for the study of the interaction of 
ScAtx1 with PacSN and CtaAN since there is no evidence to date to indicate the 
localisation of Atx1 in the yeast nucleus or that Ccs1 or Sod1 can interact with ScAtx1, 
PacSN or CtaAN.  
Additional limitations when studying the protein-protein interactions of 
copper-binding proteins by yeast two-hybrid involve the potential effects of altered 
copper concentration or copper availability on other copper-dependent pathways.  For 
instance, copper is required by cytochrome c oxidase for respiration (section 1.3.2.4.3), 
superoxide dismutases for (primarily) anti-oxidant defense (section 1.3.2.3 and 
1.3.2.4.2) and by Ccc2 for high-affinity iron uptake (section 1.3.3.1).  Consequently, 
there is a possibility that the changes in protein-protein interactions observed in this 
study when testing the effects of protein mutations or altered copper conditions are due 
to an indirect effect on respiration, redox balance or iron homeostasis.  Altered iron 
homeostastis in particular can cause a cascading effect by disrupting copper 
homeostasis, since the two pathways are closely linked and can overlap, as shown in 
Figure 17.  Unfortunately, these potential problems could not be investigated in this 
study, however, given further time these issues can be investigated further by some of 
the measures discussed in Chapter 5.  The results presented in this study are 
subsequently discussed under the presumption that the changes in protein-protein 
interactions observed in this study are primarily due to the mutations introduced in the 
proteins or due to altered copper conditions when studying the effects of added CuSO4 
or BCS on these interactions. 
 
   
 174 
4.1 The molecular basis of the interaction of hCCS and HAH1 with hBACE1 CTD  
The results obtained in this study demonstrate that the interaction of hCCS with 
hBACE1 CTD is mediated by Cu(I)-binding to the Cys residues in the CXXC motif of 
both molecules.  Arg71 on loop 5 of hCCS may be important for mediating the 
hCCS/hBACE1 CTD interaction, although further evidence is required to confirm this.  
The Cu(I)-binding residues in hCCSD3 were not found to affect the hCCS/hBACE1 CTD 
interaction.  Several amino acids located close to the CXXC motif in hBACE1 CTD 
influence the interaction with hCCS.  In addition, this study demonstrates a significant 
interaction between HAH1 and hBACE1 CTD which is also mediated by the Cys 
residues in the CXXC motif of hBACE1 CTD and the surrounding amino acids.  The 
results obtained are summarised in Table 7. 
The hCCS/hBACE1 CTD interaction is mediated by the D1 of hCCS.  
These results are in agreement with the study by Angeletti et al. (2005) where a 
significant interaction between hBACE1 CTD and hCCSD2 or hCCSD3 was not 
observed.  The fact that the hCCS/hBACE1 CTD interaction is ~ 5-fold stronger than 
the hCCSD1/hBACE1 CTD interaction indicates that although hCCSD2 and hCCSD3 
do not interact with hBACE1 CTD directly, their presence does assist in interaction.  
Similar to the previous finding (Angeletti et al., 2005), no significant interaction was 
observed between Ccs1 and hBACE1 CTD.  A key difference between hCCS and Ccs1 
is their quaternary structure.  hCCS is a dimer irrespective of Cu(I) loading (Rae et al., 
2001), while apo-Ccs1 is a monomer with the Cu(I)-bound protein a mixture of 
monomeric and dimeric forms (Schmidt et al., 1999a).  This suggests that the 
dimerisation of CCS may be an important requirement for its interaction with hBACE1 
CTD.  That is, hBACE1 CTD may interact more strongly with the homo-dimer of hCCS 
than with the hCCS monomer.  A significant interaction was consistently detected 
between HAH1 and hBACE1 CTD which was similar in strength to the 
hCCSD1/hBACE1 CTD interaction.  Since hCCSD1 and HAH1 both have a ferredoxin-
fold, and high amino acid homology (as discussed in 1.3.2.4.2), the similarity in their 
interactions with hBACE1 CTD is not surprising.  However, Angeletti et al. (2005) did 
not detect a significant interaction between HAH1 and hBACE1 CTD.  The reason 
underlying this discrepancy is not clear especially because the HAH1 construct and the 
yeast two-hybrid strain used in this study and by Angeletti et al. (2005) were obtained 
from the same source. 
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Table 7: Summary of the results obtained for the interaction of hBACE1 CTD with 
hCCS, hCCSD1 and HAH1. The effects of the mutations made in hCCS and hCCSD1 on the 
interaction with hBACE1 CTD are shown in (A) and (B).  The effects of mutating the residues in 
hBACE1 CTD on the interaction with hCCS, hCCSD1 and HAH1 are shown in (C). A decreased 
interaction (compared to the interaction with WT protein) is represented by ‘↓’, increased 
interaction by ‘↑’ and the lack of significant protein-protein interaction by ‘X’.  Interactions that are 
similar to WT are represented by ‘~ WT’. 
A 
 
hCCS mutations 
Effect on yeast two-hybrid 
interaction with hBACE1 CTD 
Figure 
Reference 
Cys22Ser 9-fold ↓ 36 
Cys25Ser 8-fold ↓ 36 
Cys22Ser,Cys25Ser X 36 
Arg71Ala 3-fold ↓ 39 
Arg71Glu 10-fold ↓ 39 
Arg71Lys 11-fold ↓ 39 
Cys244Ser ~ WT 44 
Cys244Ser,Cys246Ser ~ WT 44 
 
B 
 
 
hCCSD1 mutations 
Effect on yeast two-hybrid 
interaction with hBACE1 CTD 
Figure 
Reference 
Cys22Ser 2-fold ↓ 37 
Cys25Ser 2-fold ↓ 37 
Cys22Ser,Cys25Ser X 37 
Arg71Ala 3-fold ↓ 40 
Arg71Glu 3-fold ↓ 40 
Arg71Lys 3-fold ↓ 40 
 
C 
 
 
hBACE1 CTD 
mutations 
Effect on yeast two-hybrid 
interactions with copper 
metallochaperones 
 
 
Figure 
Reference hCCS hCCSD1 HAH1 
Cys478Ser 2-fold ↑ 2-fold ↑ 2-fold ↑ 46 
Trp480Met 2-fold ↓ 4-fold ↓ X 50 
Arg481Ala 2-fold ↓ X 2-fold ↓ 51 
Arg481Glu 7-fold ↓ X 2-fold ↓ 52 
Arg481Lys 2-fold ↑ 3-fold ↑ X 51 
Cys482Ser X X X 47 
Arg484Ala 2-fold ↑ 3-fold ↑ 3-fold ↑ 53 
Cys485Ser X X X 48 
Arg487Ala 2-fold ↑ ~ WT 2-fold ↑ 54 
Asp491Ala,Asp492Ala ~ WT ~ WT X 55 
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The experiments investigating the effect of copper concentration on the hCCS/hBACE1 
CTD interaction indicate that this interaction may be mediated by the formation of a 
Cu(I)-bridged complex.  While the hCCS/hBACE1 CTD interaction is not significantly 
affected in the presence of excess copper, the interaction significantly decreases in 
copper-deficient conditions (Figure 28e, Figure 32 and Figure 33).  The addition of 500 
µM BCS to the growth medium results in the induction of CTR1 transcription as a 
consequence of decreased cellular copper content.  In these conditions, the 
hCCS/hBACE1 CTD interaction was found to be ~ 2-fold lower compared to the 
interaction in basal medium (Figure 28e and Figure 32).  The data also reveal an ~ 2-
fold decrease in the amount of CTR1 mRNA in co-transformants containing hCCS and 
hBACE1 CTD, compared to those containing empty vectors (Figure 28a, c).  Since the 
copper content of the hCCS/hBACE1 CTD co-transformants in 500 µM BCS was similar 
to those containing empty vectors (Figure 28e, f), similar CTR1 transcription levels were 
expected.  This suggests that the presence of hCCS and hBACE1 CTD results in a 
decrease in CTR1 transcription.  There are two main factors that may account for this 
observation.  Firstly, the binding of Cu(I) by hCCS and hBACE1 CTD in the nucleus can 
result in increased copper content in the yeast nucleus resulting in decreased Mac1 
activation and subsequently reduced induction of CTR1 transcription.  Since the copper 
content determined is that for the whole cell, the nuclear copper concentration in the co-
transformants is not known.  Secondly, hCCS or hBACE1 CTD may directly interact 
with Mac1 or bind to another protein that regulates the activity of Mac1.  The second 
hypothesis is supported by the results presented by Wood and Thiele (2009) who found 
that functional Sod1 was required for Mac1 activity.  It has previously been shown that 
hCCS can interact with Sod1 in S. cerevisiae (Schmidt et al., 2000).  Based on these 
data it is very likely that hCCS can interact with endogenous Sod1 in the 
hCCS/hBACE1 CTD co-transformants.  Whether this interaction can result in the 
activation of Sod1 too, considering hCCS is expressed as a fusion protein, is not 
known.  If the interaction of the hCCS fusion protein with endogenous Sod1 can not 
activate Sod1 then this could result in decreased Sod1 activity in hCCS/hBACE1 CTD 
co-transformants accounting for the reduced CTR1 transcription observed in this study.  
Alternatively, the activity of Sod1 in the yeast nucleus may also be reduced as a 
consequence of decreased availability of Ccs1 since hCCS has also been shown to 
dimerise with Ccs1 in S. cerevisiae (Schmidt et al., 2000). 
Irrespective of the reasons underlying decreased CTR1 transcription in 
hCCS/hBACE1 CTD co-transformants, it can be concluded that the addition of 500 µM 
or higher concentrations of BCS results in decreased copper content and decreased 
interaction of hCCS with hBACE1 CTD (Figure 28e and Figure 32).  Even though the 
addition of 1 mM and 3 mM BCS resulted in ~ 3-fold and > 100-fold reduction in the 
total-cell copper content respectively, compared to the hCCS/hBACE1 CTD co-
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transformants incubated in medium containing 500 µM BCS, no significant differences 
were detected between the yeast two-hybrid interactions of these co-transformants.  
Therefore, while the hCCS/hBACE1 CTD interaction decreases in copper-deficient 
conditions it is not abolished even at high BCS concentrations.  This may reflect the 
presence of sufficient Cu(I) ions in the nucleus to enable the formation of hCCS-Cu(I)-
hBACE1 CTD complex even when incubated in the presence of up to 3 mM BCS.  
Unlike the hCCS/hBACE1 CTD interaction, the hCCSD1/hBACE1 CTD and the 
HAH1/hBACE1 CTD interactions did not decrease in copper-deficient conditions (Figure 
34 and Figure 35).  Therefore, the effect of copper concentration on the hCCS/hBACE1 
CTD interaction requires the presence of domains 2 and 3 of hCCS in addition to D1.  
This leads to the possibility that the decrease in hCCS/hBACE1 CTD interaction in 
copper-deficient conditions may be influenced by decreased availability of hCCS for 
interaction with hBACE1 CTD as a consequence of its interactions with endogenous 
Ccs1 and Sod1.  As shown in Figure 60, the presence of BCS results in ~ 2-fold 
increase in the hSOD1/hCCS interaction.  However, these results have to be treated 
with caution since the hCCS/hSOD1 experiments were conducted in the SAY1 strain 
instead of the EGY48 strain.  Based on the study by Wood and Thiele (2009) this can 
have an aberrant effect on the Mac1 activity, as discussed further in section 4.2. 
The formation of a Cu(I)-bridged complex between hCCS and hBACE1 
CTD is also supported by the data showing that the mutation of the Cys residues in the 
CXXC motifs of hCCS and hBACE1 CTD abolishes their interaction (Table 7).  While 
the mutation of Cys482 or Cys485 in hBACE1 CTD completely impairs the interaction 
with hCCS (and hCCSD1), the mutation of both Cys22 and Cys25 in hCCS is required 
to abolish the interaction with hBACE1 CTD.  Similar results have also been reported 
for the interaction of other copper metallochaperones with their target proteins.  The 
mutation of the Cys residues in the CXXC motif of Atx1, HAH1 and ScAtx1 abolished 
the interactions with their respective target proteins (Larin et al., 1999; Portnoy et al., 
1999; Tottey et al., 2002).  Cu(I) transfer between Cu(I) metallochaperones and their 
partner proteins is proposed to proceed via ligand exchange reactions involving three 
coordinate Cu(I)-thiol intermediates (Banci et al., 2006b; Banci et al., 2009; Rae et al., 
2001).  The data presented in this study also indicate that the complex formation 
between hCCS and hBACE1 CTD involves Cu(I) coordination by three thiol ligands.  
hCCS-Cu(I)-hBACE1 CTD complex formation requires the presence of Cys482 and 
Cys485 of hBACE1 CTD and either one of the two Cys in the CXXC motif of hCCS, as 
shown in Figure 90a,b.   
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Figure 90: Possible copper-mediated coordinations sites involving the Cys 
residues in hBACE1 CTD and the CXXC motifs of hCCS and HAH1.  Cu(I)-bridged 
complex formation between hBACE1 CTD and hCCS or HAH1 is shown in (A) and (B) where 
Cu(I) is bound by Cys482 and Cys485 of hBACE1 CTD and one of the Cys in the CXXC motif of 
the copper metallochaperone.  The hBACE1 CTD Cys478-Cys485 amino acid sequence is 
represented by circles containing ‘C’ and ‘X’ in black (one letter amino acid code).  Cu(I) is 
shown as a brown sphere.  The CXXC motif from the copper metallochaperones is represented 
by circles containing ‘C’ and ‘X’ in green.  Tri-coordinated Cu(I)-binding in hBACE1 CTD is 
shown in (C), (D) and (E).  Cu(I) is bound by Cys478 and Cys482 or Cys482 and Cys485 of 
hBACE1 CTD in addition to an unidentified third ligand represented by the circle labelled ‘?’ in 
(C) and (D) respectively (based on the study by Angeletti et al. (2005)).  Cu(I) is bound by 
Cys478, Cys482 and Cys485 of hBACE1 CTD in (E). 
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Three coordinate Cu(I)-thiolate centres have also been reported for other copper 
metallochaperone-target protein complexes including Atx1-Cu(I)-Ccc2a (Banci et al., 
2006b) and HAH1-Cu(I)-ATP7A MBD1 (Banci et al., 2009).  In these studies, the N-
terminal Cys residues in the CXXC motif of both proteins were essential for complex 
formation.  In the NMR study investigating the complex formation between Atx1 and 
Ccc2a, the dominant complex involved both of the Cys residues of the CXXC motif of 
Ccc2a and the N-terminal Cys of the CXXC motif of Atx1 (Banci et al., 2006b).  It was 
further proposed that in the copper metallochaperone-Cu(I)-partner protein complexes, 
Cu(I) is localised comparatively closer towards the ‘acceptor’ protein (Banci et al., 
2010c).  Based on the data obtained in this study, this may indicate that Cu(I) is 
transferred from hCCS to hBACE1 CTD since both of the Cys residues in the CXXC 
motif of hBACE1 CTD are essential for interaction whereas only one Cys residue in the 
CXXC motif of hCCS is required.  A similar three coordinate Cu(I)-bridged complex may 
also form between HAH1 and hBACE1 CTD, since the mutation of either Cys482 or 
Cys485 in hBACE1 CTD also abolishes the interaction with HAH1 (Table 7c).    
Interestingly, the hBACE1 CTD Cys478Ser mutation enhances the 
interaction of hBACE1 CTD with hCCS, hCCSD1 and HAH1 (Table 7c).  Cu(I)-binding 
by hBACE1 CTD has been proposed to be a tri-coordinated site where Cys482 was 
found to be vital for Cu(I)-binding, in addition to either Cys478 or Cys485 and a third 
unidentified non-thiol ligand (Angeletti et al., 2005) (Figure 90c,d).  The hBACE1 CTD 
fusion protein may therefore exist in several different states in the presence of Cu(I) in 
the co-transformants containing hBACE1 CTD and hCCS (or HAH1), as shown in 
Figure 90.  Based on the Cu(I)-coordination sites shown in Figure 90c,e; the hBACE1 
CTD Cys478Ser mutation would remove one of the Cu(I)-ligands and disrupt the 
formation these coordination sites which could increase the complex formation with 
copper metallochaperones, accounting for the increase in interactions observed with 
the hBACE1 CTD Cys478Ser mutation.  In contrast to this study, Angeletti et al. (2005) 
found that the mutation of all three Cys residues in hBACE1 CTD to Ala (triple mutant) 
did not impair the interaction of hBACE1 CTD with hCCS in a GST pull-down assay.  All 
of the hBACE1 CTD mutant proteins in this study were studied in vivo to mimic the 
native environment.  The different experimental conditions used in in vitro GST pull-
down assays may account for the observed discrepancies. 
In addition to the Cu(I)-binding Cys residues, the interaction of hBACE1 
CTD with hCCS and HAH1 is also influenced by the residues surrounding the CXXC 
motif in hBACE1 CTD (Table 7c).  The data show that the Trp480Met mutation in 
hBACE1 CTD decreases the interaction with hCCS and hCCSD1 and abolishes the 
interaction with HAH1.  As discussed in section 3.1.4, Trp480 was mutated to Met to 
mimic the ‘MXCXXC’ motif commonly found in copper metallochaperones and other 
Cu(I)-binding proteins.  The large hydrophobic side chain of Trp480 may play a 
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structural role in hBACE1 CTD by organising the arrangement of Cys482 and Cys485 in 
hBACE1 CTD for Cu(I) binding and for the interaction with copper metallochaperones.  
Since Trp has the largest side chain of all the amino acids, mutation of this residue to 
any other amino acid can potentially alter the peptide fold.  However, to understand the 
role of this residue further Trp480 can be mutated to Phe or Tyr which also contain 
aromatic side chains and are more similar in size to Trp than Met.  In addition, the 
effects of these (and other) mutations on the peptide fold can be studied by NMR or CD 
spectroscopy.   
The hBACE1 CTD Arg481 residue was also found to be important for the 
interactions with hCCS and HAH1.  The proximity of Arg481 to the CXXC motif in 
hBACE1 CTD suggests that the side chain of this residue may serve a two-fold 
purpose.  It may be involved in the arrangement of the CXXC motif and also in assisting 
the neutralisation of the negative charge generated on the deprotonated Cys residues 
as a consequence of Cu(I)-binding to hBACE1 CTD.  A similar role has been 
associated with the Lys65 residue in loop 5 of the ferredoxin-fold of Atx1 which is 
located close to the Atx1 MBS (Arnesano et al., 2001b; Portnoy et al., 1999).  The data 
indicate that the presence of a positive charge in this position is important for the 
interaction of hBACE1 CTD with hCCS since the mutation of Arg481 to Lys not only 
preserves but in fact, increases the interaction whereas the mutation to Glu significantly 
decreases the interaction.  The increase in interaction of hBACE1 CTD Arg481Lys with 
its partner proteins is likely because the positive charge in Lys is more localised 
compared to the side chain of Arg where the positive charge in the guanidinium group is 
more diffused (Creighton, 1993).  The Arg481Ala mutation not only removes the 
positive charge associated with the Arg residue but also introduces a small hydrophobic 
residue in this position.  Since the Arg481Ala mutation results in decreased interaction 
with hCCS and hCCSD1, this further suggests that both the size and property of Arg481 
are important for interaction (Table 7c).  In contrast to the interactions of hBACE1 CTD 
Arg481Lys with hCCS and hCCSD1, the hBACE1 CTD Arg481Lys mutation abolishes 
the interaction with HAH1.  The substitution of hBACE1 CTD Arg481 with a neutral 
(Ala), acidic (Glu) or another basic (Lys) residue all had a detrimental effect on the 
interaction with HAH1.  This suggests that hBACE1 CTD Arg481 is absolutely essential 
for the interaction with HAH1.    
It was hypothesised that a similar function to hBACE1 CTD Arg481 may 
be performed by Arg71 in hCCS (analogous to Lys65 in Atx1).  That is, Arg71 may also 
be involved in neutralisation of the net negative charge created in the metal-binding 
region upon Cu(I)-binding due to the deprotonation of the Cys residues.  Based on this 
hypothesis it was expected that the mutation of Arg71 to Lys would not have a 
significant effect on the interaction with hBACE1 CTD, whereas the Arg71Ala and 
Arg71Glu mutations would result in decreased interactions.  As expected, the mutation 
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of Arg71 to Ala or Glu in hCCS results in significantly decreased interaction with 
hBACE1 CTD (Table 7a-b).  The presence of the negatively charged Glu residue in the 
place of Arg71 had a more drastic effect on protein-protein interaction than the 
presence of the neutral Ala residue.  This is probably due to disrupted Cu(I)-binding in 
the hCCS Arg71Glu mutant protein as a result of the increase in negative charge in the 
metal-binding region.  Contrary to expectations, the hCCS Arg71Lys mutation abolishes 
the interaction with hBACE1 CTD.  This result is very surprising and difficult to 
rationalise based on the above hypothesis.  It is possible that Arg71 plays a 
fundamental role in Cu(I)-binding in domain 1 of hCCS and Cu(I)-transfer, as proposed 
by Rae et al. (2001), which may be disrupted by the presence of Ala, Glu or Lys in this 
position.  Perhaps Arg is the ideal residue in this position to allow both Cu(I)-binding 
and Cu(I)-transfer to take place in hCCSD1.  This theory can be tested by studying the 
binding of Cu(I) in both WT and Arg71 mutants of hCCS using in vitro methods, as 
discussed in section 5.1.  However, based on the results obtained in this study, the 
precise role of hCCS Arg71 in mediating the interaction with hBACE1 CTD can not be 
conclusively determined.   
Unlike the Arg481Ala mutation in hBACE1 CTD, the Arg484Ala and 
Arg487Ala mutations increase the interaction of hBACE1 CTD with hCCS and HAH1 
(Table 7c).  Based on the structure of apo-hCCSD1 (Figure 91a), the only positively 
charged residue located close to the MBS is Arg71.  However, the hCCS Arg71Ala and 
Arg71Lys mutations both decrease the interaction with hBACE1 CTD which indicates 
that the side chains of hBACE1 CTD Arg484 and Arg487 probably do not cause 
electrostatic repulsion in the complex with hCCS.  The increase in interaction observed 
with the Arg484Ala and Arg487Ala mutations in hBACE1 CTD may therefore be due to 
altered arrangement of the CXXC motif in hBACE1 CTD which enhances its interaction 
with hCCS and HAH1.  To clarify this hypothesis further, both Arg484 and Arg487 can 
be mutated to Lys as a positive control and to an acidic residue to further clarify the role 
(or the lack of importance) of charge in this position.   
The interaction of hBACE1 CTD with HAH1 was also abolished by the 
Asp491Ala,Asp492Ala double mutation in hBACE1 CTD, whereas these changes did 
not have a significant effect on the interactions with hCCS and hCCSD1 (Table 7c).  
These mutations not only remove the negative charge in these positions but also 
introduce a small hydrophobic residue in place of them, which can potentially alter the 
peptide fold.  Since these mutations did not have a significant effect on the interaction 
with hCCS, it suggests that these mutations likely have a specific effect on the 
interaction with HAH1 and not a global effect on peptide fold.  The Asp491 and 492 
residues may be important for mediating electrostatic interactions with one or more of 
the positively charged residues in HAH1.  One of the differences between HAH1 and 
hCCSD1 is that HAH1 contains several Lys residues that generate a positively charged 
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surface on the molecule (Figure 91b).  Some of these residues in HAH1 have been 
implicated in forming favourable electrostatic interactions with the negatively charged 
residues in the target protein which stabilise the formation of a complex between them 
(Banci et al., 2009; Larin et al., 1999).  A similar interaction is also possible with 
hBACE1 CTD Asp491 and Asp492.  Mutation of the Lys residues that are exposed on 
the surface of HAH1 and can potentially interact with Asp491 and Asp492 in hBACE1 
CTD to either negatively charged residues or to a neutral residue will provide more 
evidence towards this theory.  These positively charged residues in HAH1 are however, 
not conserved in the analogous locations in hCCSD1, which may account for the lack of 
significant effect observed with the hBACE1 CTD Asp491Ala, Asp492Ala mutations on 
the interactions with hCCS and hCCSD1.   
 
4.1.1 Physiological relevance of the hCCS/hBACE1 CTD interaction 
The results presented in this study provide important information regarding the 
molecular basis of the interaction of hCCS with hBACE1 CTD.  Elucidating the 
physiological importance of this interaction is complicated by the fact that hCCS and 
hBACE1 CTD can both interact with several other proteins (Cole and Vassar, 2007; 
Dingwall, 2007). A multi-protein complex where hCCSD1 can bind hBACE1, hCCSD2 
binds hSOD1 and hCCSD3 can interact with X11α which in turn can also associate with 
APP has been postulated (Dingwall, 2007).  Although the existence of such a complex 
in vivo has not been shown, it nevertheless emphasises the difficulty in elucidating the 
molecular basis of the individual protein-protein interactions since other proteins can 
potentially influence them.  There are only three studies to date that have addressed 
the hCCS/hBACE1 CTD interaction, but none of them have identified the amino acids 
involved in mediating this interaction (Angeletti et al., 2005; Gray et al., 2010; 
Rentmeister et al., 2006).  The most recent of these studies by Gray et al. (2010) 
reported increased BACE1 mediated cleavage of APP in cells lacking CCS, although 
whether this is due to factors including altered copper homeostasis or changes in the 
localisation of hBACE1 is currently not known.  Investigating these factors is vital 
because hBACE1 CTD is known to be important for mediating the localisation and 
trafficking of hBACE1 (Benjannet et al., 2001; Capell et al., 2000; He et al., 2002; Huse 
et al., 2000; Walter et al., 2001), as summarised in Figure 92.   
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Figure 91: Structures of apo-hCCSD1 and Cu(I)-HAH1 monomers.  The NMR 
structure of hCCSD1 (PDB accession code: 2crl) is shown in (A).  The side chains of the Cys 
residues of the CXXC motif and Arg71 on loop 5 are shown.  The crystal structure of Cu(I)-HAH1 
is shown in (B) (PDB accession code: 1fee; only a monomer with the bound Cu(I) ion of the 
dimeric asymmetric unit is shown) (Wernimont et al., 2000).  The side chains of the Cys residues 
of the CXXC motif and some of the positively charges residues located close to the CXXC motif 
are shown, as labelled.   
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Figure 92: Model depicting the intracellular trafficking of hBACE1 and some of 
the post-translational modifications that hBACE1 CTD can undergo.  hBACE1 is 
synthesised and glycosylated in the endoplasmic reticulum (ER) with its propeptide domain 
intact (Capell et al., 2000; Huse et al., 2000).  The Cys residues in the CTD can undergo 
palmitoylation (represented by red lines) which has been suggested to facilitate its exit from the 
ER and may provide an additional anchor for plasma membrane (PM)-bound hBACE1 
(Benjannet et al., 2001).  The propeptide domain is cleaved in the Golgi apparatus where 
hBACE1 is further glycosylated (Capell et al., 2000; Huse et al., 2000) and can be 
phosphorylated (green sphere) at Ser498 (highlighted in blue in the amino acid sequence) in the 
CTD (Walter et al., 2001).  The DISLL sequence (highlighted in the amino acid sequence) is 
required to mediate the intracellular localisation and trafficking of hBACE1 (Pastorino et al., 
2002; Walter et al., 2001).  It has been suggested that hBACE1 can traffic from the Golgi to the 
endosomal compartment (Huse et al., 2000) although this is yet to be confirmed experimentally.  
Leu499 and Leu500 are vital for the re-internalisation of hBACE1 from the PM, which is 
independent of the Ser498 phosphorylation status (Walter et al., 2001).  In the endosome, 
phosphorylated hBACE1 CTD can interact with γ-ear-containing ADP-ribosylation factor-binding 
(GGA) proteins which can mediate its trafficking to the Golgi or the lysosome (He et al., 2002; He 
et al., 2005; Pastorino et al., 2002; Shiba et al., 2004; von Arnim et al., 2004).  Non-
phosphorylated hBACE1 can also recycle back to the PM (He et al., 2005).  hBACE1 undergoes 
degradation in the lysosomal compartment (von Arnim et al., 2006).   
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hBACE1 CTD undergoes several post-translational modifications including 
phosphorylation (Walter et al., 2001), palmitoylaton (Benjannet et al., 2001) and 
farnesylation (Parsons and Austen, 2007).  Particularly important for the hCCS/hBACE1 
CTD interaction is the fact that the Cys478, Cys482 and Cys485 residues can all 
undergo palmitoylation (Benjannet et al., 2001).  However the precise role of 
palmitoylation of hBACE1 CTD is not clear.  Benjannet et al. (2001) found that 
palmitoylation decreased the ectodomain shedding of hBACE1 and suggested that this 
could lead to decreased amyloidogenic processing of APP.  In contrast, a study by 
Westmeyer et al. (2004) reported palmitoylation to be important for mediating the 
dimerisation of hBACE1 which significantly enhances the amyloidogenic processing of 
APP.  The data obtained in this study indicate that only hBACE1 CTD that is not 
palmitoylated at Cys482 or Cys485, should be able to interact with hCCS.  A previous 
study demonstrated that less than 10 % of hBACE1 locates to the plasma membrane, 
suggesting that ~ 90 % of hBACE1 is likely not palmitoylated (Hussain et al., 2003).  
This implies that a large proportion of hBACE1 should be available for interaction with 
hCCS.   
The data presented in this study also demonstrate that the 
hCCS/hBACE1 CTD interaction is impaired under copper-limiting conditions.  Since 
decreased intracellular neuronal copper concentration has been implicated in AD (Filiz 
et al., 2008), it suggests that in the diseased neurons hCCS may not be able to interact 
with hBACE1 CTD.  Based on the findings by Gray et al. (2010) the decreased 
interaction of hCCS with hBACE1 CTD as a consequence of decreased intracellular 
copper concentration may subsequently result in increased amyloidogenic processing 
of APP and increased Aβ production, as summarised in Figure 93.  The proposed role 
of hBACE1 in intracellular copper homeostasis also extends to the inactive form of 
hBACE1.  Inactive hBACE1 is highly expressed in the pancreas although its function is 
currently not known (Vassar et al., 1999).  Since active and inactive hBACE1 differ in 
the luminal region of hBACE1 rather than its cytoplasmic domain (Bodendorf et al., 
2001; Ehehalt et al., 2002), both forms of the protein should be able to bind copper and 
interact with hCCS.  Further studies are however required to elucidate the role of this 
interaction in vivo.  Some of the unanswered questions include – can hBACE1 bind 
Cu(I) via CTD in native conditions?  Is Cu(I) transferred from hCCS to hBACE1 CTD or 
vice versa?  Is the interaction between hCCS and hBACE1 CTD reduced in AD tissue 
as a consequence of decreased intracellular copper concentration? 
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Figure 93: Model demonstrating the effect of copper concentration on the interactions of hBACE1 with hCCS and HAH1, and the interaction 
of hCCS with hSOD1 with respect to Aβ production.  Under basal conditions, for example in healthy human cells, hBACE1 can interact with hCCS and HAH1 
via its CTD and hCCS interacts with hSOD1 in the cytosol.  In these cells basal levels of Aβ are produced.  In conditions where the intracellular copper concentration 
is low, for example in AD, the interaction of hBACE1 with hCCS decreases whereas the interaction of hCCS with hSOD1 increases.  This can lead to increased 
amyloidogenic processing of APP by hBACE1 resulting in increased production of Aβ (based on the study by Gray et al. 2010).  The interaction of hBACE1 with 
HAH1 remains largely unaltered irrespective of the copper concentration. 
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4.2 Interaction of hSOD1 with hCCS 
This study also aimed to further the understanding of the interaction of hCCS with 
hSOD1.  The experiments investigating the effect of copper concentration on the 
hSOD1/hCCS interaction demonstrate that the interaction remains unaffected at high 
copper concentration (Figure 60).  Similar results were also obtained for the interaction 
of hCCS with hSOD1 in the presence of 1 mM CuSO4 in a GST-column binding assay 
(Casareno et al., 1998).  However, more than a two-fold increase was observed in the 
hSOD1/hCCS interaction in copper-deficient conditions (Figure 60).  A study by Schmidt 
et al. (2000) found that the yeast two-hybrid interaction of Ccs1 with Sod1 also 
increased in the presence of BCS.  Although no interactions were reported between 
hCCSD1 and hSOD1 (Casareno et al., 1998) or between Ccs1D1 and Sod1 (Schmidt 
et al., 2000), the presence of Ccs1D1 was shown to increase the interaction of Ccs1 
with Sod1 (Schmidt et al., 2000).  In addition, it has been proposed that the CCS-
dependent activation of SOD1 may involve the transfer of copper from D1 to D3 of CCS 
(Furukawa et al., 2004; Rae et al., 2001; Schmidt et al., 1999a).  However, no 
significant interaction was observed between full-length hCCS and hCCSD3 or between 
hCCSD1 and hCCSD3 in this study (Figure 61).  While there is no information available 
regarding the structural conformation of hCCSD3, some knowledge can be gained from 
the Ccs1-Sod1 dimer where Ccs1D3 was partially folded into an α-helix (Lamb et al., 
2001).  Submission of the hCCSD3 amino acid sequence into the Swiss PDB modelling 
software (http://swissmodel.expasy.org) did not yield any results, likely due to the 
relatively small size of this domain (comprising less than 40 amino acids). It is possible 
that hCCSD3 may only be able to obtain its native fold when expressed with hCCSD2 
(and perhaps hCCSD1 too).  Alternatively, the interaction of hCCSD3 with hCCS may 
be too weak to be detected by the yeast two-hybrid system. 
To further investigate the role of hCCSD1 and hCCSD3 in the interaction 
with hSOD1, the Cu(I)-binding Cys residues in hCCSD1 and hCCSD3 were mutated.  
The data obtained in this study indicate that the mutation of Cys22 and Cys25 in hCCS 
do not have a significant effect on the interaction with hSOD1.  The mutation of hCCS 
Cys244 and Cys246 also did not have a significant effect on the interaction with hSOD1 
(Figure 62).  Similar results were also observed for the yeast two-hybrid interaction of 
Sod1 with Ccs1 where the Cu(I)-binding residues in Ccs1D3 were mutated to Ser 
(Schmidt et al., 2000).  The role of Arg71 in hCCS in the interaction with hSOD1 is not 
clear since the mutation of Arg71 to Ala or Lys does not have a significant effect on the 
interaction with hSOD1, but the Arg71Glu mutation decreases the interaction (Figure 
64).  However, the mutation of Lys66Arg in Ccs1 increases its interaction with hSOD1 
(Figure 65) suggesting that the residue in loop 5 of Ccs1 may be involved in mediating 
the interaction with hSOD1.   
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While the Cu(I)-binding Cys residues in hCCS do not have a significant effect on the 
interaction with hSOD1 in basal conditions, these residues may play a more important 
role in copper-deficient conditions.  For instance, the absence of Ccs1D1 increased the 
interaction of Sod1 with a Ccs1 construct lacking D1 under copper-deficient conditions 
(Schmidt et al., 2000).  In addition, a Cu(I) cluster involving Cys244 and Cys246 of 
hCCS was reported to form when the concentration of Cu(I) was ~ 2-fold higher than 
the protein concentration (Stasser et al., 2007).  The authors further proposed that in 
excess copper conditions, hCCS may dimerise via the Cu(I) cluster in D3 which would 
subsequently increase the availability of hCCSD2 for interaction with hSOD1 (Stasser 
et al., 2007).  As mentioned above, the addition of up to 300 µM CuSO4 did not have a 
significant effect on the hSOD1/hCCS interaction, whereas the interaction decreases in 
copper-deficient conditions.  These data indicate that either a Cu(I)-cluster in hCCSD3 
can not form in the yeast two-hybrid system used in this study or that the formation of a 
Cu(I)-cluster does not have a significant effect on the interaction of hCCS with hSOD1.  
However, it would be interesting to investigate the effects of mutating the Cu(I)-binding 
residues in hCCSD3 on the interaction with hSOD1 in copper-deficient and excess 
copper conditions.  Before these experiments could be carried out, a study published by 
Wood and Thiele (2009) demonstrated that the deletion of CCS1 or SOD1 impaired the 
activation of Mac1 resulting in significantly decreased transcription of CTR1 in the 
presence of 10 µM or 100 µM BCS.  The authors further demonstrated that active 
SOD1 is required for Mac1 activity (Wood and Thiele, 2009).  Since the hSOD1/hCCS 
two-hybrid experiments were carried out in the SAY1 strain which lacks CCS1, the 
nuclear copper homeostasis may have been severely compromised and severely 
altered the copper concentration in this strain compared to the EGY48 (WT) strain.  
However, it is possible that the presence of hCCS in the hSOD1/hCCS co-
transformants may be able to activate endogenous Sod1 and restore Mac1 activity.  In 
addition, the highest BCS concentration studied by Wood and Thiele (2009) was 100 
µM whereas in this study up to 3 mM BCS was added to the growth medium.  High 
concentrations of BCS (> 500 µM) may result in decreased nuclear copper 
concentration despite the absence of CCS1 in SAY1 cells.  Hence, prior to carrying out 
further experiments in this strain it is vital to perform S1 nuclease experiments on the 
above co-transformants to verify the induction of CTR1 in the presence of BCS.    
 
4.3 The interaction of ScAtx1 with PacSN and CtaAN 
Copper metallochaperones such as HAH1, Atx1, ScAtx1 and CopZ are known to 
interact with cognate MBDs of Cu(I)-ATPases (Banci et al., 2003a; Larin et al., 1999; 
Portnoy et al., 1999; Pufahl et al., 1997; Radford et al., 2003; Tottey et al., 2002).  
These protein-protein interactions tend to involve the formation of a Cu(I)-bridged 
complex where Cu(I) is coordinated by the Cys residues of the CXXC motif (Banci et al., 
   
 189 
2006b; Banci et al., 2009; Pufahl et al., 1997).  However, the functional implications of 
the interactions of copper metallochaperones with the MBDs and the role of the MBDs 
have not been elucidated.  Studies investigating the role of MBDs in A. fulgidus led to 
the proposal that apo-MBDs in AfCopA can interact with the N-domain of AfCopA and 
occlude ATP-binding, thereby preventing Cu(I) transport by AfCopA (Gonzalez-
Guerrero et al., 2009; Gonzalez-Guerro and Arguello, 2008; Wu et al., 2008).  The 
acquisition of Cu(I) from Cu(I)-AfCopZ by the MBDs of AfCopA leads to a 
conformational change which enables ATP binding and Cu(I) transport (Gonzalez-
Guerrero et al., 2009; Gonzalez-Guerro and Arguello, 2008; Wu et al., 2008).  Cu(I)-
bound AfCopZ has also been shown to transport Cu(I) directly to the intramembranous 
Cu(I)-binding site in AfCopA in vitro (Gonzalez-Guerro and Arguello, 2008).  A 
regulatory role has also been proposed for the eukaryotic MBDs in mediating the 
trafficking and localisation of the Cu(I)-ATPases (Lutsenko et al., 2007a).  Atx1 can 
deliver Cu(I) to both of the MBDs of Ccc2 (Morin et al., 2009; Portnoy et al., 1999; 
Pufahl et al., 1997; van Dongen et al., 2004).  Deletion of both of the MBDs of Ccc2 
prevents the transport of Cu(I) to the trans-golgi network (Morin et al., 2009).  
Furthermore, it has been shown that each MBD of Ccc2 when expressed individually 
can transfer Cu(I) to a Ccc2 construct lacking both of the MBDs (Morin et al., 2009).  
This led to the proposal that Cu(I) is transferred from Atx1 to the MBDs of Ccc2 which 
transport Cu(I) to the intramembranous Cu(I)-binding site in Ccc2 (Morin et al., 2009).  
The mutation of the Cu(I)-binding Cys residues in the MBDs of ATP7A has been shown 
to disrupt its trafficking to the plasma membrane (Voskoboinik et al., 1999).  HAH1 has 
been reported to interact most strongly with MBDs 1 and 4 of ATP7A in a Cu(I)-
dependent manner and may simultaneously transfer copper to MBDs 5 and 6 (Banci et 
al., 2007).  It has been proposed that in excess copper conditions the interaction of 
HAH1 with ATP7A MBDs 1 and 4 can result in the localisation of ATP7A at the plasma 
membrane resulting in Cu(I)-export from the cytosol (Banci et al., 2007).   
The interaction of copper metallochaperones with the MBDs are 
therefore of particular interest for furthering the understanding of their role in regulating 
Cu(I)-ATPases localisation, trafficking or activity.  This study investigated the 
interactions of the cyanobacterial ScAtx1 with the proposed Cu(I) donor (CtaAN) and 
acceptor (PacSN).  The residues located close to the Cu(I)-binding site and the key 
residues on the loop 5 of ScAtx1, PacSN and CtaAN were shown to be important for 
mediating protein-protein interactions, as summarised in Table 8.  The idea that ScAtx1 
can interact with PacSN and CtaAN by forming two structurally different complexes 
(head-to-head or side-to-side) was also investigated.  The data indicate that both 
ScAtx1-PacSN and ScAtx1-CtaAN can likely form side-to-side complexes.  
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Table 8: Summary of the results obtained in this study demonstrating the effects 
of mutating the residues in ScAtx1 (A), PacSN (B) and CtaAN (C) on the yeast two-
hybrid interactions with their respective partner proteins.  Decreased interactions 
(compared to the interaction with WT protein) as a result of a mutation are represented by ‘↓’, 
increased interactions are represented by ‘↑’ and the lack of an interaction by ‘X’.  ‘-‘ indicates 
that the interaction was not studied.  Interactions that are similar to WT are represented by ‘~ 
WT’. 
 
A 
ScAtx1 
mutations 
Effect on yeast 
two-hybrid 
interaction with 
PacSN 
Effect on yeast two-
hybrid interaction 
with CtaAN 
Figure 
Reference 
Ala11Lys 3-fold ↓ 5-fold ↓ 74 
Ala11Arg 3-fold ↓ 4-fold ↓ 74 
Glu13Ala 4-fold ↓ X 75a, 76 
Glu13Gln 2-fold ↓ 3-fold ↓ 75b, 76 
Lys21Asp X 4-fold ↓ 87 
Asn25Arg ~ WT 4-fold ↓ 88 
Ser58Ala 3-fold ↓ 3-fold ↓ 89 
His61Ala 3-fold ↓ X 79 
His61Glu X X 80 
His61Lys 2-fold ↓ 7-fold ↓ 83 
His61Phe X 3-fold ↓ 80 
His61Tyr X ~ WT 79 
 
B 
PacSN  
mutations 
Effect on yeast two-hybrid interaction with ScAtx1 
ScAtx1 WT ScAtx1 His61Ala ScAtx1 His61Tyr 
Arg13Ala 5-fold ↓ 
(Fig. 72) 
- - 
Tyr65His 8-fold ↓ 
(Fig. 81) 
~ WT 
 (Fig. 81) 
X 
 (Fig. 81) 
 
C 
CtaAN 
mutations 
Effect on yeast two-hybrid interaction 
with ScAtx1 
Figure  
Reference 
Lys34Ala X 73 
Phe87His 3-fold ↓ 82 
Phe87Tyr 5-fold ↓ 82 
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A limited effect of copper concentration was observed on the interaction of ScAtx1 with 
PacSN and CtaAN.  A small decrease in the interaction of ScAtx1 with PacSN and CtaAN 
is evident in the presence of 300 µM CuSO4 (Figure 69 and Figure 70).  The yeast two-
hybrid interactions of HAH1 or Atx1 with ATP7B MBD2 or ATP7B MBD4 have also been 
shown to decrease at high copper concentrations (van Dongen et al., 2004).  High 
copper concentrations may facilitate Cu(I)-bound homo-dimerisation of ScAtx1, which 
would reduce the amount of ScAtx1 available for interaction with PacSN or CtaAN.  It 
has previously been shown that apo-ScAtx1 is monomeric with Cu(I)-loading inducing 
dimerisation (Badarau et al., 2010; Banci et al., 2004a).  It was further reported that in 
the presence of excess Cu(I), ScAtx1 can bind two Cu(I) ions per monomer which 
increases the stability of the ScAtx1 homo-dimer (Badarau et al., 2010).  The interaction 
of ScAtx1 with CtaAN increases in copper-deficient conditions.  Since less homo-
dimerisation of ScAtx1 would be expected at lower copper concentrations (Badarau et 
al., 2010), this would increase the availability of ScAtx1 monomers for interaction with 
CtaAN.  However no significant effect of BCS addition was observed on the 
ScAtx1/PacSN interaction except in the presence of 500 µM BCS.  The addition of 500 
µM BCS, results in a small decrease in the ScAtx1/PacSN interaction compared to the 
co-tranformants incubated in basal medium.  The reasons for the decrease in 
interaction in the presence of 500 µM BCS are not clear since higher concentrations of 
BCS did not have a significant effect on the ScAtx1/PacSN interaction.  This may 
indicate the presence of sufficient Cu(I) ions in the yeast nucleus to enable the 
interactions despite the addition of up to 3 mM BCS to the growth medium.    
The interactions of ScAtx1 with PacSN and CtaAN are influenced by the 
residues surrounding the CXXC motif in these proteins.  The mutation of PacSN Arg13 
and CtaAN Lys34 to Ala decreases the interaction with ScAtx1.  These data are in 
agreement with the studies by Banci et al. (2010b) who found that the presence of 
Asp18 in the analogous location in the cyanobacterial Zn(II)-transporter ZiaA, hindered 
its interaction with ScAtx1.  The authors demonstrated that the mutation of PacSN Arg13 
to Asp abolished the interaction with ScAtx1, whereas the ZiaA Asp18Arg mutation 
enhanced its interaction with ScAtx1 in a bacterial two-hybrid system (Banci et al., 
2010b).  The mutation of the analogous ScAtx1 Ala11 residue to either Lys or Arg also 
decreases the interaction with PacSN and CtaAN.  This indicates that while a positively 
charged residue is required at this position in PacSN and CtaAN, the presence of two 
positively charged residues in the complex with ScAtx1 can lead to electrostatic 
repulsion.   
Arg13 in PacSN and Lys34 in CtaAN have also been proposed to form 
favourable electrostatic interactions with Glu13 in ScAtx1 (Banci et al., 2004a).  In 
addition, the side chain of Glu13 in ScAtx1 can also form an inter-molecular hydrogen 
bond with the side chain of Cys14 in PacSN (the N-terminal Cys of the CXXC motif in 
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PacSN) (Banci et al., 2006c).  The mutation of Glu13 in ScAtx1 to Ala or Gln decreases 
the interactions with PacSN and CtaAN (Table 8).  Both of the mutations were expected 
to disrupt the formation of favourable electrostatic interactions with the MBDs (Arg13 in 
PacSN and Lys34 in CtaAN).  Future experiments can be designed to test this 
hypothesis further by comparing the interaction of wild-type proteins with various 
combinations of mutant proteins, as discussed in section 5.3.  For example, reversing 
the charges in these positions, that is, replacing ScAtx1 Glu13 with Lys and PacSN 
Arg13 or CtaAN Lys34 with Glu, would be expected to yield wild-type like yeast two-
hybrid interactions (in terms of magnitude) which would further demonstrate that these 
residues are involved in key electrostatic interactions which are important for complex 
formation between these proteins.  The data indicate that the Glu13Ala mutation in 
ScAtx1 decreases the interactions with PacSN and CtaAN more than the Glu13Gln 
mutation.  This is likely because the side chain of Ala can not form hydrogen-bonding 
interactions, whereas the side chain of Gln can.  However, depending upon the acid 
dissociation constant (pKa) of the Gln side chain, it may not be able to accept protons 
from Cys unlike ScAtx1 Glu13 (Banci et al., 2006c).  The data suggest that a hydrogen 
bond may also form between ScAtx1 Glu13 and CtaAN Cys35 as reported in the 
ScAtx1-PacSN complex which is disrupted by the mutation of Glu13 to Ala or Gln (Banci 
et al., 2006c).   
In addition to the above discussed residues, the role of the key loop 5 
residues in mediating protein-protein interactions was also investigated.  The key loop 5 
residue in ScAtx1 is His61 which is not conserved in the ferredoxin-fold of the known 
copper chaperones.  In most bacterial copper metallochaperones this residue is Tyr, 
whereas in the eukaryotic copper metallochaperones this residue is typically Lys 
(Arnesano et al., 2002).  The mutation of ScAtx1 His61 to Arg enhanced the bacterial 
two-hybrid interaction of ScAtx1 with PacS MBD but did not affect the interaction with 
CtaA MBD (Borrelly et al., 2004).  To understand the role of this residue further, ScAtx1 
His61 was mutated to a variety of amino acids and the results obtained are summarised 
in Table 8a, b. In addition, the analogous residues in PacSN (Tyr65) and CtaAN (Phe87) 
were also mutated to gain a greater understanding of the role of the key loop 5 residue 
in mediating protein-protein interactions.   
The data indicate that the substitution of ScAtx1 His61 or PacSN Tyr65 
with another amino acid containing an aromatic side chain severely disrupts the 
interaction of ScAtx1 with PacSN.  In the ScAtx1/PacSN complex – the Tyr/Tyr, Phe/Tyr 
and Tyr/His combinations impair complex formation, whereas the His/Tyr (WT proteins), 
Ala/Tyr, Ala/His combinations are less disruptive.  This suggests that the presence of 
two non-native aromatic side chains can result in steric clashes in the ScAtx1/PacSN 
complex.  Unlike the ScAtx1/PacSN interaction, the mutation of ScAtx1 His61 to Tyr or 
Phe does not abolish the interaction with CtaAN.  In fact, the interaction of CtaAN with 
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ScAtx1 His61Tyr was similar to the interaction with ScAtx1 WT protein.  The ScAtx1 
His61Tyr mutation is particularly interesting as two crystal structures for this variant are 
available.  These include a side-to-side homo-dimer containing 4 Cu(I) and one chloride 
ion, and a 4 Cu(I)-bound trimer (Badarau et al., 2010).  In addition, ScAtx1 His61Tyr 
was found to be a monomer in solution in the presence of 1 equivalent of Cu(I) 
(Badarau et al., 2010).  This further supports the data in this study demonstrating that 
the presence of two Tyr residues (in the ScAtx1 His61Tyr/PacSN complex) near the 
metal-binding region is more disruptive than the presence of a Tyr and a Phe residue 
(in ScAtx1 His61Tyr/CtaA92 complex).  Alternatively, it is possible that the interaction 
with PacSN was not detected because the formation of this complex was less 
favourable compared to the homo-dimersation of ScAtx1 His61Tyr.  Therefore, in the 
two-hybrid system there is likely an equilibrium between the formation of homo- and 
hetero-dimers where only the latter will be detected when assaying for β-galactosidase 
activity.  The mutation of Phe87 in CtaAN to Tyr or His decreases the interaction with 
ScAtx1 but does not abolish it completely.  The fact that swapping around of the loop 5 
residues in CtaAN and PacSN can have such detrimental effects on the interactions with 
ScAtx1 confirms that these residues are not interchangeable but specific for each 
interaction.   
Badarau et al. (2010) reported that His61 forms several inter- and 
intramolecular interactions in the ScAtx1 homo-dimers.  In the head-to-head two Cu(I)-
bound dimer, His61 forms an intra-subunit hydrogen bond with Cys15 and an inter-
subunit hydrogen bond with Cys12.  In the side-to-side dimer, His61 was found to 
hydrogen bond with one of the chloride ions.  Since the ScAtx1 homo-dimer structures 
have been proposed to reflect the complexes of ScAtx1 with CtaA or PacSN (Badarau et 
al., 2010), it is not surprising that the mutation of ScAtx1 His61 to Ala whose side chain 
can not form hydrogen bonds, decreases the interaction of ScAtx1 with both PacSN and 
CtaAN.  Similar results were also obtained for the interaction of HAH1 with ATP7B 
MBD4, where the authors demonstrated that the Lys60Ala mutation in HAH1 
(analogous to position His61 of ScAtx1) significantly decreased complex formation 
(Hussain et al., 2009).   It has been proposed that Lys65 in Atx1 (analogous to position 
His61 in ScAtx1) is also important for the stabilisation of the complex formation with 
Ccc2 MBDs (Arnesano et al., 2004; Portnoy et al., 1999).  The side chain of Atx1 Lys65 
has been suggested to neutralise the net negative charge of the metal-binding region 
generated as a consequence of deprotonation of the Cys ligands upon binding Cu(I) 
(Portnoy et al., 1999).  The Lys65Glu mutation in Atx1 was shown to abolish the yeast 
two-hybrid interaction with Ccc2 MBDs, further demonstrating that the presence of a 
positively charged residue in this position is important for interaction (Portnoy et al., 
1999). Depending upon the pKa of the His side chain, which is typically around 6 
(Mallesha et al., 2001), it can either be neutral or positively charged.  If present in its 
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protonated form, ScAtx1 His61 may also play a role in the neutralization of the negative 
charge of the metal-binding region in the Cu(I)-bound complex with MBD, similar to 
Lys65 in Atx1.  Therefore, the substitution of ScAtx1 His61 with a positively charged 
residue should be more favourable than the substitution with a negatively charged 
residue.   
As expected, the ScAtx1 His61Glu mutation abolishes the interactions 
with both PacSN and CtaAN.  However, the ScAtx1 His61Lys mutation also abolishes 
the interaction with CtaAN and decreases the interaction with PacSN.  The lack of 
interaction between ScAtx1 His61Lys and CtaAN indicates that the presence of a 
positively charged residue in this position is not sufficient to stabillise the interaction of 
ScAtx1 with CtaAN.  A computational study investigating the mutation of Tyr65 in loop 5 
of BsCopZ to Lys demonstrated that this mutation increases the flexibility of the Cu(I)-
binding loop in holo-BsCopZ (Rodriguez-Granillo and Wittung-Stafshede, 2009b).  If the 
ScAtx1 His61Lys mutation has a similar effect as the BsCopZ Tyr65Lys mutation, this 
could account for the decrease in interactions with the MBDs observed in this study.  
The substitution of Lys60 in HAH1 with Tyr was also reported to decrease complex 
formation with ATP7B MBD4 (Hussain et al., 2009).  Both of these studies found that 
the substitution of the loop 5 residue with a non-native residue that can donate 
hydrogen bonds (Tyr or Lys in these studies) had a less detrimental effect than the 
mutation to a non hydrogen-bond forming residue (such as Ala) (Hussain et al., 2009; 
Rodriguez-Granillo and Wittung-Stafshede, 2009b).  However, in this study the mutation 
of ScAtx1 His61 to Ala or Lys had an almost equally disruptive effect on the interaction 
with the target domains.  This signifies that the presence of a hydrogen bond donor in 
this position is not sufficient for complex formation, but properties such as charge and 
size of the loop 5 residue are also important for interactions.  The data therefore 
indicate that His61 has evolved to be the best choice of amino acid in this position to 
enable ScAtx1 to interact optimally with both PacSN and CtaAN. 
While mutations in loop 5 of these proteins can lead to disruption of 
hydrogen-bonding interactions or change the net charge of the metal-binding site all of 
which can impair complex formation, these mutations can also lead to changes in the 
structure of loop 5.  It would therefore be beneficial to study the effects of the loop 5 
residue mutations on the structure by alternative techniques such as molecular 
mechanics or computational analysis, X-ray crystallography, NMR or CD spectroscopy 
which can shed further light on the role of these residues.  While Cu(I)-binding for the 
ScAtx1 His61Tyr mutant has been studied by Badarau et al. (2010) and was found to 
be similar to WT ScAtx1, similar experiments need to be carried out for the other loop 5 
mutant proteins to deduce if the effects of these mutations seen on complex formation 
may be due to reduced Cu(I)-binding, as discussed further in section 5.3. 
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All of the above discussed mutations decrease the interaction of ScAtx1 with CtaAN 
more than the ScAtx1/PacSN interaction, suggesting that changes in the residues 
surrounding the CXXC motif are more important for ScAtx1/CtaAN complex formation 
than the ScAtx1/PacSN complex.  This was initially thought to reflect potentially different 
structural arrangements of the ScAtx1/PacSN and ScAtx1/CtaAN complexes.  A 
modelled complex of ScAtx1-PacSN demonstrates that these proteins may interact via a 
side-to-side arrangement (Banci et al., 2006c).  Since the crystal structures obtained for 
the ScAtx1 dimers demonstrate two different structural arrangements (head-to-head 
and side-to-side, see section 1.2.2.4), the authors suggested that the head-to-head 
dimer may reflect the arrangement of the ScAtx1-CtaAN complex (Badarau et al., 2010).  
The inter-subunit contact area in the head-to-head arrangement of 2 Cu(I) per ScAtx1 
dimer was found to be ~230 Å2 per monomer (Badarau et al., 2010) and is mainly 
localised to the metal-binding region of ScAtx1 (Figure 6a). Whereas, the 4 Cu(I) per 
ScAtx1 side-to-side dimer, the intersubunit contact area is much larger (~440 Å2 per 
monomer) and includes not only the metal-binding region but also areas distal from the 
MBS (Badarau et al., 2010), as evident from Figure 6c.  Therefore, any mutations that 
can affect the MBS can disrupt the formation of both the side-to-side and head-to-head 
complexes; although mutations in the metal-binding region would be expected to disrupt 
the ScAtx1/CtaAN interaction more than the ScAtx1/PacSN interaction if the former 
interacts via the formation of a head-to-head complex.  Therefore, in order to 
investigate if ScAtx1 forms structurally different complexes with its partner proteins, 
three surface residues were selected in ScAtx1 - Lys21, Asn25 and Ser58 which were 
estimated to be sufficiently distal from the MBS to not affect Cu(I)-binding in ScAtx1.  
Although Cu(I)-binding studies would be beneficial as a control to conclusively 
determine that the mutation of these three residues does not impair Cu(I)-binding.  
ScAtx1 Lys21 residue was reported to be involved in mediating 
electrostatic interactions with PacS95 in the modelled complex with ScAtx1 (Banci et 
al., 2006c).  As discussed previously in sections 2.7 and 3.3.5, a ScAtx1/PacSN model 
was created by superimposing a monomer of PacSN on the ScAtx1 4 Cu(I)-bound side-
to-side dimer.  The ScAtx1/PacSN model shown in Appendix B is presented again in 
Figure 94a to assist in comparison with the ScAtx1/CtaAN model (Figure 94b).  In the 
ScAtx1/PacSN model, the side chain of the ScAtx1 Lys21 residue is located close to the 
side chain of Glu61 in PacSN.  ScAtx1 Lys21 was therefore mutated to Asp in an 
attempt to cause electrostatic repulsion with PacSN Glu61 which would further indicate 
that ScAtx1 and PacSN form a side-to-side complex.  In contrast, the ScAtx1 Lys21Asp 
mutant was expected to interact similar to WT ScAtx1 with CtaAN based on the 
hypothesis that ScAtx1/CtaAN may form a head-to-head complex.  While the lack of an 
interaction between ScAtx1 Lys21Asp and PacSN supports the above-mentioned 
hypothesis, the decrease in interaction observed with CtaAN (Table 8a) suggests that it 
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may also form a side-to-side complex.  The residue corresponding to PacSN Glu61 is 
Ser (Ser83) in CtaAN.  While Ser can not form an electrostatic interaction with Lys21, it 
may interact via hydrogen bonding.  The presence of a potential hydrogen bond 
acceptor (Asp) in place of a potential hydrogen bond donor (Lys) in ScAtx1 Lys21Asp 
can disrupt hydrogen-bonding interactions with Ser83 of CtaAN, accounting for the 
decrease in interaction with CtaAN.   
Another residue located close to the interaction surface in the 
ScAtx1/PacSN and ScAtx1/CtaAN complexes is Asn25 of ScAtx1.  The side chain of 
ScAtx1 Asn25 can potentially interact with Glu61 and Ser83 of PacSN and CtaAN.  
ScAtx1 Asn25 has also been implicated in mediating hydrogen-bonding interactions 
between the monomers in the ScAtx1-PacS95 modelled complex (Banci et al., 2006c) 
and in the ScAtx1 4 Cu(I)-bound side-to-side dimer which may be important for the 
stabilisation of the complex (Badarau et al., 2010).  This residue was substituted with 
Arg with the aim to disrupt potential hydrogen-bonding interactions in the side-to-side 
complex due to the increase in bulk at this position.  Surprisingly, the ScAtx1 Asn25Arg 
mutation decreases the interaction with CtaAN, but does not have a significant effect on 
the interaction with PacSN (Table 8a).  While the bulkiness of Arg in place of Asn25 in 
ScAtx1 disrupts the complex formation with both PacSN and CtaAN, in the 
ScAtx1/PacSN complex this effect may be compensated by favourable electrostatic 
interactions between the basic side chain of Arg25 in ScAtx1 and the acidic side chain 
of PacSN Glu61.  The residue analogous to Glu61 of PacSN is Ser83 in CtaAN (Figure 
70) which will not form a favourable electrostatic interaction with the side chain of 
Arg25.  In the ScAtx1/CtaAN complex, presence of the long side chain of Arg25 in 
ScAtx1 can instead interfere with the side chains of some of the residues in the second 
α-helix of CtaAN, accounting for the decrease in interaction observed for ScAtx1 
Asn25Arg with CtaAN.   
The third residue chosen to investigate the potentially different structural 
complexes of ScAtx1 with its binding partners was Ser58.  Ser58 was implicated in 
forming key hydrogen-bonding interactions with the PacSN monomer in the model of 
this complex (Banci et al., 2006c).  In the ScAtx1-PacSN modelled complex, the side 
chain of Ser58 is proposed to form a hydrogen-bonding interaction with the side chain 
of Lys27 of PacSN (Banci et al., 2006c).  This is also represented by the models shown 
in Figure 95a.  In addition, the backbone carbonyl of Ser58 was proposed to interact 
with the side chains of Arg23 and Arg62 of PacSN (Banci et al., 2006c).  In CtaAN, the 
residues in the analogous position to Arg23, Lys27 and Arg62 of PacSN are Arg44, 
Gln48 and Gln84 respectively, as shown in Figure 95b.  ScAtx1 Ser58 was therefore 
mutated to the non-hydrogen-bonding Ala residue in an attempt to destabilise complex 
formation.  The ScAtx1 Ser58Ala mutation had an equally disruptive effect on the 
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interactions with both PacSN and CtaAN suggesting that both of these complexes form 
via a side-to-side arrangement.  
In the absence of structural information regarding the ScAtx1/CtaAN 
complex, in particular, the results obtained in this study contribute vitally to furthering 
the understanding of the complex formation of ScAtx1 with the target MBDs.  However, 
it must be emphasised that the data analyses in this study is based on theoretical 
models of the complexes created by superimposition of PacSN and CtaAN molecules on 
the ScAtx1 homodimer.  In addition, these models do not include any bound Cu(I) ions 
and therefore present an incomplete picture of the complexes.  Cu(I)-binding is known 
to cause changes in the loop regions of ScAtx1 in particular (Banci et al., 2004a; Banci 
et al., 2006c), which may alter protein-protein interactions at the interface.  Structural 
evidence for the complex formation of ScAtx1 with its binding partners is therefore 
required to confirm the results obtained in this study, as discussed further in Section 
5.3.  The data obtained in this study indicate that both ScAtx1/PacSN and ScAtx1/CtaAN 
can form a side-to-side complex when they interact.  However, the Lys21Asp mutation 
in ScAtx1 was the only change that completely abolished the interaction of ScAtx1 with 
either of the partner proteins, whereas all of the other mutations either had no effect or 
only decreased the interactions.  Perhaps in order to abolish complex formation, the 
interacting residues have to be mutated in both of the proteins.  For example, as 
discussed above, disruption in complex formation due to the Asn25Arg mutation in 
ScAtx1 has been proposed to be compensated for by an interaction with the Glu61 
residue in PacSN.  To test this theory further, PacSN Glu61 can be mutated to Gln which 
is sterically similar to Glu and will remove the charge in this position and therefore 
disrupt potential electrostatic interactions, as discussed further in Section 5.3.  There is 
also a possibility that both ScAtx1/PacSN and ScAtx1/CtaAN may form a mixture of side-
to-side and head-to-head complexes.  If this is the case, then the interactions with 
MBDs detected by yeast two-hybrid as a consequence of the mutations in Lys21, 
Asn25 and Ser58 in ScAtx1 may represent the formation of a head-to-head complex 
which may be weaker than the side-to-side complex.  Therefore, the possibility that 
ScAtx1/PacSN and ScAtx1/CtaAN can form head-to-head complexes as well as side-to-
side complexes can not be excluded.   
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Figure 94: Models of possible complexes of ScAtx1 with PacSN and CtaAN 
showing the interactions of ScAtx1 Lys21 and Asn25.  Models of complex formation of 
ScAtx1 (shown in yellow) (PDB accession code: 2xmk) with PacSN (PDB accession code: 2xmw) 
shown in green (A) or CtaAN shown in grey (B) (Badarau et al., 2010).  The side chains of PacSN 
Glu61 (red), ScAtx1 Lys21 (purple), ScAtx1 Asn25 (blue) and CtaAN Ser83 (orange) are shown 
as sticks.  Neither Cu(I) nor the chloride ions bound in the original structures are shown.   
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Figure 95: Models of possible complexes of ScAtx1 with PacSN and CtaAN 
showing the interactions of ScAtx1 Ser58.  Models of complex formation of ScAtx1 
(shown in yellow) (PDB accession code: 2xmk) with PacSN (PDB accession code: 2xmw) shown 
in green (A) or CtaAN shown in grey (B) (Badarau et al., 2010).  The side chains of PacSN Lys27 
(purple), PacSN Arg23 (orange), PacSN Arg62 (grey), ScAtx1 Ser58 (blue), CtaAN Arg44 (brown), 
CtaAN Gln48 (green) and CtaAN Gln84 (red) are shown as sticks.  Neither Cu(I) nor the chloride 
ions bound in the original structures are shown.   
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5. Future Work 
As discussed in Chapter 4, the results obtained in this study are analysed based on the 
presumption that the changes in protein-protein interactions observed in this study are 
as a consequence of the introduced protein mutations or altered copper conditions 
(when analysed in the presence of CuSO4 or BCS).  However, it is possible that the 
observed changes may be due to an indirect effect of impaired respiration, redox 
imbalance or disrupted iron homeostasis.  In order to confirm that these pathways were 
not significantly affected in the co-transformants analysed in this study, it is vital to 
perform some control experiments.  For instance, cytochrome c oxidase activity assays 
can be carried out on all co-tranfsormants to investigate if the introduced mutations or 
altered copper conditions have a significant effect on respiration.  Similarly Sod1 activity 
assays can be performed to ensure that the cotransformed proteins or the presence of 
CuSO4 and BCS are not disrupting its activity.  In order to determine the effects of 
protein mutations, CuSO4 or BCS on iron homeostasis, S1 nuclease assays can be 
carried out to analyse the transcriptional levels of FRE1 or FET3.  However, the 
transcription of FRE1 and FET3 are affected by both copper and iron levels sensed by 
Mac1 and the iron-responsive transcription factor Aft1 (Georgatsou et al., 1997; Labbe 
et al., 1997; Yamaguchi-Iwai et al., 1995; Yamaguchi-Iwai et al., 1996).  Hence, it is 
quite possible that the transcriptional levels of FRE1 and FET3 may be altered in the 
presence of CuSO4 and BCS.  It would therefore be useful to study protein-protein 
interactions in the presence of FeCl3 or an iron chelator to investigate the effects of 
altered iron concentration on them. 
5.1 Interaction of hCCS with hBACE1 CTD 
This study demonstrates that hCCS and hBACE1 CTD may form a Cu(I)-bridged 
complex.  The interaction of hCCS with hBACE1 CTD requires the Cys residues in the 
CXXC motifs of both molecules.  To provide further support for the Cu(I)-dependent 
interaction between hCCS and hBACE1 CTD, the complex formation can be studied in 
vitro using NMR or CD spectroscopy.  This study also suggests that hBACE1 CTD may 
accept Cu(I) from Cu(I)-loaded hCCS.  In vitro experiments using Cu(I) chelators such 
as BCS can be performed in an anaerobic chamber to determine the precise Cu(I)-
affinity of hBACE1 CTD and compare them to the Cu(I)-binding affinity of hCCSD1.  
These experiments can also be used to investigate if Cu(I) is transferred from hCCS to 
hBACE1 CTD of vice versa.  Cu(I) transfer can also be studied in vivo in S. cerevisae 
similar to the method used previously for studying the transfer of Cu(I) from Cox17 to 
Sco1 (Horng et al., 2004).  Similar to Sco1 and Cox17, hBACE1 CTD and hCCS can 
also be cloned in a yeast episomal expression vector under an inducible promoter.  The 
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proteins can be purified and the Cu(I) content can be analysed by ICP-MS allowing for 
comparisons between the Cu(I)-loaded state of each protein in single and double 
transformants.  This experiment would also provide the added advantage of studying 
these proteins in the cytoplasm which is where they are typically located instead of the 
yeast nucleus (the site of yeast two-hybrid interaction). 
The data presented in this study also highlight several residues in 
hBACE1 CTD that may be important for the arrangement of the CXXC motif in hBACE1 
CTD.  Additional mutations to some of these residues can however provide further 
evidence to demonstrate the role of these residues in complex formation with hCCS 
and HAH1.  For example, hBACE1 CTD Trp480 residue can be mutated to Phe and Tyr 
which are both hydrophobic and most similar in size to Trp than any of the other 
naturally produced amino acids, and would therefore be expected to have a milder 
effect on protein-protein interactions compared to the Trp480Met mutant created in this 
study.  Trp480 can also be mutated to Ala to create a drastic mutation where both 
residues are hydrophobic but very different in size, this mutation would be expected to 
abolish the interaction with hCCS and HAH1 if Trp480 plays a major role in the 
arrangement of the CXXC motif for Cu(I)-binding.  The Arg484 and 487 residues in 
hBACE1 CTD can be mutated to Lys or the acidic residues Glu or Asp to determine if 
the presence of charge in this position can have any effect on complex formation.  The 
above discussed in vitro and in vivo experiments can provide further information 
regarding the effects of these mutations on the Cu(I)-binding affinity of hBACE1 CTD.  
In addition, it would also be useful to investigate the folding or the structure of hBACE1 
CTD in both its apo- and Cu(I)-loaded form, which can again be studied by either CD or 
NMR spectroscopy. 
The role of hCCS Arg71 residue in mediating complex formation with 
hBACE1 CTD is not clear.  To understand its role further, the mutants created in this 
study should be studied using UV-Vis spectroscopy by conducting competition assays 
between BCS and the purified mutant proteins in an anaerobic chamber to determine 
the Cu(I)-binding affinities of these mutant proteins and compare this with WT hCCS.  
This would indicate if the mutation of Arg71 can affect Cu(I)-binding in hCCS.  These 
mutants can also be studied by CD spectroscopy to determine if the mutations have a 
significant effect on protein folding.  This study also suggests that hBACE1 CTD may 
interact more strongly with the dimeric form of hCCS rather than an hCCS monomer in 
the yeast two-hybrid system.  This hypothesis can be tested by mutating Phe133 and 
Gly134 to Glu in domain 2 of hCCS which has previously been shown to disrupt 
complex formation with Sod1 (Schmidt et al., 2000).   
CCS deficiency has been shown to result in increased amyloidogenic 
processing of APP by BACE1 leading to enhanced Aβ-production in vivo (Gray et al., 
2010), although the reasons underlying this are currently not known.  This study 
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indicates that the interaction of hCCS with hBACE1 CTD decreases in copper-deficient 
conditions.  On the basis of these results, it would be useful to investigate if the effects 
on the amyloidogenic processing of APP by BACE1 can be ameliorated by increasing 
the concentration of copper in these cells.  In addition, the role of copper concentration 
on hBACE1 should be studied in the context of localisation and trafficking of hBACE1 in 
vivo. 
 
5.2 Interaction of hSOD1 with hCCS 
The data obtained in this study indicate that the yeast two-hybrid interaction of hSOD1 
with hCCS increases in copper-deficient conditions.  However, these experiments were 
carried out in the SAY1 strain which lacks CCS1 to prevent interference by the 
interaction of hCCS with endogenous Ccs1.  There is evidence to indicate that the 
transcription of CTR1 may be compromised in the absence of CCS1 (Wood and Thiele, 
2009).  The authors demonstrated that the activity of Mac1 (which regulates the 
transcription of CTR1) requires the presence of functional Sod1 in S. cerevisiae.  Since 
hCCS can interact with Sod1 in S. cerevisiae (Schmidt et al., 2000) it is possible that 
Sod1 activity and CTR1 transcription may be rescued in the SAY1 strain used in this 
study.  This hypothesis can be tested by assaying for the transcription of CTR1 in the 
hSOD1/hCCS co-transformants (from the SAY1 strain) using the S1 nuclease 
experiments.  This study also shows that the Cu(I)-binding Cys residues in hCCSD1 
and hCCSD3 are not involved in the interaction of hSOD1 with hCCS.  However, these 
residues may play a more important role under conditions of copper-deficiency.  
Provided the transcription of CTR1 is not impaired in the SAY1 strain, yeast two-hybrid 
experiments can be designed to investigate this hypothesis. 
  If the expression of CTR1 is compromised in the SAY1 strain then 
additional measures would have to be employed to study the interaction of hSOD1 with 
hCCS in yeast.  By introducing mutations in the nuclear localisaton signal for CCS1 and 
SOD1, the presence of Ccs1 and Sod1 in the nucleus can be prevented.  However, this 
would likely result in disrupted Mac1 activity.  One possible way to overcome this issue 
could be by replacing SOD1 with the gene coding for C. elegans SOD1.  It has been 
shown that C. elegans SOD1 can be activated by a CCS-independent pathway (Jensen 
and Culotta, 2005) and can also restore Mac1 activity in S. cerevisiae cells lacking 
CCS1 and SOD1 (Wood and Thiele, 2009).  Whether hCCS or hSOD1 can form a 
complex with C. elegans SOD1 would also need to be tested prior to manipulating the 
strain used for yeast two-hybrid analysis. 
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5.3 Interaction of ScAtx1 with PacSN and CtaAN 
The key residues in the loop 5 of the ferredoxin-like fold of ScAtx1 (His61), PacSN 
(Tyr65) and CtaAN (Phe87) have been shown to be important for the interaction of 
ScAtx1 with PacSN and CtaAN in this study.  However, the precise role of these residues 
in mediating the protein-protein interactions is not very clear.  Additional experiments 
are therefore required to elucidate this further.  Mutation of analogous residues has 
been studied in BsCopZ (Rodriguez-Granillo and Wittung-Stafshede, 2009b) and HAH1 
(Rodriguez-Granillo and Wittung-Stafshede, 2009a) using computational analysis.  
Similar experiments can also be performed with the ScAtx1, PacSN and CtaAN loop 5 
mutants to study their effects on protein folding.  Additional information about these 
mutations on both the protein itself and the complex formation with its partner protein 
can be gained by studying these proteins by NMR or CD spectroscopy and X-ray 
crystallography.   The effects of these mutations on the Cu(I)-binding affinity of these 
proteins should also be investigated.  In addition, the role of these residues in Cu(I) 
transfer and the kinetics of Cu(I)-binding and transfer between ScAtx1 and PacSN or 
CtaAN should also be investigated. 
The residues surrounding the metal-binding region in these proteins 
were also shown to be important for complex formation.  Due to the proximity of these 
residues to the Cu(I)-binding site, it would be useful to determine if these amino acids 
can also affect the Cu(I)-binding or Cu(I)-transfer between ScAtx1 and its target MBDs.  
The role of some of these residues can be deciphered further by studying additional 
mutants.  For example, studying the interaction of ScAtx1 Glu13Lys and ScAtx1 
Glu13Ala with PacSN Arg13Glu or CtaAN Lys34Glu will indicate if the complex formation 
can tolerate the swapping of charges in these positions.  This study also indicates that 
ScAtx1 can likely form a side-to-side complex with CtaAN, similar to PacSN.  Due to time 
constraints, this study concentrated on mutating some of the residues on the interacting 
surface of ScAtx1 only to determine the effects on complex formation with its MBDs.  To 
understand the role of Lys21, Asn25 and Ser58 in ScAtx1 further, complimentary 
mutations should also be made in PacSN and CtaAN.  These would include mutating the 
Glu61 residue in PacSN to Gln (to remove the charge in this position but retain 
hydrogen-bonding ability), Lys (to reverse the charge in this position) or Ala (to remove 
both the charge and the hydrogen-bonding ability at this position); mutating Ser83 in 
CtaAN to Ala to disrupt hydrogen-bonding interactions with ScAtx1.  As discussed in 
section 4.3, Arg23 and Arg62 in PacSN have also been implicated in mediating 
hydrogen-bonding and electrostatic interactions with ScAtx1 residues, to investigate this 
further these residues can be mutated to either an acidic or a neutral residue and study 
their effects by yeast two-hybrid analysis.  Analogous mutations can also be made in 
CtaAN to provide similar information.  While a HADDOCK model is available for the 
ScAtx1-PacS95 complex (Banci et al., 2006c), there is no structure available for the 
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ScAtx1-CtaAN complex.  However, the modelled complex of ScAtx1-PacS95 is not 
available publically and since it is a model and not a crystal structure, it is essential to 
study the complex formation of ScAtx1 with PacSN and CtaAN using NMR spectroscopy 
or X-ray crystallography to provide detailed structural information regarding their 
interaction.   
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Figure 96: Crystal structures of the ScAtx1 dimers depicting the position of 
Lys21, Asn25 and Ser58.  The crystal structures of the ScAtx1 head-to-head (PDB 
accession code: 2xmt) and side-to-side (PDB accession code: 2xmk) dimers are shown in (A) 
and (B) respectively (Badarau et al., 2010).  Each subunit in the dimer is represented in brown or 
yellow.  The Cu(I) ions are shown as blue spheres while the chloride ions in (B) are shown as 
orange spheres.  The side-chains of Lys21 (green), Asn25 (blue) and Ser58 (purple) are shown 
as sticks in the right-hand side subunit of the dimers.   
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Figure 97: Model of the ScAtx1 and PacSN complex.  In the above model, the 
ScAtx1 subunit (PDB accession code: 2xmk) is shown in yellow and the PacSN subunit (PDB 
accession code: 2xmw) is shown in green (Badarau et al., 2010).  The side-chains of PacSN 
Glu61 (red), ScAtx1 Lys21 (purple), and ScAtx1 Asn25 (blue) are shown as sticks.  Neither the 
bound Cu(I) ions nor the chloride ions present in the original ScAtx1 homodimer are shown.   
